var title_f30_17_30992="Trichorrhexis invaginata";
var content_f30_17_30992=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87483&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87483&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Trichorrhexis invaginata",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 433px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Trichorrhexis invaginata is a ball and socket-like deformity of the hair shaft that is seen in patients with Netherton syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_17_30992=[""].join("\n");
var outline_f30_17_30992=null;
var title_f30_17_30993="Gluteal muscle tear MRI";
var content_f30_17_30993=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F68007&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F68007&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Muscle tear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 291px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    T2-weighted axial image of the pelvis shows a large hematoma of the left gluteus muscle from muscle tear.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Shahla Modarresi, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_17_30993=[""].join("\n");
var outline_f30_17_30993=null;
var title_f30_17_30994="Intestinal lesions celiac";
var content_f30_17_30994=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F60343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F60343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Intestinal lesions in celiac disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 200px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the five main lesions associated with gluten sensitivity. The lesions range in histologic severity from a mild alteration characterized by increased intraepithelial lymphocytes (type 0 lesion) to a flat mucosa with total mucosal atrophy, complete loss of villi, enhanced epithelial apoptosis and crypt hyperplasia (type 3 lesion). The type 4 lesion is seen in T cell lymphoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992; 102:330.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_17_30994=[""].join("\n");
var outline_f30_17_30994=null;
var title_f30_17_30995="Argatroban: Patient drug information";
var content_f30_17_30995=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Argatroban: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/57/20375?source=see_link\">",
"     see \"Argatroban: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?14/13/14551?source=see_link\">",
"     see \"Argatroban: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10014348\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to thin the blood so that clots will not form.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691311",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used in patients who had low platelet counts while on heparin.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10014347\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701543",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to argatroban or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703718",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have bleeding problems.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10014352\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697249",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had spinal anesthesia, surgery, or any spinal care, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10014353\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bleeding problems.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10014355\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698653",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fall or crash when you hit your head. Talk with your doctor even if you feel fine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10014350\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10014356\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10014357\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10966 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.243-684EC2BD62-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_17_30995=[""].join("\n");
var outline_f30_17_30995=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014348\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014347\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014352\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014353\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014355\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014350\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014356\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014357\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?19/57/20375?source=related_link\">",
"      Argatroban: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?14/13/14551?source=related_link\">",
"      Argatroban: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_17_30996="Aminocaproic acid: Patient drug information";
var content_f30_17_30996=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Aminocaproic acid: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/38/30311?source=see_link\">",
"     see \"Aminocaproic acid: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?14/32/14854?source=see_link\">",
"     see \"Aminocaproic acid: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F133225\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Amicar&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10022868\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10022870\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691426",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop and treat bleeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10022869\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701492",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to aminocaproic acid or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703723",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have blood clots.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10022874\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10022875\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nose stuffiness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698296",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Pain and irritation where this drug goes into the body.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698333",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Short-term pain after use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10022877\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10022872\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694356",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (syrup) if you cannot swallow pills.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10022873\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10022878\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699155",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not freeze liquid.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10022879\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11582 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-0C172D990F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_17_30996=[""].join("\n");
var outline_f30_17_30996=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F133225\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022868\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022870\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022869\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022874\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022875\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022877\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022872\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022873\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022878\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10022879\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?29/38/30311?source=related_link\">",
"      Aminocaproic acid: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?14/32/14854?source=related_link\">",
"      Aminocaproic acid: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_17_30997="Sharp curettage";
var content_f30_17_30997=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F56727&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F56727&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 563px\">",
"   <div class=\"ttl\">",
"    Sharp curette inserted into uterine cavity",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 543px; height: 358px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_17_30997=[""].join("\n");
var outline_f30_17_30997=null;
var title_f30_17_30998="Selective IgA deficiency: Management and prognosis";
var content_f30_17_30998=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Selective IgA deficiency: Management and prognosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/17/30998/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/17/30998/contributors\">",
"     Robert Hostoffer, DO, FACOP, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/17/30998/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/17/30998/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/17/30998/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/17/30998/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/17/30998/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION AND DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Selective IgA deficiency (sIgAD) (MIM 137100) is defined as the isolated deficiency of serum IgA (ie, serum levels of IgG and IgM are normal) in a patient older than four years of age, in whom other causes of hypogammaglobulinemia have been excluded. It is the most common primary antibody defect in humans.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Severe IgA deficiency refers to serum levels below 7",
"      <span class=\"nowrap\">",
"       mg/dL,",
"      </span>",
"      which is the lower limit of detection for most assays.",
"     </li>",
"     <li>",
"      Partial IgA deficiency refers to serum levels above 7",
"      <span class=\"nowrap\">",
"       mg/dL,",
"      </span>",
"      but below the lower limit of normal (ie, lower than 2 standard deviations below the age-adjusted mean).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinical manifestations of IgA deficiency vary, ranging from an asymptomatic laboratory finding to recurrent infections and autoimmune disease. This topic reviews the management and prognosis of patients with sIgAD. The clinical features, pathophysiology, and diagnosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/63/24570?source=see_link\">",
"     \"Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24165524\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;All individuals with sIgAD should be informed about the associated conditions, but also reassured that the majority of people with this laboratory finding are healthy and live normal lives.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24166694\">",
"    <span class=\"h2\">",
"     Vaccinations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Local live virus vaccine, such as intranasal influenza vaccine and live",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/50/42789?source=see_link\">",
"     rotavirus vaccine",
"    </a>",
"    , should not be given to patients with IgA deficiency until their immune status is fully evaluated, because the patient may have other underlying immune defects that preclude the use of these vaccines (eg, ataxia telangiectasia). Other vaccines, such as those against pneumococcus, are specifically recommended (",
"    <a class=\"graphic graphic_table graphicRef55584 \" href=\"mobipreview.htm?35/6/35949\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Symptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptomatic patients with sIgAD are managed according to the disorder present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Sinopulmonary infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common clinical manifestation of symptomatic sIgAD is recurrent sinopulmonary infections, which may impact the patient&rsquo;s full participation in life (school, job, social functioning). Patients may benefit from several interventions to prevent or reduce the frequency of these illnesses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h4\">",
"     Treat concomitant disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;The finding of sIgAD in a patient with recurrent infections does not exclude other causes of sinopulmonary infections. Patients with sIgAD may also have chronic rhinosinusitis, allergic",
"    <span class=\"nowrap\">",
"     rhinitis/asthma,",
"    </span>",
"    or chronic nonallergic rhinitis. In theory, these other conditions could be more important causes of recurrent infection. Therefore, identification and treatment of other concomitant conditions is an important initial intervention. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/61/12250?source=see_link\">",
"     \"Chronic nonallergic rhinitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/37/8794?source=see_link\">",
"     \"An overview of asthma management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h4\">",
"     Prophylactic antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with continued infections despite management of underlying conditions, a six month course of daily prophylactic antibiotics can be instituted. Maintenance prophylactic antibiotic may be continued if the initial course is successful. It may also be possible to administer these antibiotics only during the winter, depending upon the patient's historic pattern of infections. The use of prophylactic antibiotics in immunodeficiency disorders is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/27/8633?source=see_link&amp;anchor=H18#H18\">",
"     \"Medical management of immune deficiency\", section on 'Prophylactic antibiotics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h4\">",
"     Immune globulin",
"    </span>",
"    &nbsp;&mdash;&nbsp;A trial of immune globulin replacement therapy may be warranted in patients with recurrent infections if prophylactic antibiotics fail to diminish the number of infections. In our experience, only a minority of patients with sIgAD require immune globulin to control infections. This therapy does not replete IgA in the serum or secretions, but rather provides pathogen-specific IgG pooled from the general adult population.",
"   </p>",
"   <p>",
"    Immune globulin replacement may be administered intravenously (",
"    <a class=\"graphic graphic_table graphicRef68573 \" href=\"mobipreview.htm?0/29/478\">",
"     table 2",
"    </a>",
"    ) or subcutaneously (",
"    <a class=\"graphic graphic_table graphicRef59390 \" href=\"mobipreview.htm?41/59/42940\">",
"     table 3",
"    </a>",
"    ). A potential complication of intravenous therapy in patients with anti-IgA antibodies is anaphylaxis and infusion reactions resembling anaphylaxis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30998/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. To reduce the risk, intravenous preparations with the lowest content of IgA should be utilized whenever possible (",
"    <a class=\"graphic graphic_table graphicRef68573 \" href=\"mobipreview.htm?0/29/478\">",
"     table 2",
"    </a>",
"    ). The use of immune globulin in patients with immunodeficiency is reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/32/38409?source=see_link&amp;anchor=H10#H10\">",
"     \"Intravenous immune globulin: Adverse effects\", section on 'Anaphylaxis in IgA deficient patients'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/9/31896?source=see_link\">",
"     \"Subcutaneous and intramuscular immune globulin therapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/11/28857?source=see_link\">",
"     \"General principles in the use of immune globulin\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18735965\">",
"    <span class=\"h3\">",
"     Giardia infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Private wells, public sources, and bottled water may be contaminated with Giardia lamblia. Measures to reduce exposure through drinking water are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/17/6424?source=see_link&amp;anchor=H17#H17\">",
"     \"Treatment and prevention of giardiasis\", section on 'Prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1732469\">",
"    <span class=\"h3\">",
"     Autoimmune disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of patients with sIgAD and autoimmune disease is dictated by the autoimmune disorder present. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/38/41578?source=see_link\">",
"     \"Overview of the therapy and prognosis of systemic lupus erythematosus in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/11/39098?source=see_link\">",
"     \"General principles of management of rheumatoid arthritis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/9/5274?source=see_link\">",
"     \"Systemic onset juvenile idiopathic arthritis: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10738974\">",
"    <span class=\"h3\">",
"     Malignancies",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no data to suggest that sIgAD, even severe, is associated with a substantially increased risk of malignancy. Although the absence of data does not prove that there is no increased risk, additional cancer screening beyond that recommended for the healthy population does not appear to be indicated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30998/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24166115\">",
"    <span class=\"h3\">",
"     Screening for anti-IgA antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who are",
"    <strong>",
"     severely",
"    </strong>",
"    IgA deficient may form antibodies directed against IgA. In studies of blood donors, anti-IgA antibodies where detected in severely IgA deficient patients at a frequency of approximately 1 in 1200 to 1600 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30998/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Anti-IgA antibodies are generally not found in patients with partial IgA deficiency or in patients who have a global antibody deficiency eg, X linked agammaglobulinemia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/63/24570?source=see_link&amp;anchor=H23#H23\">",
"     \"Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis\", section on 'Anaphylactic reactions to blood products'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Anti-IgA antibodies have been identified in severely IgA deficient patients who experienced infusion reactions to blood products containing small amounts of IgA, typically in plasma, including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Whole blood",
"     </li>",
"     <li>",
"      Red blood cells",
"     </li>",
"     <li>",
"      Platelets",
"     </li>",
"     <li>",
"      Fresh frozen plasma",
"     </li>",
"     <li>",
"      Cryoprecipitate",
"     </li>",
"     <li>",
"      Granulocytes",
"     </li>",
"     <li>",
"      Intravenous gammaglobulin (although immune globulin contains very low amounts of IgA compared to other products above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although anti-IgA antibodies have been implicated as the cause of these infusion reactions, this mechanism has not been proven. Indirect evidence in support of the role of anti-IgA antibodies includes the finding that these antibodies are more prevalent in patients with sIgAD who experience anaphylaxis compared with those who do not (76 compared to 22 percent in one study of approximately 200 patients) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30998/abstract/10\">",
"     10",
"    </a>",
"    ]. In addition, it is not clear which isotype, IgG or IgE, is responsible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30998/abstract/6,11,12\">",
"     6,11,12",
"    </a>",
"    ]. Despite these uncertainties, the diagnosis of IgA-related anaphylaxis is usually made if a patient who experiences infusion-related anaphylaxis has undetectable serum IgA, and anti-IgA antibodies can be detected.",
"   </p>",
"   <p>",
"    In the past, assays for anti-IgA antibodies were time consuming and largely limited to research or blood bank laboratories [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30998/abstract/13\">",
"     13",
"    </a>",
"    ]. However, a commercial assay has become available that detects IgG against IgA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30998/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. There is no commercial test for IgE anti-IgA, but testing for the IgG isotype assumes that a patient with this antibody might also be capable of producing IgE against IgA as a result of downstream isotype switching.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24166158\">",
"    <span class=\"h4\">",
"     Indication for screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Screening for anti-IgA antibodies allows clinicians to identify patients at risk for infusion reactions and help these patients become informed about the potential risks of receiving blood products. We suggest screening for anti-IgA antibodies in all patients with severe IgA deficiency and for patients with partial IgA deficiency who have received blood products in the past and experienced an infusion reaction.",
"   </p>",
"   <p>",
"    In patients who have anti-IgA antibodies, we suggest repeat testing before each administration of plasma-containing blood products (except immune globulin).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24166165\">",
"    <span class=\"h4\">",
"     Preparation for future treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with severe sIgAD, either with or without positive screening tests for anti-IgA antibodies (as patients with negative screens can become sensitized over time), can obtain a medical alert",
"    <span class=\"nowrap\">",
"     bracelet/necklace",
"    </span>",
"    inscribed with the following information:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient has selective IgA deficiency",
"     </li>",
"     <li>",
"      The patient is at risk for an allergic reaction to any injected plasma-containing blood products and testing for anti-IgA antibodies should be performed before such blood products are administered",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24166172\">",
"    <span class=\"h4\">",
"     Safe administration of blood products",
"    </span>",
"    &nbsp;&mdash;&nbsp;All blood products should be used with caution in IgA deficient patients, and appropriate staff and medication should be available to treat anaphylaxis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30998/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who have already experienced an infusion reaction to plasma-containing blood products should be tested for anti-IgA antibodies prior to receiving any additional blood products. If positive, a strategy should be devised for safe administration of future blood products. The approach will differ depending upon the blood product needed. Consultation with a transfusion medicine specialist should be considered. Examples include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients who require transfusions of red blood cells can receive cells that have been washed to remove as much of the contaminating IgA as possible [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/17/30998/abstract/13,14,17\">",
"       13,14,17",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/31/11769?source=see_link\">",
"       \"Immunologic blood transfusion reactions\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients who require immune globulin therapy can receive products that are low in IgA content or receive the therapy subcutaneously. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/9/31896?source=see_link&amp;anchor=H27#H27\">",
"       \"Subcutaneous and intramuscular immune globulin therapy\", section on 'IgA deficient patients'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Desensitization to blood products is another management approach that may be appropriate in specific circumstances. A case report described desensitization of a patient with selective IgA deficiency who experienced anaphylaxis to blood products but subsequently required numerous infusions of various blood products in the context of liver transplant. The patient was successfully desensitized to a gammaglobulin preparation, which was then administered weekly to maintain the desensitized state.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24165585\">",
"    <span class=\"h2\">",
"     Asymptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asymptomatic patients require no specific treatment beyond education. Vaccination recommendations are the same as those for the general population, although live local vaccines (eg, intranasal influenza and live rotavirus) should be avoided if the diagnosis of sIgAD is unsure. Other vaccines, such as the pneumococcal vaccine, are specifically recommended (",
"    <a class=\"graphic graphic_table graphicRef55584 \" href=\"mobipreview.htm?35/6/35949\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/56/39818?source=see_link\">",
"     \"Standard immunizations for children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/44/41670?source=see_link\">",
"     \"Approach to immunizations in healthy adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is no consensus about how asymptomatic patients should be monitored. The approach of the author and editors of UpToDate is to ask patients to return at periodic intervals to review the frequency of infections, as well as a thorough review of systems. Further studies are needed to evaluate specific symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe IgA deficiency in children usually persists, whereas partial IgA deficiency in children may resolve over time, particularly if no other primary immune disorder is present [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30998/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. This was demonstrated in a study that followed 40 children with severe IgA deficiency (defined as serum IgA concentration less than 5",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    and 40 with partial deficiency (greater than 5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    but less than 2 standard deviations from normal mean values) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30998/abstract/18\">",
"     18",
"    </a>",
"    ]. At four years after initial diagnosis, serum levels of IgA were normal in one-half of those in the partial deficiency group. In contrast, IgA levels remained low in those with severe initial deficiency.",
"   </p>",
"   <p>",
"    SIgAD can progress to common variable immunodeficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30998/abstract/21-26\">",
"     21-26",
"    </a>",
"    ]. This tended to occur in adolescence or young adulthood in the available case reports. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/63/24570?source=see_link&amp;anchor=H7#H7\">",
"     \"Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis\", section on 'Pathophysiology of IgA deficiency'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The prognosis of IgA deficiency diagnosed in adulthood is not well studied and it is not known if the condition spontaneously remits in a subset of individuals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Information for patients about sIgAD is available on-line through the Immune Deficiency Foundation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30998/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;IgA deficiency (MIM 137100) may be defined as the selective deficiency of serum IgA (ie, serum levels of IgG and IgM are normal) in a patient older than four years of age, in whom other causes of hypogammaglobulinemia have been excluded. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction and definition'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The majority of patients with IgA deficiency are asymptomatic. These patients require only education about the condition. (See",
"      <a class=\"local\" href=\"#H24165585\">",
"       'Asymptomatic patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with undetectable levels of serum IgA, and in those with past infusion reactions to plasma-containing blood products, we perform a baseline screening test for anti-IgA antibodies to better assess the patient&rsquo;s risk for future infusion reactions to blood products. If these antibodies are identified, various steps can be taken to prevent recurrent reactions, depending upon the blood product needed. (See",
"      <a class=\"local\" href=\"#H24166115\">",
"       'Screening for anti-IgA antibodies'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H24166172\">",
"       'Safe administration of blood products'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptomatic patients with selective IgA deficiency most commonly suffer from recurrent sinopulmonary infections, autoimmune disorders, gastrointestinal disorders,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      associated immune deficiencies. Anaphylactic transfusion reactions to plasma-containing blood products can occur, although these are rare. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Symptomatic patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with recurrent sinopulmonary symptoms should be thoroughly evaluated and treated for other conditions predisposing to upper respiratory tract infections (eg, allergic",
"      <span class=\"nowrap\">",
"       rhinitis/asthma,",
"      </span>",
"      chronic rhinosinusitis). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Treat concomitant disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients who continue to have sinopulmonary infections despite aggressive management of predisposing conditions (eg, allergic",
"      <span class=\"nowrap\">",
"       rhinitis/asthma,",
"      </span>",
"      chronic rhinosinusitis), we suggest a trial of prophylactic antibiotics (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Prophylactic antibiotics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with recurrent sinopulmonary infections, clearly impaired vaccine responses, and no improvement with prophylactic antibiotics, we suggest administering immune globulin replacement therapy to reduce the number and severity of infections (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). An intravenous or subcutaneous preparation that is low in IgA content is preferred. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Immune globulin'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/1\">",
"      Cunningham-Rundles C, Zhou Z, Mankarious S, Courter S. Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies. J Clin Immunol 1993; 13:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/2\">",
"      Bj&ouml;rkander J, Hammarstr&ouml;m L, Smith CI, et al. Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies. J Clin Immunol 1987; 7:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/3\">",
"      Ferreira A, Garcia Rodriguez MC, Lopez-Trascasa M, et al. Anti-IgA antibodies in selective IgA deficiency and in primary immunodeficient patients treated with gamma-globulin. Clin Immunol Immunopathol 1988; 47:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/4\">",
"      Sandler SG, Mallory D, Malamut D, Eckrich R. IgA anaphylactic transfusion reactions. Transfus Med Rev 1995; 9:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/5\">",
"      Vassallo RR. Review: IgA anaphylactic transfusion reactions. Part I. Laboratory diagnosis, incidence, and supply of IgA-deficient products. Immunohematology 2004; 20:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/6\">",
"      Horn J, Thon V, Bartonkova D, et al. Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy. Clin Immunol 2007; 122:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/7\">",
"      Buckley RH. Clinical and immunologic features of selective IgA deficiency. Birth Defects Orig Artic Ser 1975; 11:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/8\">",
"      De Laat PC, Weemaes CM, Gonera R, et al. Clinical manifestations in selective IgA deficiency in childhood. A follow-up report. Acta Paediatr Scand 1991; 80:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/9\">",
"      Palmer DS, O'Toole J, Montreuil T, et al. Screening of Canadian Blood Services donors for severe immunoglobulin A deficiency. Transfusion 2010; 50:1524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/10\">",
"      Sandler SG, Eckrich R, Malamut D, Mallory D. Hemagglutination assays for the diagnosis and prevention of IgA anaphylactic transfusion reactions. Blood 1994; 84:2031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/11\">",
"      Burks AW, Sampson HA, Buckley RH. Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. N Engl J Med 1986; 314:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/12\">",
"      Rachid R, Castells M, Cunningham-Rundles C, Bonilla FA. Association of anti-IgA antibodies with adverse reactions to &gamma;-globulin infusion. J Allergy Clin Immunol 2011; 128:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/13\">",
"      Yuan S, Goldfinger D. A readily available assay for anti-immunoglobulin A: is this what we have been waiting for? Transfusion 2008; 48:2048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/14\">",
"      Brown R, Nelson M, Aklilu E, et al. An evaluation of the DiaMed assays for immunoglobulin A antibodies (anti-IgA) and IgA deficiency. Transfusion 2008; 48:2057.",
"     </a>",
"    </li>",
"    <li>",
"     ID-PaGIA Anti-IgA antibody test: information available at  www.diamed.com (Accessed on September 13, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/16\">",
"      Chowdary P, Nair D, Davies N, et al. Anaphylactic reaction with prothrombin complex concentrate in a patient with IgA deficiency and anti-IgA antibodies. Blood Coagul Fibrinolysis 2010; 21:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/17\">",
"      Meena-Leist CE, Fleming DR, Heye M, Herzig RH. The transfusion needs of an autologous bone marrow transplant patient with IgA deficiency. Transfusion 1999; 39:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/18\">",
"      Plebani A, Ugazio AG, Monafo V, Burgio GR. Clinical heterogeneity and reversibility of selective immunoglobulin A deficiency in 80 children. Lancet 1986; 1:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/19\">",
"      Joller PW, Buehler AK, Hitzig WH. Transitory and persistent IgA deficiency. Reevaluation of 19 pediatric patients once found to be deficient in serum IGA. J Clin Lab Immunol 1981; 6:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/20\">",
"      Blum PM, Hong R, Stiehm ER. Spontaneous recovery of selective IgA deficiency. Additional case reports and a review. Clin Pediatr (Phila) 1982; 21:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/21\">",
"      Aghamohammadi A, Mohammadi J, Parvaneh N, et al. Progression of selective IgA deficiency to common variable immunodeficiency. Int Arch Allergy Immunol 2008; 147:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/22\">",
"      Espa&ntilde;ol T, Catala M, Hernandez M, et al. Development of a common variable immunodeficiency in IgA-deficient patients. Clin Immunol Immunopathol 1996; 80:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/23\">",
"      Gutierrez MG, Kirkpatrick CH. Progressive immunodeficiency in a patient with IgA deficiency. Ann Allergy Asthma Immunol 1997; 79:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/24\">",
"      Slyper AH, Pietryga D. Conversion of selective IgA deficiency to common variable immunodeficiency in an adolescent female with 18q deletion syndrome. Eur J Pediatr 1997; 156:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/25\">",
"      Litzman J, Burianova M, Thon V, Lokaj J. Progression of selective IgA deficiency to common variable immunodeficiency in a 16 year old boy. Allergol Immunopathol (Madr) 1996; 24:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30998/abstract/26\">",
"      Hostoffer RW, Bay CA, Wagner K, et al. Kabuki make-up syndrome associated with an acquired hypogammaglobulinemia and anti-IgA antibodies. Clin Pediatr (Phila) 1996; 35:273.",
"     </a>",
"    </li>",
"    <li>",
"     Information about IgA deficiency is available through the Immune Deficiency Foundation. www.primaryimmune.org/publications/book_pats/book_pats.htm.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3936 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-125.39.66.147-B9BF6B98CC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_17_30998=[""].join("\n");
var outline_f30_17_30998=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION AND DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24165524\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24166694\">",
"      Vaccinations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Symptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Sinopulmonary infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Treat concomitant disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Prophylactic antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Immune globulin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18735965\">",
"      - Giardia infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1732469\">",
"      - Autoimmune disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10738974\">",
"      - Malignancies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24166115\">",
"      - Screening for anti-IgA antibodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H24166158\">",
"      Indication for screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H24166165\">",
"      Preparation for future treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H24166172\">",
"      Safe administration of blood products",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24165585\">",
"      Asymptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/3936\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/3936|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?35/6/35949\" title=\"table 1\">",
"      Vaccination in primary immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?0/29/478\" title=\"table 2\">",
"      Immune globulins for intravenous administration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/59/42940\" title=\"table 3\">",
"      Brands Ig for SQ IM use",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/37/8794?source=related_link\">",
"      An overview of asthma management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/44/41670?source=related_link\">",
"      Approach to immunizations in healthy adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/61/12250?source=related_link\">",
"      Chronic nonallergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/11/28857?source=related_link\">",
"      General principles in the use of immune globulin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/11/39098?source=related_link\">",
"      General principles of management of rheumatoid arthritis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/31/11769?source=related_link\">",
"      Immunologic blood transfusion reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/32/38409?source=related_link\">",
"      Intravenous immune globulin: Adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/27/8633?source=related_link\">",
"      Medical management of immune deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/38/41578?source=related_link\">",
"      Overview of the therapy and prognosis of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/63/24570?source=related_link\">",
"      Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/56/39818?source=related_link\">",
"      Standard immunizations for children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/9/31896?source=related_link\">",
"      Subcutaneous and intramuscular immune globulin therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/9/5274?source=related_link\">",
"      Systemic onset juvenile idiopathic arthritis: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/17/6424?source=related_link\">",
"      Treatment and prevention of giardiasis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_17_30999="An overview of rhinitis";
var content_f30_17_30999=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   An overview of rhinitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/17/30999/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/17/30999/contributors\">",
"     Robert H Fletcher, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/17/30999/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/17/30999/contributors\">",
"     Jonathan Corren, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/17/30999/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/17/30999/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/17/30999/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION AND DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rhinitis is the presence of one or more of the following nasal symptoms:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sneezing",
"     </li>",
"     <li>",
"      Rhinorrhea (anterior",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      posterior)",
"     </li>",
"     <li>",
"      Nasal congestion (stuffiness)",
"     </li>",
"     <li>",
"      Nasal itching",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Rhinitis is common, affecting nearly everyone at one time or another. Many cases can be classified into a specific syndrome, each with its own causes and treatments (",
"    <a class=\"graphic graphic_table graphicRef75862 \" href=\"mobipreview.htm?25/47/26364\">",
"     table 1",
"    </a>",
"    ). These syndromes are recognized mainly by patterns of symptoms and, to a lesser extent, physical signs.",
"   </p>",
"   <p>",
"    This topic provides an overview of the various types of acute and chronic rhinitis that are most common among adults and children. Rhinitis caused by viral respiratory infection is usually self-evident and is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/59/19383?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and pathogenesis of rhinovirus infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/55/24440?source=see_link\">",
"     \"The common cold in adults: Diagnosis and clinical features\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rhinosinusitis is a term that encompasses disorders affecting both the nasal passages and paranasal sinuses, and has overlapping but distinct symptoms from pure rhinitis. Symptoms of sinus involvement may include nasal congestion, posterior nasal drainage (which is often purulent), facial pressure",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pain, headache, and in some cases, reduced sense of smell. Rhinosinusitis is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/48/39688?source=see_link\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/0/11273?source=see_link\">",
"     \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35370?source=see_link\">",
"     \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/15/2297?source=see_link\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6555769\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common forms of rhinitis include the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30999/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Allergic rhinitis",
"     </li>",
"     <li>",
"      Various forms of nonallergic rhinitis",
"     </li>",
"     <li>",
"      Rhinitis due to structural nasal problems",
"     </li>",
"     <li>",
"      Atrophic rhinitis",
"     </li>",
"     <li>",
"      Rhinitis of pregnancy",
"     </li>",
"     <li>",
"      Occupational rhinitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Less common causes of rhinitis include systemic diseases that can present with prominent rhinitis and rhinitis caused by nasal or systemic",
"    <span class=\"nowrap\">",
"     medications/drugs.",
"    </span>",
"   </p>",
"   <p>",
"    Uncommon conditions that can mimic rhinitis include nasal tumors and leakage of cerebral spinal fluid into the nasal cavity. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ALLERGIC RHINITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ten to 30 percent of adults, and up to 40 percent of children suffer from allergic rhinitis. The risk is increased in individuals with eczema or asthma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30999/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Allergic rhinitis can begin at any age; most affected individuals develop symptoms as children or young adults. Some combination of nasal itching, watery rhinorrhea, nasal congestion (stuffiness), and sneezing are typical. Nasal itching helps distinguish allergic rhinitis from most other forms of rhinitis. Children often manifest nasal itch with various types of nose rubbing, rather than actually complaining of itch. Approximately 40 percent of adults and children note poor sleep and over 75 percent report fatigue. Snoring due to nasal congestion is often noted by the patient&rsquo;s family members. Common comorbidities include increased frequencies of headaches, rhinosinusitis (~40 percent), and asthma (~35 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30999/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gross physical findings of chronic allergic rhinitis may include \"allergic shiners,\" which are",
"    <span class=\"nowrap\">",
"     blue/grey",
"    </span>",
"    to purple discoloration under the eyes, and a transverse nasal crease, which forms from repeatedly rubbing the nose and pushing the tip of the nose up with the hand in response to nasal itching (the &ldquo;allergic salute&rdquo;).",
"   </p>",
"   <p>",
"    Examination of the anterior nasal mucosa with an otoscope may be normal but can yield useful information. The nasal mucosa in patients with allergic rhinitis classically appears edematous and pale. In contrast, the nasal mucosa in patient with nonallergic rhinitis is usually normal in color, and it is beefy red in patients with an acute viral rhinosinusitis or rhinitis medicamentosa. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Topical nasal medications'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Allergic rhinitis is classified as intermittent if symptoms typically occur at a particular time of the year or in response to specific environmental exposures, or persistent if symptoms occur year round [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30999/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Patients should also be categorized in terms of mild, moderate, or severe based on the magnitude of their symptoms and whether they compromise an individual&rsquo;s quality of life. Patients with seasonal allergic rhinitis have associated allergic conjunctivitis in about 70 percent of cases, characterized by itchy, red, watery eyes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/2/34856?source=see_link\">",
"     \"Allergic conjunctivitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Common allergens causing seasonal allergic rhinitis are tree, grass, and weed pollens, as well as outdoor molds (",
"      <a class=\"graphic graphic_table graphicRef70448 \" href=\"mobipreview.htm?23/21/23899\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Indoor allergens, including house dust mites, cockroaches, allergens from household fur bearing pets, rodents, and fungi, are most commonly associated with perennial rhinitis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnosis and treatment of allergic rhinitis are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35370?source=see_link\">",
"     \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/39/6775?source=see_link\">",
"     \"Pathogenesis of allergic rhinitis (rhinosinusitis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/53/22362?source=see_link\">",
"     \"Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37834?source=see_link\">",
"     \"Pharmacotherapy of allergic rhinitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     NONALLERGIC RHINITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonallergic rhinitis is a common condition characterized by the chronic presence of one or more of the following: nasal congestion (stuffiness), rhinorrhea, and postnasal drainage. It is a diagnosis of exclusion and thus specific etiologies must be excluded (such as immunologic [especially due to IgE sensitivities], infectious, pharmacologic, structural, hormonal, vasculitic, metabolic, and atrophic causes).",
"   </p>",
"   <p>",
"    Clinically, it is distinguished from allergic rhinitis by the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Onset at a later age",
"     </li>",
"     <li>",
"      Absence of nasal and ocular itching and prominent sneezing",
"     </li>",
"     <li>",
"      Nasal congestion and postnasal drainage are prominent symptoms",
"     </li>",
"     <li>",
"      Symptoms are perennial",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Typical triggers in nonallergic rhinitis include irritant odors and strong fragrances such as tobacco smoke, diesel and car exhaust (ie, patients become congested when sitting in traffic), cleaning products, newsprint, changes in temperature, and alcoholic beverages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30999/abstract/5\">",
"     5",
"    </a>",
"    ]. Subtypes of nonallergic rhinitis include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vasomotor rhinitis, which is characterized by intermittent symptoms of congestion (stuffiness)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      watery nasal discharge, and an exaggerated reaction to nonspecific irritants such as air pollution or temperature changes, especially exposure to cold, dry air [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/17/30999/abstract/6\">",
"       6",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Gustatory rhinitis, which is an episodic condition with prominent watery rhinorrhea triggered most often by hot or spicy foods, and is caused by a vagally-mediated reflex [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/17/30999/abstract/7\">",
"       7",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Diagnosis and management of the different forms of nonallergic rhinitis are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/61/12250?source=see_link\">",
"     \"Chronic nonallergic rhinitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MIXED RHINITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mixed rhinitis is the combination of allergic and nonallergic rhinitis. It is the most common form of rhinitis, affecting approximately 45 percent of the population. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/61/12250?source=see_link\">",
"     \"Chronic nonallergic rhinitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     OCCUPATIONAL RHINITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occupational rhinitis is caused by airborne allergens or irritants in the patient's workplace [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30999/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Patients with occupational rhinitis often report that symptoms are more prominent at work and improved on days off. The underlying mechanism may be allergic or irritant (",
"    <a class=\"graphic graphic_table graphicRef72564 \" href=\"mobipreview.htm?24/34/25132\">",
"     table 3",
"    </a>",
"    ). Common examples of substances which can cause occupational rhinitis include proteins from the urine and fur of laboratory animals, food proteins in food processing workers, enzymatic proteins in detergent manufacturers, and organic dusts in wood workers. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/48/7945?source=see_link\">",
"     \"Occupational rhinitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     OTHER CAUSES OF RHINITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of other causes of rhinitis (",
"    <a class=\"graphic graphic_table graphicRef75862 \" href=\"mobipreview.htm?25/47/26364\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Topical nasal medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain topical nasal medications can cause a disorder called rhinitis medicamentosa (",
"    <a class=\"graphic graphic_table graphicRef75862 \" href=\"mobipreview.htm?25/47/26364\">",
"     table 1",
"    </a>",
"    ). The physical examination in patients with rhinitis medicamentosa often reveals swollen, red nasal mucous membranes. Diagnosis most heavily relies upon the history of use of a causative medication.",
"   </p>",
"   <p>",
"    The most common precipitant is overuse of over-the-counter decongestant nasal sprays. Many days of regular use leads to rebound nasal congestion as the medication wears off, prompting patients to administer the medicine more frequently to obtain relief. This begins a vicious cycle of nasal congestion both caused and temporarily relieved by the medication, with escalating use and eventual dependency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30999/abstract/10\">",
"     10",
"    </a>",
"    ]. The risk of developing rhinitis medicamentosa from over-the-counter nasal decongestants can be minimized by limiting use to a maximum of approximately five days, and using as few doses as possible during those days. There is also evidence that this is less likely to occur if the patient is administering an intranasal corticosteroid along with the nasal decongestant.",
"   </p>",
"   <p>",
"    Treatment begins with withdrawal of the medication. Other measures are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/61/12250?source=see_link&amp;anchor=H11252036#H11252036\">",
"     \"Chronic nonallergic rhinitis\", section on 'Medication-induced rhinitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Systemic medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain systemic medications have been implicated in causing rhinitis symptoms through local inflammation, neurogenic effects, or unknown mechanisms. The presenting symptom is usually nasal congestion without other nasal symptoms. These include the following (",
"    <a class=\"graphic graphic_table graphicRef75862 \" href=\"mobipreview.htm?25/47/26364\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30999/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Alpha-blockers, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?18/53/19289?source=see_link\">",
"       clonidine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?28/15/28918?source=see_link\">",
"       methyldopa",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/17/32023?source=see_link\">",
"       guanfacine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?23/16/23814?source=see_link\">",
"       prazosin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?7/59/8119?source=see_link\">",
"       doxazosin",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/43/34485?source=see_link\">",
"       phentolamine",
"      </a>",
"     </li>",
"     <li>",
"      Other antihypertensives, such as ACE inhibitors, beta-blockers (both oral and ophthalmic preparations), calcium channel blockers,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/35/16950?source=see_link\">",
"       reserpine",
"      </a>",
"      , mecamylamine,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?37/12/38085?source=see_link\">",
"       amiloride",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?14/57/15254?source=see_link\">",
"       hydralazine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?35/2/35878?source=see_link\">",
"       chlorothiazide",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/4/8263?source=see_link\">",
"       hydrochlorothiazide",
"      </a>",
"     </li>",
"     <li>",
"      Erectile dysfunction drugs, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/19/33080?source=see_link\">",
"       sildenafil",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/4/19528?source=see_link\">",
"       tadalafil",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?20/40/21127?source=see_link\">",
"       vardenafil",
"      </a>",
"     </li>",
"     <li>",
"      Some antidepressants, benzodiazepines, psychotropics, and antiepileptics, such as chlordiazepoxide-amitriptyline,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?29/38/30312?source=see_link\">",
"       chlorpromazine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?11/33/11802?source=see_link\">",
"       risperidone",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/35/32311?source=see_link\">",
"       thioridazine",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/19/19768?source=see_link\">",
"       gabapentin",
"      </a>",
"     </li>",
"     <li>",
"      Intermittent use of nonsteroidal antiinflammatory drugs (in patients with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      exacerbated respiratory disease) (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/0/39944?source=see_link\">",
"       \"Aspirin exacerbated respiratory disease\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Estrogens and progesterone may contribute to rhinitis symptoms, although data from clinical trials have been mixed [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/17/30999/abstract/12-17\">",
"       12-17",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Structural abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Structural causes of nasal symptoms include congenital abnormalities, acquired abnormalities (enlarged adenoids, foreign bodies, septal deviation and perforation, nasal polyps) and tumors. These are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/44/16072?source=see_link\">",
"     \"Etiologies of nasal symptoms: An overview\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H2599869\">",
"     'Nasal tumors'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Rhinitis of pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rhinitis associated with pregnancy has been defined as \"nasal congestion in the last six or more weeks of pregnancy without other signs of respiratory tract infection and with no known allergic cause, disappearing completely within two weeks after delivery\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30999/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Other causes of rhinitis must be excluded. This condition is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/52/3914?source=see_link&amp;anchor=H7#H7\">",
"     \"Recognition and management of allergic disease during pregnancy\", section on 'Pregnancy rhinitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Atrophic rhinitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrophic rhinitis in Westernized countries typically occurs in older adults who have undergone repeated sinus and nasal surgeries. Although mild thinning of the nasal mucosa is seen with normal aging, atrophic rhinitis refers to exaggerated and progressive atrophy of the nasal lining leading to colonization with bacteria. Symptoms include nasal congestion, crusting, and a persistent bad smell. Treatment consists of daily nasal lavage and lubrication combined with topical antibiotics. This topic is reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/5/18519?source=see_link\">",
"     \"Atrophic rhinosinusitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Systemic diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic diseases that are associated with rhinitis symptoms include granulomatous diseases (eg, granulomatosis with polyangiitis (Wegener's), sarcoidosis, midline granuloma), cystic fibrosis, hypothyroidism, immotile cilia syndromes, and immunodeficiencies. However, most of these conditions more typically involve the nose and sinuses, rather than just the nose, as well as symptoms in other organ systems. (See multiple relevant topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2599649\">",
"    <span class=\"h2\">",
"     Disorders causing prominent nasal obstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal obstruction is a common symptom of rhinitis, although not all patients with nasal obstruction have rhinitis. A general approach to the patient presenting with nasal obstruction is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/49/34584?source=see_link\">",
"     \"Clinical presentation, diagnosis, and treatment of nasal obstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A patient with persistent unilateral nasal obstruction needs further evaluation for a different disorder other than rhinitis, since almost all forms of rhinitis mentioned above (other than structural problems as with a deviated septum) present with bilateral obstruction, when obstruction is present as a symptom.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2599869\">",
"    <span class=\"h2\">",
"     Nasal tumors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with tumors of the nasal cavity usually present with a chronic history of sinus congestion and recurrent nasal obstruction. Many patients complain of nasal discharge and intermittent epistaxis. These symptoms can mimic those of chronic sinusitis or nasal polyps and may delay the diagnosis of cancer. However, unilateral symptoms should prompt further evaluation, such as nasal endoscopy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    imaging.",
"   </p>",
"   <p>",
"    An overview of nasal tumors is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/44/16072?source=see_link\">",
"     \"Etiologies of nasal symptoms: An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/45/13013?source=see_link\">",
"     \"Cancer of the nasal vestibule\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/18/39206?source=see_link\">",
"     \"Tumors of the nasal cavity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/9/4249?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of extranodal NK/T cell lymphoma, nasal type\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2599579\">",
"    <span class=\"h2\">",
"     CSF rhinorrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leakage of cerebral spinal fluid (CSF) may cause one or more nasal symptoms and usually results in unilateral or bilateral clear nasal discharge, without signs and symptoms of mucosal inflammation. CSF rhinorrhea can result from skull or nasal fractures, intracranial surgery, and inferior extension of sellar masses. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/50/33575?source=see_link\">",
"     \"Nasal trauma and fractures in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/18/29992?source=see_link\">",
"     \"Causes, presentation, and evaluation of sellar masses\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/25/3481?source=see_link\">",
"     \"Skull fractures in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/24/13704?source=see_link\">",
"     \"Skull fractures in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     NORMAL NASAL REFLEXES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nasal tissues are extensively innervated. There are multiple nasal reflexes that cause periodic nasal congestion, rhinorrhea, or sneezing. These are overlooked by most people; however, patients may occasionally notice them. A basic knowledge of nasal reflexes is useful in distinguishing normal from pathologic triggers. Normal nasal reflexes include the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/30999/abstract/17,20\">",
"     17,20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Postural reflexes: increased congestion with supine position and increased congestion in the lower nasal passage when lying on one side. The normal nasal cycle in the vertical position produces alternating congestion of the nostrils.",
"     </li>",
"     <li>",
"      Crutch reflex: increased congestion with pressure in the ipsilateral axilla",
"     </li>",
"     <li>",
"      Hot and cold cutaneous temperature reflexes: sneezing upon sudden exposure of the skin to dramatic temperature extremes",
"     </li>",
"     <li>",
"      Visible and infrared light reflexes: sneezing upon sudden exposure to bright light",
"     </li>",
"     <li>",
"      Bronchonasal reflex: bronchoconstriction in response to nasal stimulation (such as with cold air)",
"     </li>",
"     <li>",
"      Ovulatory rhinitis: increased nasal congestion in the periovulatory period of the menstrual cycle in women",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are stimuli that can trigger sneezing, specifically, in some individuals. The prevalence of these reflexes is not well-defined, and thus, it is difficult to categorize these as &ldquo;normal&rdquo; reflexes, although they are described in otherwise healthy people:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sneezing after meals has been reported as a familial trait, apparently provoked by gastric fullness [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/17/30999/abstract/21,22\">",
"       21,22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Sneezing immediately upon sexual ideation, or shortly after orgasm, has also been described [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/17/30999/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6556597\">",
"    <span class=\"h1\">",
"     REFERRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both allergists and otolaryngologists manage patients with various types of rhinitis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Referral to an",
"      <span class=\"nowrap\">",
"       allergy/immunology",
"      </span>",
"      specialist is appropriate if the suspected diagnosis is allergic rhinitis and basic medical management has already been tried without adequate relief. Such patients may benefit from allergy testing (eg, skin testing or in vitro testing) to identify specific allergens relevant to that patient, which can then guide environmental control measures or allergen immunotherapy, as appropriate. Similarly, the diagnosis of nonallergic rhinitis is one of exclusion, and skin testing is often performed to exclude allergic causes. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/53/22362?source=see_link\">",
"       \"Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Referral to an otolaryngology expert is appropriate if structural issues are suspected or the patient has a history of past facial trauma or unilateral symptoms. If the diagnosis of rhinitis is uncertain or if reflux of gastric acid is suspected, an otolaryngologist can visualize the anatomy of the larynx (to determine if laryngeal edema is present) as well as examine the nasal cavity and pharynx for abnormalities. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/10/33960?source=see_link\">",
"       \"Laryngopharyngeal reflux\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/38/37474?source=see_link\">",
"       \"Patient information: Seasonal allergies in adults (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/10/13475?source=see_link\">",
"       \"Patient information: Seasonal allergies in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?40/8/41092?source=see_link\">",
"       \"Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/15/24818?source=see_link\">",
"       \"Patient information: Nonallergic rhinitis (runny or stuffy nose) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?5/40/5764?source=see_link\">",
"       \"Patient information: Trigger avoidance in allergic rhinitis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rhinitis is a common condition characterized by one or more of the following symptoms: sneezing, rhinorrhea (anterior or posterior), nasal congestion (stuffiness), and nasal itching. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction and definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common forms of rhinitis are allergic, nonallergic, and mixed allergic, although there are several additional disorders that are seen with regularity (",
"      <a class=\"graphic graphic_table graphicRef75862 \" href=\"mobipreview.htm?25/47/26364\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6555769\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Allergic rhinitis may be seasonal or perennial,",
"      <span class=\"nowrap\">",
"       episodic/intermittent,",
"      </span>",
"      or persistent. Patients should be categorized as to the severity of their disease. Patients with seasonal allergic rhinitis are typically sensitized to pollens and may have associated allergic conjunctivitis (",
"      <a class=\"graphic graphic_table graphicRef70448 \" href=\"mobipreview.htm?23/21/23899\">",
"       table 2",
"      </a>",
"      ). Indoor allergens, such as dust mites and pet danders, are common triggers for perennial rhinitis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Allergic rhinitis'",
"      </a>",
"      above.) Comorbidities should be assessed.",
"     </li>",
"     <li>",
"      Nonallergic rhinitis is a diagnosis of exclusion, distinguished clinically from allergic rhinitis by the absence of nasal and ocular itching, a later age of onset, prominent nasal congestion, no relevant specific IgE sensitivity, and different triggers. Vasomotor rhinitis and gustatory rhinitis are variably classified as subtypes of nonallergic rhinitis. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Nonallergic rhinitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Occupational rhinitis can be caused by many different exposures in the workplace. The pathophysiology can be allergic, nonallergic, or irritant in nature (",
"      <a class=\"graphic graphic_table graphicRef72564 \" href=\"mobipreview.htm?24/34/25132\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Occupational rhinitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other causes of rhinitis include decongestant nasal sprays and systemic medications, structural abnormalities, pregnancy, atopic rhinitis, and certain systemic diseases (",
"      <a class=\"graphic graphic_table graphicRef75862 \" href=\"mobipreview.htm?25/47/26364\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Other causes of rhinitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Occasionally, patients notice normal nasal reflexes and ask about them. Familiarity with these is helpful in discerning pathologic triggers from normal variations in nasal function. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Normal nasal reflexes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/1\">",
"      Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008; 122:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/2\">",
"      Meltzer EO, Nathan R, Derebery J, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc 2009; 30:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/3\">",
"      Bousquet J, Van Cauwenberge P, Khaltaev N, et al. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108:S147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/4\">",
"      Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010; 126:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/5\">",
"      Brandt D, Bernstein JA. Questionnaire evaluation and risk factor identification for nonallergic vasomotor rhinitis. Ann Allergy Asthma Immunol 2006; 96:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/6\">",
"      Kaliner MA. The treatment of vasomotor nonallergic rhinitis. Clin Allergy Immunol 2007; 19:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/7\">",
"      Raphael G, Raphael MH, Kaliner M. Gustatory rhinitis: a syndrome of food-induced rhinorrhea. J Allergy Clin Immunol 1989; 83:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/8\">",
"      Gautrin D, Desrosiers M, Castano R. Occupational rhinitis. Curr Opin Allergy Clin Immunol 2006; 6:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/9\">",
"      Hellgren J, Karlsson G, Tor&eacute;n K. The dilemma of occupational rhinitis: management options. Am J Respir Med 2003; 2:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/10\">",
"      Vaidyanathan S, Williamson P, Clearie K, et al. Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion. Am J Respir Crit Care Med 2010; 182:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/11\">",
"      Varghese M, Glaum MC, Lockey RF. Drug-induced rhinitis. Clin Exp Allergy 2010; 40:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/12\">",
"      Bachert C. Persistent rhinitis - allergic or nonallergic? Allergy 2004; 59 Suppl 76:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/13\">",
"      Macsali F, Real FG, Omenaas ER, et al. Oral contraception, body mass index, and asthma: a cross-sectional Nordic-Baltic population survey. J Allergy Clin Immunol 2009; 123:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/14\">",
"      Wild DC, Philpott CM, Wolstenholme CR, Murty GE. Does hormone replacement therapy in post-menopausal women have any effect upon nasal physiology? J Laryngol Otol 2008; 122:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/15\">",
"      G&oacute;mez Real F, Svanes C, Bj&ouml;rnsson EH, et al. Hormone replacement therapy, body mass index and asthma in perimenopausal women: a cross sectional survey. Thorax 2006; 61:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/16\">",
"      St&uuml;bner UP, Gruber D, Berger UE, et al. The influence of female sex hormones on nasal reactivity in seasonal allergic rhinitis. Allergy 1999; 54:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/17\">",
"      Philpott CM, El-Alami M, Murty GE. The effect of the steroid sex hormones on the nasal airway during the normal menstrual cycle. Clin Otolaryngol Allied Sci 2004; 29:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/18\">",
"      Elleg&aring;rd EK. Pregnancy rhinitis. Immunol Allergy Clin North Am 2006; 26:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/19\">",
"      Elleg&aring;rd E, Hellgren M, Tor&eacute;n K, Karlsson G. The incidence of pregnancy rhinitis. Gynecol Obstet Invest 2000; 49:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/20\">",
"      Baraniuk JN, Kim D. Nasonasal reflexes, the nasal cycle, and sneeze. Curr Allergy Asthma Rep 2007; 7:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/21\">",
"      Teebi AS, al-Saleh QA. Autosomal dominant sneezing disorder provoked by fullness of stomach. J Med Genet 1989; 26:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/22\">",
"      Forrai G, Antal J, Balogh A. Sneezy twins. Acta Paediatr Hung 1985; 26:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/30999/abstract/23\">",
"      Bhutta MF, Maxwell H. Sneezing induced by sexual ideation or orgasm: an under-reported phenomenon. J R Soc Med 2008; 101:587.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7533 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-210.101.131.231-E769C354BE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_17_30999=[""].join("\n");
var outline_f30_17_30999=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION AND DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6555769\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ALLERGIC RHINITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      NONALLERGIC RHINITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MIXED RHINITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      OCCUPATIONAL RHINITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      OTHER CAUSES OF RHINITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Topical nasal medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Systemic medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Structural abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Rhinitis of pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Atrophic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Systemic diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2599649\">",
"      Disorders causing prominent nasal obstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2599869\">",
"      Nasal tumors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2599579\">",
"      CSF rhinorrhea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      NORMAL NASAL REFLEXES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6556597\">",
"      REFERRAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/7533\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/7533|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?25/47/26364\" title=\"table 1\">",
"      Causes of rhinitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/21/23899\" title=\"table 2\">",
"      Allergens in allergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?24/34/25132\" title=\"table 3\">",
"      Types of occupational rhinitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/0/11273?source=related_link\">",
"      Acute bacterial rhinosinusitis in children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/48/39688?source=related_link\">",
"      Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/15/2297?source=related_link\">",
"      Acute sinusitis and rhinosinusitis in adults: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/2/34856?source=related_link\">",
"      Allergic conjunctivitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/53/22362?source=related_link\">",
"      Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/0/39944?source=related_link\">",
"      Aspirin exacerbated respiratory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/5/18519?source=related_link\">",
"      Atrophic rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/45/13013?source=related_link\">",
"      Cancer of the nasal vestibule",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/18/29992?source=related_link\">",
"      Causes, presentation, and evaluation of sellar masses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/61/12250?source=related_link\">",
"      Chronic nonallergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/9/4249?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of extranodal NK/T cell lymphoma, nasal type",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35370?source=related_link\">",
"      Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/49/34584?source=related_link\">",
"      Clinical presentation, diagnosis, and treatment of nasal obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/59/19383?source=related_link\">",
"      Epidemiology, clinical manifestations, and pathogenesis of rhinovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/44/16072?source=related_link\">",
"      Etiologies of nasal symptoms: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/10/33960?source=related_link\">",
"      Laryngopharyngeal reflux",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/50/33575?source=related_link\">",
"      Nasal trauma and fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/48/7945?source=related_link\">",
"      Occupational rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/39/6775?source=related_link\">",
"      Pathogenesis of allergic rhinitis (rhinosinusitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?40/8/41092?source=related_link\">",
"      Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/15/24818?source=related_link\">",
"      Patient information: Nonallergic rhinitis (runny or stuffy nose) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/38/37474?source=related_link\">",
"      Patient information: Seasonal allergies in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?13/10/13475?source=related_link\">",
"      Patient information: Seasonal allergies in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?5/40/5764?source=related_link\">",
"      Patient information: Trigger avoidance in allergic rhinitis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37834?source=related_link\">",
"      Pharmacotherapy of allergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/52/3914?source=related_link\">",
"      Recognition and management of allergic disease during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/25/3481?source=related_link\">",
"      Skull fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/24/13704?source=related_link\">",
"      Skull fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/55/24440?source=related_link\">",
"      The common cold in adults: Diagnosis and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/18/39206?source=related_link\">",
"      Tumors of the nasal cavity",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_17_31000="Acute lupus generalized 1";
var content_f30_17_31000=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86900%7EDERM%2F86901&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86900%7EDERM%2F86901&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Acute cutaneous lupus erythematosus (ACLE)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     A morbilliform eruption involving the sun-exposed V area of the neck and upper chest in a patient with ACLE.",
"    </p>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Acute cutaneous lupus erythematosus (ACLE)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5Yoopa0sMSilFFIAFLRRQAY9a3vC2omzvFic/u3NYVPRtpDDqORSaTHF2Z7lbOJrUMOvf2qaAHc29jn27VzPhLVBd2EYyAwGDmupjTMLHBwT171ySVj04S5lcsx7pE3chCcEgVamn82NY8kIMHIGM0tqo8kA4AC/lUYhwhYAZK5wTxipNkadtKI1JYA5PynNaEVysj4J9DnNc4kzDKKA+DgemPWtjSISGIcYAAPPc1XL3OpJW1NZJHPzIASx5PYD1q/EPKUNn5mHb+tVjGq4aQiNYx36t+FXE2vHuJwDgKuP1rNkPYkgdTNlxgAkdevvVmAytkArlWP8ADnAqkiPvZj8ysR0FX7aRXxHhUxzkknj3oIWjIroyN8wwTt4PAArKu1dWDDZvxyAc5roYYgzBBt29EGBj64rJ1GBISqZJ3k/Njoam9jdJPRGOJwxORtJOG7ms/WYmTkI2B0OOmavSxltrqoRlJyQetNZi6lZgCccEVaY3G55f450ZdQsJCgBuYQWjwecd68jZdpIPHavovVrQriRUyMYb6V4p4z037FqbvGuIZTuHHQ967Kc76Hi4ujyyuc53pDTj1NJWiOIZRTjRVAMNLSnmkoASjFOxxSUAJijFLRQAlGKUUuPSgBAKKWlxQAgFKBQKcoqRm34P0z+0tetoiMoh3t9BX0TaxokKAYC45xXl3wl0kiGS/fgythfoP/r16xAhJGOWPH0rCrI9HB0+rL9lbgLu2kZ696mRG8uaNgwQjj0FMtZSzYwxAAH41Zu1LQFxkOp6A5rnPQtbclWFGT5WIKjrj9KicKVO7IkU8gj9at2yoYWDM5ySfbNZ97KjAOrdDwR+tGwK7Zn30e5iQw3A7lwM/UVl3wWZCvAxjnHT61qhW80F8AElgaz7jaiyEDDZ69jTi7inJozJ4sruyCAcdKpy/vIih5c9a1dw2lgNynsB+dUp7aOVmxwH+ZSTzimLcxhApdo23GMjKk+tQOjxjy3AZl6HHLCtbyXWIoybyDx6msy+LGNWjOSOnrkVRjLXQ5vVZgimPqvUcYrgNVctJjPGeldtr0vmLuUHI6g1wupnNxjjHtWsDz65TopaK3SOYSiiimIbRSmigBKKUUGgBKKKKAClxRilpAJS0UUAFLSUtSAU4U0U4UwN3wnetb6gsRPySfzr12xlLQhSD2GT3rwiN2R1dCQynIr1fwxqwu7BJMjftAINc9WPU68PO3us66JirNuYBMYqfy3mEakHZ6gdaz7NTOcgkjqf8a2rdQqgkMV9D0xWGx6cCaC3VQpbbk8+5rcigDBVC/NwemT/APWqjp8Ydxkjc2MZPAHvW2WKSmMhdiD86C5OzGSbnQqR5iP39cU+J2igbaFPsOmarp5+4sjZ5wBwcf4VYUbQm07ietRIexLbTO8S+b8mDyBz+lWllaNUWCPMhJzx0qhKGQgx5YA/dPSr9q8z43KdvTOOBQtiG7M0beSV1YtJhiNuAvzVVvbcy7Wn55O0Ejj3OKegITbkFlPzcY+lNubRlTeOvU7ic/lUs2jq7nO3KtHKQrHA6+9ZskYfJG4EHBGe/rWnqMZZ0A+9g9OpqgYTDIm4k7zgE9QacTWWmpUuUfblvnGP0rg/HukR3dixVMOo+Ug969Iu7GSFWKsQRzgnI5rndVtj5TrKg2H165reErM48RT54nzvIpUlSMEdqj7V0Xi/SzZag7oRskOQMVztda7nhtWdmIaTFONJVEiUlLQaYCUdTRS4oASjFKKDQAlLigUYoAMUoopaACp7S3a6uIoIxl5GC1CK7L4aaX9s1Y3LDiHhQfX1qG7IqKu7HrnhewTT7CGFVB2IAM10ERY7SeCTgAGs+12IqDBc8nAHoOK0oInjtxKSFKAnHU1xzdz3aEeVFvZ0MZA3sM5zxzVoI2+RJGPz/cJNNjciKPq42qSB3q1u3qm1mzH0/CoubN6Dlt2QGVOEGN4HI/8A11n346hY12Z+7WrPKrID5hyWGFK1lXDNkk47g8YzQxR7mbt2qccZPrVG/ZUjYk4DenXNah2uMg+3pWbqFu720nQqBwe9NMibuY8Dhc/Nh1PPP609283Y4XEinp7etZ4ZoZWVuo9e9aUC749y4O3jNMSegs5EsBIGwhcn1BrHuk3O2RyVDEY6GtZnYzogCnKHJ6YqjcIwKK2A2NjEc/SmmZzWpwPiCEAPt46kV5/dtumPtxXqPiuAfOwA6Y9vrXlk/Ezj3rop6nm4hWkR4opaDWxyiGkpaDTASiiigApMUtFACYooooGLRRRQIKKKWlYAxRRQKLALSikpRSAUcdK3/C18YZWtznY53ew9awBU1rJ5NxHIDjB557VLV0XCVpJnuPh7UFYDjIxwTXTJOrnaDkY+ZvSvPfDVwPs6EHaTXdacQ5BGM9TXJLc9ylKL1Ojs9ihZI49oIwF4zV113bUOExy/OaqQyr5aIq8uT9R+NTxRFLY5IRT1JPLfWoCVmQeYAw80A46qOmPwq0rrIVJxyMKO5/wFZ01wNjeUm45xu6DHtTVbYRvZcD+AH+ZqXuXa5qlv3yhBnnH1rUtQxRlDO2MEBflH51iWUbyShgcRDHXit63Dqz8eYqjovyrmhXRG7FQlXY7Qu7jA53fj6VpWpimGGjyCM4UcfixrMAZX3SKi8DAHP4VJLfsdsRkJVedoXCg/hU7mzXNoh19psTPuGFbqBnpWBrNupXy9mMnAcDvWybqS4fzJQzNkAsRhTVa9QSgREgYO7jnH40N9iuVrRnO3LuzbHYgr8vAyD9azbkRzxSLIfmBwCo71u3EJ3xunKE8gdaxNRjMczKmQD39RVpi3PPfGukfabI7APMThG968llQq7Bhgg4I9K9/v4A4MchOWGBXkHjDTDaX7Oi4QnkiuulK+h4+Mp2lzI5o0mKeRTTW6RxCUlOpDTEJS0UUAJigUtFABSikpRQAUYopy+nelcYDrjvXsXw908WmnwKyjLfM/bJ615j4csG1DVYUxmNDvf6V7dpEIijQKOO/HesajtodWGp8zuzpIIjJPhc7dnyj8a1SsiRiI42v8nI9qpae6iRS5zweOmK00D3BU8E9R2rikz24O2hHaAbSg5dEB44H1q7bKRbJtYqScsD3NQ2cbLlpxldxXmrcjLGH2HZjBAIzQnccmnZEV0o2ZUhZAdyk/yrJnZmOASTj5smtC5YBtu4r2A7VmMy+c5ywbOOvANTzFJaDCNpDcgEc+hqOcP8wRsfQVYdUZGUdD129qqhjtKn7yng9xVJmMkcvq8bJPllA7iptPkJt8swIHSn+JARFvU5yeRWTbSlYiIzjA6VbMYmo0pMzjg4HGOoqvdzB13AgNxg1EbgLKjFgoIwc96zdRugCyjGMnGPpQgm+pjeI7gSRyAkYA5FeXSkNK7epNdZ4lvfLiaNWyTXIHrXTT2ueZiZqUtBaSlNJW5ygaQ0ppKYCUUGigAooooATFFLRQAUCiigBaKSloAKBRS4oAKUUlKKmwC0vBpKBSGdf4S1HYAkp4HSvUtBvll2sM7Sfzrx7wwVLujdQcivStDnMUUe0LnjkjpXNUWp3YebtY9Ct7hQVypZs5Ck4Ap00zSllkI5Oevy1l2UxYDaC7dR6VbkViCJTgHslYHctBxkTHlocuOhHf2qWOIZG7CHqT3P1qG1CRycNtI5IXmtSNm8oGNVGT97GSRSK53sXLJWWHCpkN1LnAP4d6vZlhiBaQlX5IA+79KoIpR9wlAJ6F2zirEbF8kMHx2A5/OpbNIwsWftEZ2NKxBU45xwKgfMkyGMEDqN3PB9RSysxx5O0FSOAvNXYmklO+Qnew+8zgY/KpNFo7ohDOI9nyKwOCzfxfQVFLcCOQhtvpgdPxq9CFw0kLRMQCpUKWP61UmgYx7xk88HIxQS5FSBtpZNpAzuH0NZWrKit5scYfyz8yg1sSsXjSSPC7SVqnfwZUM+A+MZX+L/GqbFFnL61BHJg2+OBuBHb2rgfE9kl1byq64cHBPfNejbWSRlcZI4OR29K53X9ODMXg/iGWGMitoSsc9eHMrHhFxE0EzxSDDIcVF1rpfFdiY5WkCEOv3x3+tc1XandXPGkrOw2kNOoqkQMpaKMUMAooxRilZgApe9AooAUUtItafh3Tm1PVI4QCYx8zkdgKTZSV2dr4C0swWQndP3s/PPZa9FtQyxqq8AkAA9zWXpdsqBY0BVcdvSuhtIWMkapksF3AY6fWuWcj1cPDlRp2yJuCFmOOCQOta9rGQ+8YbJ2gdqzraB8x4xg85B5rbVDDExIHH3SemfSud6ncth8ciRxzF1wN20nPPsQKgmeXhdyENkZ/vA+34VEhaSSRdvL9CT0NPuZR5ojdcOq7gw6k0InYq3D7miXfghfmHas1V3SSJuYgn5T0/OrbOGuCkmGAThj3Jqsg+Q7Tkk4PHOaTVjSMnYco2jBcMg5471nTOzSDcoUkkAir91G8EXyk5J3c9vY1QvMvEuPvEZyOgNCZTSsZWuMslo2Mbl5xWLbD92CCuMVpX2ZYwGzgnBP9KycmIhCDjqtaXucdtQfcY9rKpZffGKw9Vn+VmB6CtiZt7KNze4xXN663lQuecEEE44px3Mqr0OJ1uYzXZz27Vm1NdHM7nPU1DXZFWR5UndgaKKK1ICk60tBoAQikpaKAEooooAKKKKACiiigApe1IKWgApaSjNAC5waKTvSipuAtLTadSGW9MuTbXkcnvg16hos6PErSNx9a8lHNd54NQSWiS3Dhx2TPGPesqiubUpWZ6dp2ooIwkHLYxxzVxLnewBVjJ3ycViWM8KIBHjPolaNp5hk3suc8AZx+NcjPUg7q5qRhxJj5VLHt1ratAix5LAn35J9vSsJZlCncuWHTmtCyO4soVgfTNJjb6msxWMhkQDPQsc4p8MZVy+Sc9SeB+VQQfImAAreuc5rRgUMq/vFRu4C5NZM6YuyJo3Z0AAYj0UfzNPWF2IQRsTjOAO1IzoXMatlT/tYx9avQwhERV+fdzgg0hczQkESRRnEa7W4JDEfhSNFGAGiETZ5xirUx8gE+QkOCMOpqtJCDMXeQOACRx+lNCepn3DRhiFjCrjse9UJ4iq5D7yorUuoTISdp+UZDY7+lQzQyBV2Atu5yF6VbJjZGBdxJt8wjLHoKxrgIg2vkRtxn+6a6e4AYSIY8kcE+1YF9C04YcuBnqMZFEWU1c8+8YaYq7J8Eo4KuQK8q1SzazuSn8DcofavdtRh8+zlgYkrjKZrzzXtJN0rwEYlTlDjpXZTn0PKr0rvQ8/HSinyRskjI4KupwQfWmV0XOIMUmKWiqEFGKUDNAoATFFLSipaGIFycDqeBXq3gjQzp9krzrtmlO+T2HYVzXgTw81/cre3KHyIzmMEfePr9K9QlUouxcktxisKk+h00KfVkmnRlrwqBlRzXT6bbMBNKxHzDIPoKx/D8RT53AyOAa6i3QAhNo2qAOO+f8iuaTPSpqxZhK28CyOUCxtz6nPT8atKPPVd6gHqFJ5BqvZxmS0Uvt3o24lhk5BrRtigDP5nXBAHUVBo58pl3MOxTMpZJI+CCMk1LNEZ28+VZEcL8rA8DjpVq3lF15u3ex5wD3qHUP3dqcqyjbgnIOT9KLBzXdjEm/eOdzHcPlwRjOKYsRhkMkJbkZIDZwO/FS2++UL5mF44OKUnbgYO4Nj5Rx9alu5stNCGWWFImEjEB/lBK9aybjdEGUcgmt91Dv8pjJA43dx6Vm6kvySKUwMZWkh3OUu3fGxSOSCAazrosJ1fOQQQfQj0rSvI9saEk7xg/hWXdOoZMAYz0HStkck9GZ13cHLFM5HrzXNa7dl4gpRgD14rdkVWkYs2foaw9TUkuecL61pA5asji5iDIxFMp9xj7RJgY5pldaPOYYpKU0lWIKSlNJQAUUUUAIaKWigBKKKKACiiikwAUvekFGaAFNFAopWAKUUAUuKLAJThQKU0hijpXU+EmLxskrkIpG0Y4P41y3QfSvQfD1g1vo8KyqAXAkPtmpnsXDVnV6KUjQAsMHpit+M/cOMqPQ1gaTCJGAJ6dAe9dEkRCAAYB6muNnp0tiwoXkhSQf4m7VoaZIFaQplvTPQVVQMsXCA8cZ9adbLIiZYkknJx2qC5K7OlhQuiBmBHUY4ArRgUAqGOQey+tYVk00qZY7F9GPWtGzlbzfnXeo7jk1lK1zoitLGpDF5zNs2/QHtVtUaNgqZdhyCRkD25qhaSBd8KxuCOdx4/Cr1vgFMsoJ4Ix0oVrjbaL0UIIIEDSEDIViNv5VHdAD5kRYmU8ov8AOhrjYse4M+W25GAFouRINnlxrsJ+YsuRj6+tMzbbZWnlcu7NIwLLggkfyrPDmNXw4yeBxgE1e4RHm3BwD0K5xxUF4qS/MpVD/srxmmtULrYz7lwrLsyxbgj+lY1yFLYXhSTwePrWsQ0aOGxuHUjvWXcRHbkduefWhGituYOtWf7rzkAOOori9Zh+5cRklwOeOorvrtXCY2kADnPPHrXOXlqZN+UHuPat4s55xueYeLtKElumo26kHGJB6+9ccwr1mSHy1ubOZcxSjKEnoa8z1O0NpeywkEbTkfQ10030PNrQ5dUUqKCKK0MABpe9N704daaYDl5roPCXh99avAZARaqcMR1Y+grK0ixfUdQhtY/42GSOw9a9w8PabHYWsUcaBFVcccYNZznZWN6FL2ju9i1aW0NlbKE2oiLgLjgVFCrT3McgyQ3H0qa9fzCEGPmGDx0rU0yxWIRxgbuB82fxrlbPRUbF20tfLBCqSFGAPfvW9bxFHkfaWkCjGPu4FUU3Ou1CuAvJHQZrXjRmbLfLHhVyeBgd6hsvyINNGy03EhXdiS+eoNJZTyRwSiSMZVyAVGRnPX8qVix+VcYGPu+npT8Z5y/PzYA4FSXo1ccizb2WMH5OOGAyD60l7GHX92BleCvJFK58i2ldonaZyGG48EdqkdowiAo0YYZK7cYJ96oUW7mNKpijiMcaHHLbh0NVllxuJBTnnBrSvXWM+W7FhjqR/OsYCSSaQsm0DgZ6H3qJHTHbUu42LvZsg8H6VnzFpXZGchvQ1JsfaTIWKt0I7Gq10jqN7Abj2HU0lcmTsc7rjBSVfk9AB61z5fexC4yO5ra1dt+JAVB7r3rn2J3bhzz09K1TOOe5FcRvuGCAD1I6VzWqfaAxVGRh296691ypDMSo6bRXJaqDJL5cZy3IFaQOeocbISZG3Yznmm1Pd2728zK9QV1rY89iGkpTSVQhDRRiimAUUHmigAoo70UAIaKWigA9aKO1FABRRS4pWASloxRTAUUtNp1JgFLjmkp1SMu6NaNe6lDAo6tk/Qc167FagwAenAA7VxHw508zXctyeg+QH+delGNQMKDgfrWVRnVQhcZpK4lwAePUVtGYqQT09B1xVTTICXAPCnk/StGRAiEoAB056/hXIejGNhFBCBY2cEjJJHQVZRmEeGzvYc7ecVBC/ljJVs9D9akicFy2Wx6UpbBFXlY1NPPlRqGYsexPrW1bRnbv2Mw+uPzrno3AjwCSx6HH3a19P2rbhZc5GDubmo3Lb5WXxdWqMFkCJnjrkk+laNsEn+a2jwq87tvX3rOa2inKG4YcEkYwBWjDGsUYMbI449cCosynJNGir7ACQWGMdBmpJTK1qyt54iPYnOf0rIOUlC7eWOSe2KslpVZH/ffZ8EbAQRVktEuIw+C5HBPDZGfcVi30yWhcoyn0PTP1FW579IUOGbjuQAVxWHqGoJPmSJVcH5W2dxVxsa0KXNLXYzLjWkSTDHcvX5T8w+ntVT+1xk7/AJgw4JXrUJtDEwdwv7wnaN3aoZApcH5lgwQ3GWX2q+RHoSo00hv28i4WKQZVvun+lOuoSQo24BGf8apum3MqNuC8keo9qvJKs1tiFueu1qGuU4q9Dl1icpr1juj3JjevKn6V534ytCywXoHDfI2PWvX9UtH8vKhjuH3R2NcT4l08TWU0OPlYZ6fdPtW1OWp5VendM8rYc4oxUjIysyuPmU4pn06V1HnDcYpR1pcVPawNc3MUEfLSELSegHc/DXSyA166Z3nCnuBXpiOBbSBiC3933rH0G2Sy0uNEwu1Qo/DvWhEj3EnlRckDk+9ckpatnrUYckLEtpC8k285OOMe1dHDECiqx2u4PPqOmKqQWyoBHHhgcKW9T/hWwsIdQEP7xDkE96xZqXdOgAtdqELgnAXvjj/GrCBkVVZmMTKFAPJ4PNVLSVonUgeWFG3kZzWjJOcsrbQuRlu5PtRoRZp6hE+G+ceWck7vakmRnZMBjEOAOmB6mhLeTyWVGB38nnnFW3hMcaoSgA+XPXJqd2VdGZPbjcF3fMOQM9TUzArGIy649frSSPEEHlneUyFABHWoA7NuDo4RepY55pNmsYtq5VuAjzyF8Ow7kdKoXMgwETIz0A7+9Xb+dBGGdyEPA2r0+tVJdghKuVVuORxSW5dyrM8i4UFSB97HX8apah+7hc4ATHQHmrOwgOqkbmycDjNZuqFIYWKsMkZxWis2Z1b2OeupPMyynpwA1ZUmGJUlmI5AArSlUngH5T1PaqUVuGcvvfCjqehPrTOezZNLAXtQBgH2rk7iHydTycZ6c9K9BiiBiQEBVI/ya5nxHZKMyofunNVF2JnC6OV8QaWJbczxEljk8fyrj2GK9OgAeOVJAC23hD6V5/rNq1veN8pCPytdUH0OCpDqZ5pKU0laoxCg0UGmAlFFFABQelFJ3oAKKMUUALR3oooAU0CiigApaTOKM80AFO7U2lFS2AtLnFAqWFN8ip/eIH5mgaPVvAtt9l0KLj9443fnXTy/uYVcjOeMeprL0cC3s4UUc7QorXc7whxlgRiuWoejQSUTR0+Nm2OwCjHc1b2M+4E456isuW7aBVji5dh97sua09Pik2kyk84yz9DWJ3crUeZla1jkMkm4HYOgxwferCoxCsSc+1aTKiorM+4A9MjAqlPIWO1BtTqxP8hUSXQUdXckglEmQo78Gt+2bAC4Y5xgetc7ps/mDdgmMHsM1s2lywmRHjZo+pYHFLYUk2acTs1wMxlY8c455960bW4zIUaYRoBx8oPPpWUtzErgFwNrcgcH861ND8ucyvIFVwwwzEZpK9ynG0eYZfbbdTI7s6jgKRtrNkvbgyqxTy4V4RcnI+tX9eWZlc5dtr5XcMg+ozWPBfyo8SzPvVCXUeWCwJ4xWkYxe5vRpXjfctyLYKjfbpWkcDedvGfYcVmG2FqgubV/3M2eF/h9zWmIQ6+YzHDE9R09jVTU2MF0UKrhkHyqemK1drHVSavZGNNpUksivuDcblP8P1ouLUhG3E+b3PrWzpO0gMFHkscle/8A+uk1SPJ2BSgY4U9Bz2NF7hWqO9jk8NCxBAcSnjHr/jUN1bNFmWNj2JAPFarIwcJtG4Hp3FVp3Ysy/cUgihroy6clLcr2t/lvJm3bWGVPvWXrtr8zMgHPIzWzZQq0b+av7xOhAqlqmyeJHQ5IOGB9alOzPPxUI8z5UeKeK9MNhqblVPkTfPG38xWJ2r1DxtYLdaLM20edAd4PrXmHWuyDujwa8OSWg3BrqPAlh9o1IzN0T5Qc8Z71zPQZr1HwRbLY6IsrgBz8xPuaVR6DoR5pq51sSbkSPBORlsYzWvptt5UZZRxIePT0qtpNi2zzWO7d1wPXtW5CuY0jAwwGea5Jvoj1EmX7S3jMQwCCRjntWjawBV3bQMeveqsS+aNirwCBWmyCIBS2CRxx0rMTfQzo2YXM6IC653DJ71N9jLphi2WOSc9DUscO3BCnLc/KcfnU5ViTk7TjhB296SFKVmSxDcqqg+78p7n86fIvmoodGLHAwfWq9gEtfM+bIHq3OfarDsFg3kscj9KfKDWpHcW4UMUUFunB61zOpmaBXk85DKThY0J6ep9632m/0QhMr2Ixg1iaiIxI4iyu0ZG7qDinGLZ6OGXcyI7raApfLjqN3rV2FIpVJUFpegJ6CsSS3W4lZkILjlqYdQuLdUK7dp/hP86Ti47mksPzP3TRnK27M08nzf3QKxNQYzsxGBGehHrTr+WW5YS5AyMZNYDyG2wJGcE+veqjHsY1aVl5l512LiRzs9FrNmuI+UGVyKnmvAYQI15H41TSPzn3qpwepNUlrZnOo8k7M2dLmPliKQFwOD6+1M1K2EsTgqvI6ZyamsUjjYqScnHPWrV9CzICm3aPWk9GVOKlscVICrI7Kw2fLuPcVzviq2Etn5qD5k+auzvAY2ZHTB6D6VgXUI2SRt8ynitoSuebWhbQ84IpDU13F5NxJH/dOKhrpRwMSiiiqEJRQaKACiiigAooooAKKKKACiigUALRiiigApcUClpALVqw/wCP23z/AHx/Oq2c8VPZnF3Ce4cUmPqexaZL8qhuSBwDW1ChMgO4kDnisLRwWZe4AHA711FlCq7WGB321yTPUoLQtWsMaKkkwX15/wAKoXerGW4VYlIjLYzU2oEyQuUPyjnjtWMjpFb4YsGDZB68VCV3Y9WhSTvJnRR3sSDLMA445Gc1LdNvQMAdrnAAFYWi2xuNssnK7iea6abYFQADjPepkrvQmpFR23H6VAsUZIJ57AVYlvRbh2Y4iVsL2yals7Y/YUkSbOecLwQR2IrB10B54jGSYx94H19qlwfUzopTlZl+GS4ulMhKDnrV60vru1uwqkHgnaR1FZulI7gYfA6qP6V0NvZxtJEdziU4EmQMEZ6Z9K1UIpHpRcIqzRYl0+6ubX7ZJejZ94IvT8PWs+znFtqTNKQQg37jwT6CtC9hntsQ27gJv+SFF4z9fWq8728QxNC8k7DLHsh9PfFPToiE1a29ya2me8cquxVX5w7cZqMrPDIWuoY5F5ClOcD1rPgvJvMCoh8rPUdq145y8Ejsnl7RkDrRoyUnBlKyEcdwfLLsp+ZR0I9v/rVNqSvc+UImUEDJA6H6+9UnnZZRIgdRjcVxk59aWLVDLfxqyhHI5cLjcOnIpRMsRe90LLAEj3xgDsax7t403My7iT94fzrrXSIqGcL8wO4jofeue1HTY9/7sMUOFYdiO1NahRmuplWlxsuNrrw3IY9xUV1CjB3Q4VucEdai1DzILlFI+XkA9xUP2hzEyyN0NS1YMRBW5omHqMQmuBaMciY7R9K8buU8qeWP+45X8jivZY5o/wC3rNnBbAfAPY4ryHV0Katdr/01b+db0meDi+4zT4Dc30EI6u4FezabaCW6tLVV/cphjj0zgZrzPwLafada3n7sK7ifSvX/AA/bebDdSRg70yM/QUVZBhYX1OutbZfs4DDGc4x6etLDHtO0nODu3Cp7MpJHG3Xag+UfTpVqGKITAx7stwF9vWuZrU9DnsifTCo3MzheMgE1NB/r98u45B4J4wKEjZXRgEIOcgjsKS4lVIpHkGFUfIB/KlYiOr06kyMjnAzzyx7n/wCtS3Vz5bBxgsvQjsKwbTUJG/erEQOf07Vdtp/tEZY7QWHIJwB9aLWNJ0XHVoPPSUyOwwH+ZmPf2FWYW3Q5m3Ln7qk9fcVVhjhNr50sRC7sFT0JrP1DULgShYo8RryHYdB6CizLp0ZVNEb0lzFDDtjk2BVyQSMg/U1xepX8s927+YyqykBiM5PoKLm7nmA3MvJPbrWWsjC3Zd7ERN+8XGSMngg9hWsFpqd9KDpLXcfDCovLYszujNtkCjGB61f8V2yS5ktRIQE/jGPwFTaHsbBZf3mS24N933qLUYJ7kS4fy06Zz7+lVLY0hP3tehiWFyJLcCMAyKcZYcCqXiiJJ7bfvUnknA6H2q8LaS1Z0jAywOD3aqdyhbzFjCMB1J5Bz2+tOMWlqcmIa57xOe0tZRGwkPzVp2wCKCMfMCOuc1St18ifZIWVySCT2rShg+UKq/N6g8getR0OT4ndluz3GdWjBV8YJ7EVsKU8uQN8pUcDOQawVLtK+BwvHmdCfoK3LTynjfbkHuD3NVujZI5i9eKaSRRw684Pesa/2SAELhk4Pv6Vp63F5d4xAxIDgAVkXrn7ShHIzgiiBy4umoPQ4PxFFsvt4HyuP1rKNdT4tiHlq6jo2fzrlyK6YbHkTWo2kIpTSVZmJRS4pKACilUFmCqMsTgD1Nbeq6NZaTrlvp9/qDMqhReyQxZ8hj1VQT82ARSuBjTQyQPsmjeN8A7XUg4PIOD7UVqeKrW6s9YeK9uzet5cbRXBJPmRFQUIz22447UUIDIooopgApaSjFADs0lFLQAUo6ikpc0ALjmp7ME3cA/2x/Ooegq1poLX9uB/fFSxrc9l8PLiIMwyvc+9bDTOtu3lkK78D0FZulRlNPjPc9c1l3N/Kb0QR7ipfYD9Otcj1PbwlPmaR0iFZU8mNT5h568H3qjLGYp3YgMSMAH2q1bwKgPltmQLyVNWbeBZBGNu7HVsdCaux6nwrQi06ZbYEDcNy4A9K0muBPPEiopbABA96yZ4vJubnHOFAXHrU2mMiAK4Znj7qeazJgk3c7OKNbWFNswDsMFSenvWBfMgaQx4JU43VJv3RlyxVQOvUn3qOwt5LgPGq5ifnnrk80SbT0FSpqMm2WbACAo/G7bwuK14pfKSIzO/mseiDp7msG+vVjYQxoGkjAyR/Oo7SeWdi4nCIp4Unk0t9jo9k5O6Ovmmd5VZnLKOAT0qaRQZ/NmzgJ0VBg+9VdPurc2rOjliOCrZwT7VPHrMDAwiN2Vf4inIPcGh2jqYzUo7EdskQikWdQ0i/cK4AGfWp4Y3ltCIgP8AeZv88VFOI3RWjh3k8jBx+FOmnijgCsjJKBjbnIqU22YczbsZN9wkrwRPI0Y27hyoJ7fSqsUkRhjM45HORwc1ZmutsdwtsTAJf7vOfqaz/InOPMlBTH3f7taM64UFJXkaT3soJFoElgA5BqjFrTpKYXAUkgqT0UVnRXEtlcFgr7P4h13CodRDXCCaBVyOfl6HNJW6FOjG1mat6EullaQrgHPTODXMalmN1PIBGDin6beyrO8cudn3WB9KPER2RBxz24pPY46z9neJzEUpbW4m+8Y0dsetcB4mg8jWplJySck+/evQPD0H2jU7ydziOFMFvTPWuL8aKF1FmI+Ykkj0zVU37yPIrq9Ns6D4c2nl2FxdMPmkYKD7Zr1fwbCptCXJKyFl46jng1wnhKDyfDoGAMKrf1rv/CY2Woj6OhPuCDzU1JdTajC0Ei3ps3lme3lc7o2K5x+tatpjePmNc7fO0esEH5fNUMMHhhW3YuGTsMHkVL1LaN0qn2U5PJXGT0qhdk3phtrZlJIwWPGKr3NwzzskhKwqMdM1aspfsdo19JsRQSqALloz7/X+tXCNzqoUeX3nuUb11s5FjnBKqM7VGB9TVC3SR0Jgk24yx35GcngCp7y4M1hL5/73zZNyDpyexPoBWTbX10JmublvkVlXGMjjoAPwFaSWp38l46nRWtyHt3SdiXjX06c+lWLjfLIEk2FQPvY28EcYrPguoVtzcbd+8kljxmrMV1FPDJtYM7tnJ4wBWGzOPmcHojn5WK3EqyAJ5fJbH5CsrVYRzPBnLjPHGf8A61dNqEMEEoRipD/O3Gc+lc/euLnfEirGF4G44CjvmqizppVeeQ3w3cGS4njaTaAuN2Oo9K3pXBcxykLMq5AA+VR6se9Y+hW8EOoAgs47ED5WPT8qsa7NLvYwEJt4ZwcBvoapO2khTXNJ8pgX97I+pC3Vd27hdvtUNoHM81skIlcthVHRT7+ppbadnvDKFGSpxI3J9OK29KsPJmm6qVAAcHBHHX68046s5ZNJ2OE10zRaiGbBA4LDpxW9BbtBDDcB/lcANnvkdBUfiOH9yERAYYmAaXH3sHpTbSV51UkARL8qZPQ+tPdmTd5E9xIkbxx9OdxOauWTyLvaNwwBywxUUyW85jC/O+3gLzup1sACN7AED7vamdEbJFXWpUkVZzHufofWuX1EZO9BwOvHNdNqSEMoXoTyOhFYeqW0kQIGSSDn3pdTLEU+aByXiQb9PckdOa489K7TWxi0kjOcMueexFcWOnPWtqZ4FVWY2g0ppK1MhKQ9aWkPWgABIOQcEc59K9MGm3GsrFqOq+DLue8kRS0kV0IUn44ZkPIJ9uteaI22RW+XIYEbun413viaws9Y1ibUI/FemJ54VjG8kn7s7RlQQOg7VLA5rxg+oSa9OdWtltLnagFuuNsUYUbFHsFxRVLVrVLO+eGO9hvlUA+fCSVbI6c88dKKaAp0UUUwFHSigUUAFFFAoAWlFJSikCFrQ0JPM1e0X1cVng1f0VvL1W2b/a/pSexS3PddJUSafI4HCrxnoTXKxQhNQE/J56Hp1rrdIki/sGNMcuwBPrVO40mSK/VCm5D83+8P8a5Vue5hZJEweFHhfOFzjryR61vadEkVqZMjYrFwwPt0xXJ3kG7UfJV/kRfyroba8SW1YIm2NF2gepPeqtqzsnJ8t0Ubl3ZyJFO9/nOOy1ADIziYcRs2M+1a2o+TsW4XIYgQuezA0aLa24t5or9yqt8sbofunsSO4qUr7m9GSjG7CURvcQpETxw+T69BVv7ULHAjOC6rkn+E96p2lq5v/IYjzFOSAMZA6YrSu9OM00EmDsnBH/AhTauKpUipWKNpCPNCyMf3j5DdzmrzW8FsAhVgXIDZHJxVSDUY4rwQuhzjHNb1xFBJteCQKVAIOc5qL9jop1HZXJLW/RvJQpGWU4Bj+Q49x3q8FiLfa1YEMcPtGNy+pHrWK0lyiSRJIIRN8sjlQd49j2Na2mGOytXhlgYx7eSh3EcdfpUuSZlX+HQ0tSggigtzbMT5pGNpyB/hWOqtJfTy3ABCYBye5pkF/BFDtyzLk7SDwKLKWBpZ/NJBlwAw/r/jTg76mFGNhrWM1zcRW8Mf7xiCMY5z3qYWqRXEu4rG8AZJCehP496fZ3Vzp1wSIVmK8Bh39DVWGe3nN19skf7TncpPY+9aX1sdqcr26FOW18+Sd0U7Y1yATz7Vj2pSXdED5bLk4PBroJrqO0VjFukLH5gq5A/GuYVGjupLls5bPB7Cs7kzkmmZt8otpmJ6cqcU3UGkuNEJIAeMfy6U7UFWZmHc8/jUV3MGgI6KU2ke9DPMrz5tyh4OXOlXsrfdklwxPfGOK4nx7Gy3xLDJMmM/hXpvg63jTw7HIyj5SxGRnJzXnnj5DJctLj7si9PypRdpI4qsb0mdxpKiHQCuMAxD9BXX6AWCwyqcRPjLHscd65OAbNHRMYzGo/Ou38KRo9pHG4JBGOKio9ToprliVvFdgLPULS7iY+VKuGycgH2q1pcpcho/mHvxin+MbM/2EViYkQsGGeorD0W8Jj3g4y2CpoFbQ2p7tXvU2uRsIZh/Ste4hY2KiNiIm+d89D6H61n21vFK3mBeTzmt9RHNbC3k4HG76dTVqdkb+2skoo5bX7zzYIEtgWdvkWMryoHGatJBaW+kpBdr5rM371V4bHoPc1Z3QLcS3KsfmBVFxkhR0H41Uv54XMa+WVuiN7FxxGPf1qlU1O1VOe0TGtLdkuVhlZ0tt26TdztXPT64rQeKBNUgitSHjk3E4J6epqnLeFiyuHwQOSMbiO//ANanS3Lz3wuVhQSEBMRH5WAHf0p2urMK0JL3mR3gC6lIwcsoXcSOoFUEijnRGIZWZsgeg7ZrRvrR5LATuwM1zKFBB/hz0FSXksOmr5CR+azcLjrnHepXu6Mwpuz0KtrE7zvIoB55B4VR2qxqcbvCyyICrKWCqQFxT7VTFaqzMCznLKDjJ96o6gY3hmkhYHPzYJzt9qa11Z1WbMzTIvMvWcoqxJEdoB6nOK3byYQ7YzzNggn36CsHwvIRdTo2GZirjjqM81s3eyS6m3EqTz9R7n8qdkcns/ffMYetx/6OFjYl15IboT61y0V1JAxhYkJjJrrtUVRPIMlh25yK5SdVbUo0b7pbqP5U1C2wTpqOps6fKqwlosFjxk9varQljZwm0liNwHqaz1RBH+6J2g889akiSSJ1YOACOccHHtTv3NIwRK9yVuQZ4sgdhWfe3qTy+VwEPTP8q0oSL2eXaQpAxjHIHvWBqts0Ts8RDKjYyO1PW10RXhoYGvRgeapyDgla4NuK9A1d/tlvvGcqMVwUy7JpF9GNaUz5/FRs7kdNp1Ia2OUSg0Udc0CNLQ9XXSXmZtOsb7zQBi7j3hMdxWt/wlyf9C3oH/gN/wDXrlulITilYC5q18NRvnuVtba03ADyrZNqDAxkD3oqXUrbT4I0NhqLXb4XeDAYwMjJwcnODx29qKAM+jvR+FApgANOptANADqM0lAoAXrS0nWlFJggqezfy7qF/Rgah6Uo+UZqXsPqe6aQ+dDjQHLJ+8B9D6V1HmJeW8EgO1tvBB5DVw3hm6YWcEoAaNkAPPANdL5TPHvs22yK27b6/UVyvc9ij8NzJv1KauzAYWQ8E+lX7XdFDMuchwCMdjmptQiTUdKMsShbm3k3EHqB3FWLGOMxRKcYfqT61R1U6vuWZKlm1xYyQSuVxhw2Kl0xjLZ+VKkZdAQHbBB+tLLeeVbHadrq5yh5+U8GsyWZVLMgXyZMZUdMj0/Cjc6Yyclc0bC98m+juFz5SYVkY8qD2zXTaqIVa1SI8ljJGAeK5jTIxc8R/O5UpIjD/Wp6Z7EdqLK9ee7W0cu32diBk87aZlVinJSRSZFlvZVcnO45I7c1tW0ZRGYZIUDr82PwrN8QWkkdwZYjs8xRnjrVKyvbuJ9oY7mOCc4z7Vmkjspy57anaabHaOivO0qMSclVqa4C+butZsMBxjjPtWDFqTww7tmZe/PGPWnve+Z5VzEBGyDDknlj7Cm43KlSb1RDfTGOYF02gNkqR0P+FVnuXilQZBQ534OTjtWtcFL1Vl2l94AYetU5dJ8idFkcCFzhXIyB7Goi7aGcK6jozQ0m/MkeGy5C4IPXGKtJFAzZPzEkHnG38ajttPi+zsjEKqnAPqfU0xbKaSPCSEBe7dAPb1qG3e5mq/M+ZaGrdGH7OyqPMkbj5QAD7Adq4vXJGDEFhGc4wtbzl4oZD5kqsRyzKOfp3rkNaVnZHIfy4+cHjOfWquzWkuZ6sSJImt2A5Oc7j1zWHfuYhKhPTkfSkkvpIWZETKMOoPOapatcH7OXP3ipBI7076HJXpcrZ1PguQv4dQE5VWZsfjXEePYipz/DlWP03Cu88H2z23hi18zkyLvP0rjfHpJkcgYDMi4HpuqftI5ZL90zqIsyWcYxg4UD8K7rw1tCoRkKevNchbRFrRB/EEDZHtXS+HSGAXOA36Gs5PU63BW0Op8T2qzaXJIrZJXqOMj0rynRJjDJKknWJypyOteuzKz6a0cwDKoKn614/qCm112aLOFkwRjoeapmPL7p3OnT7bdASMOa17ks8Kqg5c4/CuU0q5jRUMp46AZ4ro5L4/ZygUlPX+lNCVN6NDreP7KfPZQ7J/q1HeqOppPNCZpFJlduQh5H1PpWhaSyzfNIwSQ/dJHCr7VT1YyhBKjqzE4C4xn3p9bnXQbUjLtoYEuUhuizRlSGKrnH096rXSiztHdYmMMfyu2cEj19qk3yiRWICqDkle1P1q+ljsbeGRP3F0N4YYJIHABrWLvqzrndtXG2Goi/uLWKLYqRKXBAzyeBxVS8kjfxBKts+/PyIT9Oak0aP7CLm5kwriI7M/w/gO9ZWmtumEqk4dimQM5Cjr+JzWcr31OeEU6jUTWuUdkeJWjAVeXPJOPSspUT7Ewc7XUkKPWtqZ7UXFn5Aj8ggebx8wPvjvWVq1zCGd41O5ieSOTWrWlzsbfLZEGkqscEdxHxLGdo/E1rXayCa5keLMP97PIrC0NHuFu0cMkZX5T/AHTXSFkFijzfMDEo46+9TFbM45+5UOX1bfAWRpAQADxzmsCzJnuWcrgLkEjrWnfTGW5lyG2nOMnpWdYttvBHkYZt5X1wK1T10DE30SNzSolMTxyfK/J/CmSeXPIFBOSeKmRUmDyRDlRyCecVctYoCvmfKi4BwepNK2pNOajuUrRzBDMiSEI5+YBRz9D1rA1C5ASZAw2FskZ61q6pOA3lxtnB4NYJhe7ukEgIiDcgDlvampW0DEzUY+pmywtHbA4++xKjviuF1Jdl9KPevUdSsjPdEk+VGi8Advb615rryeXqkyjOPetInhYtKyZnUh60tIau5wCUUUVQhUALqGbapYAt6D1r0280uDQ59V1C30eEiAQ2OmRyoZFuZG5MuDw5x6eteZKpdlVRlmOAPeu81XT7DTdKuEa41O4vNGuLdJJfP2oC2S6xL/DjGAalgYPjq0gsvEc0UEKW5MUUksCfdilZAXQemDnjtRVfxZp6abrcscM0k0EyJcRSS/fKSKGG7355opoDHopQMdaTA9aYAKMUtFAAKKKBQAvaloNAoAWl7j0pBS1LGeo/D+fzdMjiJGRxtJ9K9BSBhGjRNtlAyrH+L2ryr4cgPGx7o/QV63bPlVMhwFxyDwD6/SuSpuevhdYDJLc3cP2m1Qi5QYZV5DjuD71Rhfz9PPlEh4pPu+nqK7TTdPVh5kACyEdj1rntWjisdZkEabRcjc47bh6VMJGrfLLQz4L1L1gJ9uc8kj8KzdTtHh3hA+1TuVh3+lFzabLyUxcEndgVqaf5UluUuWJXtznb7Ve56EGuRSTMvQdR+zzJIjfvV6g9z9K6C6kK3dvfxKgeTKtjuff0NY2q6RNbusyoVkblJMcbfVh2pLO/BtJ4Zs+YpDc9CR3FFrKzIrO65rG9JezXSlZsM45BPb2rMvopBbBoQVcH5hikLSSyh4epweBV+zmkeR43cKgIPzetPoXBW2M+zu5PLw8B9ORzj1q3HZNqDkRgO+MBfuEY/nUt9H9laPPIfuD0HpVh76SC3VCWDg5BK8j0waLeZ1czcbxGwSGxKw5ZkBwVPUfSrxv4rqeNWcEFccdiPX3rEedXkcu6u46/WqEtztu4ZkBXJIPPTj9TWElZnHVp9TtftCFpHuMIhAwp6Mat2ly8kClbbPYEnC59axbASNEtzdRnP8Ckfdq/G+wKULux/iPRakxtbQmvt6Yzt4U8KtczqVu80TSjC9sAc1vzIXR2llUx9OD1/qazblM2REqtweAowKpNmnNY5R7KNo3Oct7muc16IRQOvovNdwyRhCF/dse2BmuN8WxukErMe2PrVXSRE3o7nY6ddwWmgWvmHL+UoVep6elcV4kguLuKWaUCFc5VH6n39q7LSEW20q2Jj33LxAh26qMVy+uDzFlkncPIxIVRwBWUviM1H92dHpFw09rEwjbcijI9V9a6rR0SRSULK4OQPeuX0tyltAdrABAM+1bmnyTxsklsySpnIQnBpS3OhRvE7YO5gSQ7W3/fXOPxry3xZAyavCdpGHKg+xr0bTtRhlAW5QwzD+AjHNc146gjaJpo8ZUhjVbkqLV0zEZOgVidoAAx3robQSG3h3ZIHOD/ACrntPuGZSEHA5JI5PvXQ6QZWUA5dBk8jpVqBryOMUmWLu68iORZWxgAL9KqW0tvfxBJrtvMB+WNewqdJFebZcZMIG0Fscf41SubeCNTKMO6nnAwfrkUK0Xc0pJIgucPerGJicoQAwxu9B9feoLiCV5II7mVPl/1bYz+FQySSNdtKpABwN4ydo96va3qdtLBbRwoMxDrnPPcirjZ6mzk9EjK16/Ismt8bWHy4XpmtLRIGtbLdGNxVQu4gcHqTWYqf21exQ7CsEC+dMR3PYfjXQ28bzQ5w7AKXJQdM9BUy953ONz96xQvYnhnInaNGf5iCOlZdxZoVJVpJB1JYbVp95dPGZPtCFmPCMxyR9az9Q1KQ28KF8nPQenvVqx3WfLe5Ytrj7PGzq4ypwqjuc8mtEXCtc21u/3CME+vGa403LrcouM9+K1N0rahDltuEZsnsMU76HDWsncr6tIpldYx8+c4x0FZUamLcJF/eOwO7uBV+/cLGxVT5jng9/rTbC0ea4V5B7YHJyad7ilJtJo0NKWQ2ki5LpjKjp+JNQSztI/lsxHQcdsVpSJ/Z9jJEMMzcE57VhW8hk1RVJwgPP0qpdLFylyR5mWJ7dk3PKWPOFHr6Y+taNhZfZEFxfZ89vuxY+4PT61oaJZNfXL3jj9xH8sOe/qatX8QhJY8uOhPOayk7bHE26rvI5vXAz2rtt8pew7sa8d199+qzc5I4P1r1zxDIfKZ5G+YD5R6V43qGfts+45bcc1rS3POxjekStSGlNIa3TOESg0UVQgAORg85+lerRW2uy2rx6p4Wsr65uhG0kpvVTzyg+RmUNycHtjNeVKQGUkBgDkg9/au11mz07xBqh1a28R2VnBJtbybkssttgAbVUDnGOMVMhozPGWna+LyXU9dtBH5rhC0bKyRkDCp8pO3AGADRWtrGt6bcWPiKaC6L/bvItoYGBDyGMLm4fsM4PvzRTVxHCZpaBRmmAEcc8UvakoxzQAoNKKSigBw5oBpAcj3pVoAXpS5x+VAo/lUsZ33wzcIspxyGx9eK9fsSssSfINoXGCOo968U8CS7Y5FDlGaTqPpXplhcX1m8ckkiPbM3JxyPrXJUWp62El7h6DpYa22spLKf0qt4zti1ik6gfu2DZxzjvV3SbgLAqGNJFcZUnoR9aqa44l024jUsAVI2sP5VktDea5tUcVqKPbXKzgkwuuMjpirGmWv2ohc7YmPyhe1V7TzJLLybpGmtj0I+8lbmiWiW6KsLeYh5XPBFac3RnTRrJQt1HJBOhW3vBITEP3b5xgehB61la9pLPG88AUSoDjaPvCu2Pk3MQS6hYqAcOOSprLu9PIiZrSVZVPHPBqfaO1gdXmWqOR8P3O+1PmE4TgVsOyKbck/LIw5J4FYMANpczwSKQd5OBWvbRM6xgSR7c8BxnFUp9yqdRNmkbWOc4OWjPBB9faqd7DFYyvDIJVYAHGT8o7HmrdvmSJYV2JKCQpJxmmahZ71E24mQfK7B88fj0rTfY6oNydjBvZw0gZBtOOcfzqlKBcajp0BPBlBY+oFbDWtq0m5g3AwG9azrxPsurWcm4EB8DA55FYSeupOIa2O5WQBAwj3kdGxmpYiHcKLczE/3+lR2f8ApEaqZNqDrxU00tnDEyKcnqcNj8M1JxvsR3nU4eGIoOEVfzrPuFkkBdi8iDuvFWWKrGGjCRFgDtxn9aikguG27pSoPBYdDTZSMy6sY4mEpIDYyFPWuG8Zxo8LlXJzg+3Wu51RllQHJfyycgf1rgPFu4COMMf3rgAfjSRFRu1jrEhlk0uNDKUQIq5HBPHrXIazFDEt06l3ZBhTu6mu2jQtp0QY4IHQ/SuG8TusEMpC42kAY9c9aclqTzWgdXYXF15VufJONmCua3dKv7ZlaKb9xIDkBxgisHTbjfBCVYcKAOa6W0iiuYE8yIM653k9/eo3Z1QkrK500E6TWZMjpKx5ViOSD71j+KED6c+BtG3kCrWl2UQHCbWXvnAP4U7X0J0uZiFUgEAetUr2E3Z6Hn1tuHl8McDr0wK6+11KM2sYiikUg9weT3Oe9ctpMn78BuVPBzXTjYYj8oVV6BicfhWibsbzle2g6EytJvSSFlBPyyDqKaLhFMgkEsLE87fmU/jVby0umUPD5qjjKybQDS21uzSMB86Aj5AcE0SWgnotRLp4HGV3JngsMFWHvis6W1tlh3FhkZOBWnI0UE2B8nb5l+YVheKAwtnlhKiYIR8vAIqTnlUaQ7wrIC15cSjbEzEDnsOK1rK5nlSVluGhtohvIRCdwHY1z3hpDPYxxEr5SD5z6muokVl0yYRbUjPyqSOD3NVGKYoLm1MbWZWmtkMjOrPzGvAG31xXO3UL+Y6o5kYYJ962JWNzGDjLIPTvT47IlHkKHGAfTFVpc7HLkVjL0eEfazuAZ2HUjpV7WlENxGT/ABptGPSooFkSaSUqVVQcE96TXGku7vT4ohmVjtWhy7HmYiVnZEdvYPf3gS3HCDDN1C1qvbLYxlFGH6b26j6V1Ok6fFpunpDEcEj52xyx7msjXEtwXeRyPqeTQpWNKE0viOZv7xd37w7URSST/OqmgW7XBNywKyXLiOBf9ju1Q3Nq17LJLMzrZLkkvwXx0H0rc8KYn1C3bqI4iwHpngU+bUmvV9pKy2O6iigtLCK3thyoAJx1rE1ZBE2/q3Qknv6Cukh2FdqLl8fex09q5/WoNp8y5fA/hBPQVFrhTjy6M4DxQ5jtnlcFnP8Aq1Uda8fuSxuJC+CxY5+texeIy08TqOhHAPYV49djF1MB03HFb0keXjfiIaKKK1OEbSnpSHikqkIWMKZFDnCkjcfQZ5r1q9vpbF9dtbHR9P26ckE1ohtVYywEgM2cZbIIOR0ryVF3Oq5ALHGT0Fd3ey6P4c1kW8upeIX1GyQQ/aIHRQBjO1c87eaTAx/iGrjxPK7qsfmwwyiIIF8kNGDsIH93pRWTrtxb3eqTXFnLeTRyYYyXjBpWbHJJHHWimh2KFLSYpaYgzyKO9J3pe9ACiikFA60AKOtLSDrS9O9JgKPSl9qSlFSM6XwRKqal843Io3EfpXr1gkVxauHkdQ45VfT1rxjwlcG31TIwAy7a9l8MtHKi7wu9RnBHWsZpXPWwKTg7nSeHmv7WwAhaKa1UnBc8j2pNUu5p433RmN2HI6g1WsZkitpYd5UNPuRfbHNXpljaFgg3kDp71z7s7ow3uc1ocrq6gynIJG3t1ro0MUZDSF43YcOOhrmLK5jt5yrxMrbyQQOOtdAt7A8fzSgtjBGOBQYpe8bmniV4V2lHJ5yp4NSSQMqMwQREnjJ/lWLDJAwCJIsL54dWxitIyyx2371pJk9eCDUM2tc4zVZBb6sWMZJkXo3qK2NPmgkjAIHmHt6Vn+IYhPcW79BuwfaremxrG4Jx05PrTTbM7WZdiiDpLcJEWEJ5TsB61HcXv+hzbYwJSAGR26/TjitA3Fu2wopgJG1iF+U0+WGGZkMeyZUXDI2AB7g+laqdtjrhWSeqOXZTK2/ZhR2rM1l3WS1CqP8AXLgntXU3MYyfIjix3CvxXJ+IGZI1LptKyqRg+9ZN31ZNapz6nY25drdVOAO5NaVulpBGWnVTvGBkZKn1ArCtpXSFCqmSYnOD0FadvHuHnTQzzy5z8o4FSmQ07D5pn52QFULZwVA3H1NVZoWEYMkwcnkKO2akn1hbdystpOVB/iTHFUn1S1ZcmExkcYbiruuhSTXQq3cQjRsupY8/KcY+tcLqQ+063YxHO3zM8+1dXqt7AyNsHB9DzXJ6eVvfFlnEhJHzM2ewApxV3YxqO7Ouubnam3GMjiuB8ZSA6dPtILdetdxrNtJ9qWOIEE9cdhXn/jq0e0tNyEtGxwc9q0lTbd/MMRaEH6HQeB5VurONm5O0dTmvRdPjVCjLhQOuP5GvFvAmomBGhJAKHI+lejWGsvGQ2wvGRyPWolaMmh4aXPSTueiwbNiujBiRyPSqfiF1Nt13KR2rK0jVnlYCD/VsQMHqpqXXHb7OyAIoBwQDxmrtodUKTucHYyul3IMAopIrbM0k8Z4IQdNtYlkqtfXGDxv5rZs2YMYY2IHXjv6ipg1ezNabTbNbTbmD7N5M+7YAXAjGST2ye1WNMCSNLNsxubIyev4020tWW2JhQOZASgB5HHPHepbe6iWzRcAOvXjkexq6kmrCqPTQzdTu5YNRBKq6uenYfWsPXZAxYSxMobJyh4rW1NzI5kQptxzxgmsDUHMls+2QhgCVxzmsm7nNWaktEW/Ci40cKhxnPPcnNXJVaK3eBZBvfuc5qt4WZl0qLB525PHet3RIDe5QLlw+Cqj5mHfmrpq7NMM3GPMVPsgj0oyhyhzkLjG8d81WtbgCFiW+YAnae5rT12UyEW8K/JuO01z8tvILsBsHHUDitJWTVh1WuXUz5r9nldWBYH0PQ+laXhpDca9A5UuIYy+MdCapXOmOH84H5eeM9K3PAwXzbqUsNvyoPcis5M4qvLLY3tUu51k4QRog43HJNYGqSAplvlOMkdWP+FdRewG8DSJGFwMCV/6Vzt8kKR7u/wDEx71A1FWOWv2lvkCMvlwryFB5b61r+CWLT3DqR8u1B7Yqlc72Tn5Iz/dHNW/BKtuuQFIXzMemaEZpWmd0sd08LSI2QOdinC/U1zOpO/n5lYeYx6sc7foPStW686dis90IoVG7CVzAtoru8ZwbiVR0ZmwD7U076G931MLxTKIoXTzUBZeTjJNePXAAnkx03GvWvGUa8xwMNic7mOTnHT6V5ReR+VcSoccHrXRT3Z5GM3K9FFJmtjiYh5pKWgmm9RAgBdQ+dpIzjrivUPET61b34h0/wrbXWnpGi20s1i0ztHgY3MTnPselcFoVnpt2039q6odPCAGMiAybz36dMV0n/EsH/M+ahj/rjL/8VUtDRzHiJ7p9Vka+sI9PuNq7reOHylUY4O3tkc0UmvCL+05Ps+pSanHtXFzIrKzcdMNzx0op2Az/AMaBg0metL9KoQYwOaQdKd26c0negAxS8UUUAFLQBS0AA6UvakxSjtSaGbfhNA+qYI3fL09a9f0GIx7SjKPZq8f8LsF1Qdenb617NpNvazRL5mSR2LVzVdz0sG7JnU6XABAQ3kEHnG4E5pdUcQWrYnTO35glS6NpFozDCwlcZAZjUfiVY47NkhMa4GNwAGawaO9TtoctbTR7VQjOOhPrWra+Wq5MScds1zFwJo7iKFWESHHzd61k0SORMEzu/cs5AH5U0rijqdLaQrOf3UEOTyfmyaszxywoAjAbm5Qx4P4dq5g6MtiqNm4t1JAEofIB9xXR2Ul7DEYLn/SYscMhwy++KlxKcmnqcvrzM17GQMPu/A//AF62NNllMQWWFWHY5rF1ZJl1VVzuUZZWrVsoZZdhDuD0A7Uo6Imb942YbeN2OyYxIf4GwRRcRzfcV4pIT91/LH9KiisLNlZZJNjf3i5/KmNZahaqxsZg454jlyP1plJ3Kt6jyQyKSC6njyxgCuK17zEMRlPSUDHXJzXYyW93z9okaLJzkkAVzXihJEticq5Vgwb05qWhs6S0vY7dRjDy45GK1k1DU5IgLbZHGOrP8uK5XTL2JIcowXH3nIySauiRrl8pbTXC45Mj7VxSiVJdy5IbYyO95PaO/UqXJyaoSXFnsfzZkZD0XO4VdkEkEaMNIt1XAIIw2R61h6lDZ3B5gEE/+zjH5Vo1ZDbKOoCBVMkGCOuKxvAwjfxg80nCRr09STU95b/ZsjOD39D9KyPDcxg1q7xx0GadPR3MIyvUSZ6tqka2+pxXLpuUk7gvTBrkvG2kC5trmEKd2OB+oNdDBfrcReVKQVPTHUU7XnjuoYPNjNtcxx7PM7SL2z71tOWmh2VYp2W9zw3wjAzeIoonB3KTuH0r3fTI0NuoWBRnuQK86sNINp44MrKBHPGWBHTdnmvUrMpDGpJHA6Vop31ODB0uW8X3JtU0+O0js7mGMLubaccZNU/Fj7QoYgHb29K1NWW4mOmKwPk43Ko7muI8a6jsL7mGE4HNZSknex61JcsE2zH0q4R9TuY1IyCM11FsI2fcxCuOCPUV5f4R1Hz9XvdzcnaRXodlOm9WIdnX7pT1PrXO1qcMKvO20bbu0BEdpNNuzkHHTPUD61ZhsJoo3aZ1jBOMEc5+lV7e6Fm6rJbTyTfeYk4yPr6VY+3R3czNMphVjks/J/M9ap3e7NJTbMy/iKM6xqOeCSa5rV1aFHZcbCp6djXX6jBEkLeS/mZP3s9a5LXQYrOZ87kwePSokrGbd0afhtQNLgjYEnZ8xHauk0u2gik3pMAG+VsnGKwPDSgaXbHhS6Db61vF4PKZJlJkA6Ac1SdnoVFtRshuprEgbySzrnjPt3rGfcrmSQ8kVru5Fuqz8kDIiQY49TWZesJSfLQAL0Bp7mdTXcqNKDGwAznv6Vb8DRxpYyOxYs0jH6c1hajJJGCVb5T29K3/AAMmNNEoPzMxOG6daHqYx3OnljBUNJ90jv8A4Vzep8k7U6cAt/PFdTcCUw7iytweFBGR7muTv5EQk5bA4xjP60HTFmBexNucvJhcc1N4OkAlvY928ZDA96ZesHjcMGG4cnFZvhs+Rqrpk8rwfxpoxlbmuduzxGN1lLBnOT8pIAHYVhX7qzShZZUjwQoXjPsa6+xLiDLOgAHV81ha7K8jsqPCAOCVNXobRdjgtZs41tw0gyS2OtefeI4xFqbKq7QVBxXqF7BEPnlkZ2XpXmPid/N1Z2xgY4+la0zycbvcyKQ0Ec4pK2OBhSHrS0VQjR0XQ9Q1tpl0yATNCAXBkVMZ6dSK1P8AhBfEX/Pgn/gRH/8AFVzaKZHRAcFiF/OvRLnSfCdguqxzWGoXL6S0SXEguNpk3HBYDHGD2pN2A4TVNOutKvWtL+MRXCgFlDBsAjI5HHSitDxlZ21hrskNhD5NmY45IPnLb0ZQQxJ7nOcdqKEBiYoNBpORTAcOnXijkEDqKSigB2PT8qB7UgJzRQAvSjPSigdKAHZpR1FNpRSbsBq+HCRqkYGCSCBXsvh+6VIkDAZ6bscV4t4fJGr2+DjLYr2HRYY7v5S3yp+Vc9Tc9DBLc7C21a0hYec0b4P8KmovEeoQyQJLCP3QYE/LjNQ2kahiiIuCOMjGTUerQNNYznGViG5RnuKxdz01BWuUNegg+yRXCx4jLA5J6A1oaXZxz2vztLJx94t2qnqih9HXYrZKKdoOQQeopdGlMUA+zyI6jja5warqOlubkemie3eFZZUhYY2k5/Q0y3kktrcWt6onTGIJx8rJ7NVuynupGJe1d1Ix+6YHFRTwQXrBWNxBwByuMik2Odm9Tk5JSuuSuquFjXbgnIOe9alpfkyBXco3tSQW8UN3eRyuW2qMFxzj2qhapG1yzTE7QTgA9anZGL96R0gmsSrEh7iXPRVJNHnxtgRaRKSDwwYrUMF1eSWxjtDFaoBznGaiiLg4fVyHJztGME0rG8VZamiZWePY9ncIp7sdwrlvFEaLZSsoygHI7iugnvL6zQHzY5Y/UNzXN6vqwuY3RoyC2Qc0rGLbuVdBuY47GJ503FVGB61Pd6lc3b7izpF0AXgVR8Pi3eONZACo+Vg1dLIloEwkkWBSijpgkzOig88IFafPdjKSBVR7SMTHz3lkPYlsVLLc+QxCOAOwFUZbi5uOII25/jYYAqm1YqcbLQj1aSBICixsGHq2a4uLUBBrUjEYDgcGuyvIDBaMZjmUjk4ry3XpN2pNtJG0Yq4RueXiJun7x6XZasvBjkGRjvV241jeGaWTcx65PWvIbfUp4MHOTU8mt3DrgEitOSS2LjmKtqekWmpGbV4I4TuwS2Ou33rv7QLHEt1euUhXkIfvNXzrpmr3un3wvLaXbL0ORnIrp/8AhN3mG65aR5MYO41LptEUsYnJ3dj1/VvFIlzPIwykflxheFRfavH/ABhrzXTuAxOffvWZqXiaW4BWLIBrn3dpJCznmnGDky8VmEXD2dI6DwW+NSk3EjKHpXrGnRSxJGyZLkdjXkPhEn+2Y9p7c/nXsum3bMvy4UgY6VFZe8Rgpe4asaN5ayvh3BwTK+QT9Kt4neFpWEWBwQTkD6Cqqi6WFWe8hgDdE8sEkVnGWTeyxX8O/wB1wDWZ3p3Rp6kYZkQRwmF8fMVOa57V4mW1kH3o8c8Vrxz3RO26+ZR0ZMHis/WC7Rv5W1lI5A44qZdyL2difQGeTTYCSowuAM9q3rOJo5FBMsZPIZOcHtnNcz4ThYWMchICLlgG7Cul/tDahMcMkx6nI4qtLi5tBk0U8sryNcqQQcyMMZ/Csa4UbAVlZm7jpUsuo3Dz4Fo52HoeAPrT7qdxGTLbCPjOU5qlZim3sznbvLq65JC1veDLjGnKDucBiAo+tYly7SEyICrY5GKb4cW8Zbj7M3lxq7ZI+8TSt2M46ysd/ey6ldxrFHIkEPTapya5W5iBuvJkmnlcnGAQK0llePTjPCEMuPmkkY/KfpXP2mlyTzSXN9JLycjbx+NUlc0Sd7C6nDLbx4jdiP7r9qxtLnlXVYpJUAUnZxV3xHYxWyobeaRS3+1n+dZdtbS2rwSTzByWB2kYJOadrGM73PWdJVmiAEnkk9Wxu4+lZ2qGNWkRV81zk7guMVY0i6MUXmIzso/gXv8AWs7VLppJHZ5IbdOhwcmmtDdHK62zCNgBnPrXkfiM51WTp+Fer6pKJUcLcZHtivJNbIOpTY5wcVrT3POxqKBptKelJWx57Cg0UZqhCdeACSfSu6ub/UrDxLbQ6zPpLTXVslverMpaML1Xz9vO8fKcjnpXExRzFWmhjcrEQWdVJCc8ZPbmu5v7XTNbu21HUtN8RWt5KA08Nva70kfHJVjyufcGpYHN+MjqDeIrn+1lhW5UKqrD/qxHtGzZ/s7cYopviy9kvtakkktJLJEjSKG3kB3RxqoCg56nA60UXAx6OvNFGaoBaO1HejIoAUUf5xSUd6AFpRSDB/wooAU9aUdKbThSaAv6K2zVLZu++vXvDzlMksBuPNeMW7+XPE/TawNet6NMhhRjjkdawqLU9LAato7heMPu+bPA9RV2dVaydY13Fh8xz90Vjabeom1mOQOoPIxWxJOkgeOLaoYdhUWuerZrQ5rTLtTbfZronarHa+cd+lXIbIqrGOUNu5GB0rOjVUupo2AKB+c1tadbqZgyqRnoVNS0YQdmy9ZI+3y1lQ7iMhjtNXJomhz5iSlc8FZM4FW7KEsytgllHRkDCob7AJUxBMf3eAamRfNdnH3gdNQd4maQBc7D1IzyKjj063vpA8Mjq+N2N3I9setMuroRa5EUXpkHmrksatObm1BZx82U6/QihbEJ2mEekMFxLuyWwD5hqy+kfZiQsSjHfqas2d7DOFjceX67xitWS8CW5xBFJ2++Kdkzq57HP322PTmRl5I7cVykEOELGTdjPBOcV0Gsu90VSV1ijPQA5NYd4I4AVt847moMaiL/AIYtxPazD5GIdsKf4vbPatn7LNER/wAS9GAHB61g+Cl82KRvMZcyHoa68RiLIOoOrdBlOlJIIN2M3ZJMy/6EiAHnIAzUk8aRrmQgH07Cr25yrMs8xQHgqVGaxruWBQSxZm92zVLyG3pqc14nuR5bbWOMGvJdQkMl9Kx7mvRfFVwCrtjCgcCvM2bfIx7k5raitbnk4yethaMD0pM0V1HCLRSZpCcjFACnFA96TNLmptYDd8HNt1mJs44NewaPBM6M8Kqe/PFeJ+H32arCex4r2vQTutBhyCex6GuWsvePSwT91lqG61KCfAhgZxwQW61Uvr+VZyLixRS3Uocg1YmjkSYMqk7TnINJLGZ5d8ocADrtzWXQ9ZJPcrLdWLAr5ckRI7MRUEwMVyiLOWVxxu5rdhksY4AZcd8n2rAvpopr17lEYqikDCcUpJGM/I3fCrRpphdl3pE7AY9M1pm+v7rKWSLDF0BZeT71jaYZYdHgeKFSjDIzxyTU8KyPE5nvXibOCsa5NNGaXUS6tbxZWMt8Q7HLBUp0kVzHaMyzRTqBz2b8qpzxMJhtnu3J4DE4/Si6lnt4iqyGUgf8tFwfzpoqUG0jFmvJTdGEL8xBO0+wq54TnuGimVId48zOc+orIu2eWXdNEQ49+CK2vCjOJbjYwjXcMDGccUGUFaZ0Q0+4ukBnJhhU5Cgj5j6mmzwkRYMsr46ba0ZIrma1BEqkD0O2ufvIJBKEmkUj/fLVUTZtvqZWprCuGlOXzkLncRWTEz3F5A8pITzQFXHTmty4hSMEqAD3IWsWJs6paoFJ/eVTMpXlJXO1mjZ7dYVkEIPLHuTWY9jAs5UxB1XIZ3OcN2raxtRAcEDgEnisi4nwJwTjeeufTpRy21O1U21ZGBqJgCSbI1V16YFeR6z/AMhOfP8Aer1DUGIyw4U15hrJ3anO3qaunueVmMeWxQNIKdTelbnlsSiiincRNBczxRSwRTSpFPtEiITh8HIyO+DyK9F1GW302+WzvPHOtx3AC+YvksRESOjHf1HevNVYqQynDA5B9K9KTTTryR6pqfhid72dQ37u/SBbo4+95bfMM47daTGY3i/w/t+3XcWsT6lc2fl/aRcRlXMbAbHVsncvI/Oiq2teIp2j1i2udP8As2o3jpDLkkCCGPG2JVP0HJooSA5WiijvVCAUtJRQAtFIKWgABwaM0UuKAAc06m0UmA/txXofhy686yhOcnAB5rzvtXU+CbsJcm3c9TuUGs5q52YKooVNep6noOnveSo7uVQnGB1xXR65pA0xYp7Yv5eMkE5rM8O38KIoz04Nd74yiP8AwiOmXqKhWYPF8o547mtPZwUT1o1Jcyv1PLZ3DXsm3gNg/Wul0gbyOMhRxjrmuW1FwNSUQjcFiU49a6XT7iAxKz7ozjAPSuV7kzVpNI6W1Lgl4WxtGSkg61Q1S4bymOPyNOIEkKyRXLS7eDxziqWpOqphFAHp3qJjgtTiL6U/2pG/Q78HPSteGEsRIjPC5/iTkGsDW5djhj2kH866bT+VVgflI6jtSiTN2kyaONndVuikn/TSP5T+VXF0y2miZort1I52sSKt2okwfkiuF9GWoriG2dcBHjJOSFcgA0+UFN7GZcaaY1bLqSOhzmuS1mMwbyZQwHOBXW3lqAMqdqnjhuTXG+JQkNvJt3E9OtS0NvubPg6ONNOj3j5j8xx15rqUmiVyscssRPZk3A1g6BAF0+JShZgowvqatz3N7Gdpkjt489R1FJGsVoaN6pKAvdICR0A21i6sVRS3nKTjoKGhjMReVriQ56txxWRepGwJG4Ad6dwlexxXjCaQ2rOBtQnArivwrrPG7lY4og3yls4rk+1dVJWR4eJd5h3oNHb60lbHMHPrS5wKSjtQAueKKbTqTGWdOk8q+hb/AGhXtPha5VEXcQcevavDlOCDnoa9T8I3gltomzzjmuesup24SWrR6bbtFdwySL5OYyFIcEM30Peq88zICsSW656fPVfSieGSMOev3toq3dG5dm32kXTOd2f1rHpc9KMmYd357ud8kKrjnaRiqt9JFDYyIsgZth6d61p7Vwu+SKBVPIwa5zXcJaT4Kj5SeKiWg5O51OgTH/hG7dGUOpReV6ipIYT9rEiAhejKy/kayvCc7DSoFUhl2DiugVmdCYppIzx34qo6ijZIqXNlIJPM6oem2q984WPAjLHHU1NdeaWIe4uSuOoUCsa6xg4lmYnpuFU9NjRz01Mq4WW4uVVyIlAJz1NWfDpVrm7WBvkRhGD68dap3yEg4dlH+yMGrvhHYnnqBgb8VKOe/vHoWmxBoCDtYgZGTnFZuqR+VISTiQHjjj8Kv6crZUQAF+2TxVbXokiuAQzMTzuJ798CtEtDTqc5fsSjZGRjmucsyDrtsCMZY8VtXzN83zHaea52yOdciwemT9aFuKKvNI9BjXzJhEWGFGDzXOavOIZpI8jHQCtfS7KS/uJGExiiBPTk1R1/QUilfbK8hxncT1rZ05SV0jvdVQlY5O9m3RNk15nqb776Y/7VeiayjQQ/N97Feaztvnkb1Y1NNWbPJzRptWIzSGg0netjxwoopM07AORtrqSNwBBKnv7V3HiDSk8R6xJq9hrWmraT7W/0m48uS2wB8hU88Y4xXG2djd3xcWVrPclOWEMZfb9cDirLaDrBz/xKdQ/8Bn/woYFzxrf2+o+IJZbOUzxJFHD55GDMyIFL/iRmipviBEIPEKxiMREWdtlAu3B8pc5HrmihDOcooopiDNLSUUALxRSccA0fnQAtKKTtijv7UAOPSkpTz9KTNACg9qmtZ5La4SaFtsiHKmoaWpsCdtj1vwr4s0iSOM3xlgkB+ZVXcCf/AK9eha38TNKm8JW2k2EEjvDI0gnlOAuR2HUmvmRWKtlSQfapTczkYMrfTNS+bZHZTxKVubWx6hYax9v1aVlIOwBSa7e0YNEo3Ju7A1474Bf/AE2dD82QGr0+3kR9oIBXpkcE1hJWdjuo1XVvJnSW4mikzEiK3seDTNWmby1MiFc9fT6iktY0lcFJJkRRkkOeAKoXwEhbDNsJxljk/WplsdUFqcd4syhTaP8Aloh/UV1li6xNtDhVPODXL+KICYkPJXzFH15rpraeFo42lGwgAH0qVojKa99m9asFQPHJhieVDcUXt0FP3SzEYzVKC3tiu9LgA+zcVLcBZkXZIgdepDdT61oNJGLqFw6zEHdjryK5XWXE1zBESAryjmul1DzA7B2Bx05rlZ/m1a13YYeZnFZPcdRWR21pBP8AKoudkZwBtFW208LNvaZpn52k4wKrWkxCgIvyehq1KCW8yAgBexOMU7HQlZIq3DlVJLcHjAFYF6zEkscbugrZvGbaRgKcZrFvOG5zx/OixU0uW55944P7+Fe4JrmTxW54wlEl9Go6gHNYR9K66ex81Xd5sTOKKKM8+1aGIhoHvRQaAAUtJSg8UgFBrtPAl2VyhIwpriq3fCU5i1ApxhxWdVXib0JWmj2yzusRFMqoIFbhuEeFQZsuOyDgfU1x2lSkouADjHB71081zcLANlrCARwc4zXMnoev0Kl4EDEiYux7DoK5vWADDKMAgr09a2Z7m7ZNnlxFegCGsu/DeQXeFQ3QHrUS1LS0K/gy5ZrKNS2MAqw+ldfbiXeo2GRc5IL44rz/AMETFZrqF8GSOVgB9a7qEgbWkBGPQdaqOhlF3RburSN/mQFD/daasi6BjyN+B6LXQzCOa0BVW6ZORz+dc5fTFlwSBjpgVckUn0Ma/dcNhWI6c03wkwZ7sNwfN4/IUmoEsSd3H0qDwa4/tC9XIOZahbkJe8j0vTiqjBYD61S1BEtnZUdEZjkAncw/wohmCQyYfy3HdjxWRf3VoiYOZHJznBJ/OrTN3FlDUc5b5ix9TXO2Uwh8QQkgMMHIPcVtTSQu5ZGbHYHiuI17UP7P1SC4HKliMe1C1Zi5+zkpS2R69okkkQ2GMrHgtkDPWqetX4y4IPHeuT0Px/Jp4zb+TMh6pKMiq+sePIpMubG3B9mIFdUaita5tVrJLmsmZHjPUNtigIw7KR+teen86v63qc2q3jTTYUfwov3VrPNSlq2eLiK3tZX7CGkoNGao5xCaM0UVQFvTtTv9NMh068uLUyABzC5XdjpnFXf+Eo17/oM6h/3/AG/xqfwta2RtNW1LUbZryKwiQrbBiodnbaCxHO0VauNO0/XtLnvvD9u1pfWy77nT95cNH/z0iJ5wO69ql7jOcvLu4vbhp7yeSeZgAXkYsxxwOaK2fHFpbWOvCGziWKE20D7V6ZaNST+JNFUhGBRRRQAUUUYoAKKKKADNKelJQaAFH1pRjNNFLQAoJ/ClzSA0CgBRxThTc0tSB0ngiQx6vnPBTBr1nTow+3adoPU15B4QfGpnP9z+teq6bOAgORjFYzXvHp4LWJ1FlCc7o9ztk8cj+VVNRiKDc4ALZyvpU2manBCrFyORjPoaq6neJOvyHOevOaUoqx6UU0zm9d+dbWMdPMHH41r2KyNAyoqsyN91vSsfV2Ci3PBxKp5+ta0ajzfM2SKWAztPFYkte8PdLoElba259Dg1NGJVUBrWIDuKcun28h3v5mW6MGxg+9MeAwAbLuQAfwn5hTsNJGdqk7BGQJt9hXKGQtqtqD2YnP4V0mqvlCd7OfcVzEak6rAXHBJ/lUWuyaj0Oxtr7YApI59a0TfIUzuUnGODWPp1ik65mLZ6A10D+GrRoC6TyLKMdBgV0RozeyNXOOhl3F7uJCqeB1rD1CcgMTk81qvbPbTvG7h8dCO4rn/EUot7d246VDi09QqyShdHnWuTedqUhB4HFUDT5n3yu56sSajNdUFZHzU3eTYZpCaWkNUSKDQaTNL2oAKTuaD04o9KAHCrmjyGPUYSDjnFUqkgYpKjehBqJFRdmmex6RKdigcsK2priZrfyoc56tuPX6VzGgSGSGN87TjrXaQxvcICoVtq9+M1yWPeptOKZif6ZvXc0RUdFwaZqJu4xmYRkY5xW1Nb+W6+4/KsnUUMhO7lenWoasU9zktBl+z+JbtRwH2yf0r0iCcYX3rziaIW/iG2I4DxlT7nrXUrdO6KiMQfUVadjKjBttHWyO8lkwEwQHop6gelc1dts6k7h7da0rS0YWhmeXGByTk1i3k6F2BnB561cnoimrNle8H7rcSeazvCif8AEwu2HaXP6Crs8oaIjzMkDvVbwwdmo3Kkfx5P5VmiY/EjvkjEro0bZ3AEKVyKpX0HllzgA+gHStTS40CYODz8vNN1hY4U3EYbGCCa1UNDZyu7HJ6jKRb4CDcORivNfG6eWbbJy7Fi1ei6hIoyuecZrzXxkxe5iJ7ZFEPiOPGxtA50My/dJH0NNZmPJJP1oNNrex5Nxc0hNGaTOKeogNJRRQAUUUlUBt+FZNagvJZ9At5rh1XZMiQ+ajKf4XXoQcd6ns9E8UWV8l5Z6VqcFyjb1dLdhg/l09qoeHNVvNI1WG50/c0mdrRDOJlPVCB1zWhfweIxLNPDa63b2pYsiMZG2Kegz3x61LAp+KrrU7zWZZtbgNvfFEDxmLy+AoAO3tkYorLuJpZ5DJcSSSSHq0jFj+ZopoBgooNJTAdSDpRRQAtFIKWgAooooASlpKKAFzSg0lFK4DhSim5paVwNnwwf+JqB6qa9EtS7bUUn0Feb+G226tH7givVdJABUHg4zUOHNKx6eDfLC6NvStF+2RYKhpSMjJPaqGpWb2sh8tSFA5wc12PhmNZJ41HUkgcHniqPiCJEmmDEbSCM1pKlCx6MJO5xuoHzEtw2Cd65rftWGQGHynArnZ+be2kYYVn4Prjirq3yJGQW5/lXJbUuUfeudfAoYfIxHsw+U0yeN1jAaFPLfoynI/Kufg1a5sijPGwjbONwyDT5daWZ/kcJ6gdDVaddyeRhqUaKh3gZHQgVx0g3avGf7qsf0rdv7supGRjFcj/aaW3iG2eUbkOQy+o9KlfEjCrLl3PTdLjVoYm9cDNdNb3FtHaMJZG8zP3cZyKwdIWwuZIpLW9RrZvmKk4ZT6GukE/hW1to31TVHJGcwwtuY+2BXVCdkW68DibiaN77KngKSTXnPju+CqYUYbnP5V2fijxNYRQSrZwLHHyFYj5jnqT6fSvHdTvHvbp5XOQelZ/EzmxddKFlpcq+1Jmg0lanjjqbRRTAKM0UUAFLSUZwfagBaXNNH6U4dalgek+DroNbRA8gjBBr0LT71beLY4BUcjFeQeCLoLI8TH7vOPavQhL/AKOTg+orBppntYV80Ebd3fwYYhXAJySec+1Yd1egg549MVYsdHvdUt5Js+XEgySTjP0rM1DSHgyRNuI6ipnTm1exu5R2uYWtTBbi3uOgSQA/jxXV2CKApPcVxuqxuLSbzAflII/A112jtvgjz3Xis1chO09DZmuMW4idJZhnhUGBmsS9MgkCi1jQNwAx5rbit53x5JHTr3FULmz2zh3k3kYJZvX2qrNlvYxLmOSIlZEXp0B6UzQGH9sSdumRV3UI2cPlSFPUk81m6KBDqzKhzlep570krSJiveR3gvVtSAWwF7VWv7i4vFBggcQDqzd6jWH7VqTLL/yzwCO3SuivYAdPUBuAMe9dkKbmrs1k+V6I841dzHkHIZeDXA+J3LhGPXdXo+u2iqjEdffvXnniyIxYQ9jWbg4yOXFz54PyOb7000pNJVnjMM0hoIoqnsIKKKTNIBaT8aM0VQHVeBJin9qw2VzBaaxNCq2c0rBQPm+dVY8KxHQ1fg0fxzFcrKLq7hIOfOk1BQg9yd2MVieGLKwktdT1HVopbi1sI0P2eJ9hld22rluyjuatX2l2Gr6RNqPhxZYpLUZu9OkkMjRr/wA9EPVl9c8ipYFbx1PbXPiSeS0eKX5I1mlhGEkmCgSMvsWzRSeNbG207WxBZR+XD9mgk27s8tGrE/maKa2AwKKKKYCmikpaACjNJS45oAM0ZpKKAFzS02nUAFFFFAAKWkFLntSsBPZz/Z7mOUfwtmvWtKla++zzW7qMxjI/GvHa1NO1e4swqpNIqr90q2MVLVjooVXDRH1H4Ds521CyxJDuMoxuPB9jWX4wjsdPu7n7ZOs0gdgsCnHOTj8K8UtfGN+ke1NTuU9NsmCKqy66AxdpWZyOWJyT9TSlU0skehSqXd5SXyOx1O9ib7DBHgNuIZfQ+1W9OhEjHzMFc4APrXnGm6jJea9as5Ozcce9ereFLMXuspa78BpFGcjBJqIp3uzZYqDTl0Ont4PKiSKaON1kXeM+mcVj6/pcIYNAixknGFXGK7nW9LtdDlYTQSSzxIqhmcbAQckYridR1PzZAwUDOTtFby5be8jVPnXPE5C8jaCOQMSccg+tec6zKXvmJPK9PavR9YmA0+WaTglmP4dhXlV1J5s7yDu1c8I+9ocWPl7qXU17HX5oFVZl347+tXJvFDFNsSY9cCuXzzTc5rRwOFYmoluXb7UJrtv3jHb6VTzSUd6pKxjKTlqxc8UDpSUVRIUGijvQAvSko70UAFFFHegBaKQelGeaALulXTWl7HID3wfpXq+mXIn05yMHABrxwe9dp4N1dQgtrhyo6fhWUlZ3O7B1uR8rPctDEcunbI2xlQaw9Wtf3hOODWhouoxw6dcfYplBbh0GCSPX9Kxbq8eQtyCc9M1vKd4nfCzbOU1+ECK6Q8Dy8irnhS5Etjb5xkqPzqp4yIstKee4bbPMCip32+tZXga8D2axnG9OK43vchTTmoo9RtZkUAN16elMvo4/LEmQAOvHGe2KwrjUPK8svzgc49aSOS61HAjG2KPnLdq0TvodMoJK5V1aYsCDj8Ky9LnVNbtycY5FWdUt5k3AZY/Sube5e2njlI5jbNZNNO7I51pY9JtmeG6uPMXazSfpXS6hgaXDJ5gy4PFcTput2syAT7CrfxZ5BxXUy6lo0ulCD7fCsy5OHbHX+ddVOWm5pVqqLTaOM8QTgW0h3fNjPWuB8aHDopOScH9K67xBdWAhkUXUbnbjCnJJ/CvOtevRd3fyElUGAalu7POxFeLi0upmk0maKKdjzWFJRRTewgzSUUUkhjgVw2QSe1IaSiqEaWh6xdaNcSS2oidZU8uWGZA8cq+jDvUOnaldadqCXthL5NwhJBXpg9RjuPatPwnpsN3LNcXMP2hImjiit920TTSHCKT2Xgk+wrXtbt7zU77T5U0W7ggVikEdqIlnC8sIpAAytgHBJ5x3qGBzfiDV59b1J726jijlZEQrEu1cKoAwO3SijX7GOw1Jo7Z2e1kRJ4GbgmN1DLn3GcH3FFVcDNooPWimAUUUUAFLmkoFAC0YpBTqAGmlzQaSgB1FJS0AJS0hpT1oAM0tJ3pR0oAKBRSHpSsBZspvs91FKP4GzXqWkzWkwiuSSs4wyzJ1BHQ15KvU11PhxmEceGI/Gobs7nZhJauD2PaB4j1Ca1ZLyRL1GOWkz854xyDWBfXNujtJEjA46SEYz7YrnkZtg+Y9PWs7WnYRSYZu3f2pSldHcko7FHxjrSSJ9mtzxjBNccDTpiTI5JJOe9N7VUFpc8uvUc5u4hPPHSkpKO1PcxFBpc02lqgCgUhoWgBxNJQetI3SgBRQDSCjuaAFooFBoABS5pKKAFzTo5HikDocMKZ3FLSeoXOm03xPNb7dzsjjowNaknja5AyJYiR3MYJrhaQ1DjbZnRGtJmprOsXOqzb7mV5D6n+g7Vd8I3Xk32wnCtXPf3auaX/x/wAP1pNe6KlNuomesyp5/wBmB53cfrXeaXCkemNGmxcjnC1wcR/4l2nf739a9B8Oc2c+fQfyrbDLdns1tbHOanbbWORnPpXDa/aoRcJ3C5H0r0LVq4XW/wDXSf8AXM0VNdzKa1PPrbUZrb5SSyjjr0q02tll5BJrIk/1rfWo/WsORHmfWKkVyply6vpJsgfKD6VTJooq0kjGUnJ3YmaM0GkpkimkoopvYAooopXAKDRSHrRcDe8LalDaST211M1vFMySR3Cru8iaM5RyO45IPsa6MLawTTXgTRbB5VYPewXhm2hgQxihByGIJxnpntXn3rSDrSA0tfv49Q1FpbeNorWNFhgRjkrGgCrn3wMn3NFZ1FAH/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patients with generalized ACLE may present with a widespread morbilliform eruption that is often focused on sun-exposed areas, including the extensor aspect of the arms and hands.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_17_31000=[""].join("\n");
var outline_f30_17_31000=null;
var title_f30_17_31001="Establishing the diagnosis of renovascular hypertension";
var content_f30_17_31001=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Establishing the diagnosis of renovascular hypertension",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/17/31001/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/17/31001/contributors\">",
"     Stephen Textor, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/17/31001/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/17/31001/contributors\">",
"     George L Bakris, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/17/31001/contributors\">",
"     Norman M Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/17/31001/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/17/31001/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/17/31001/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H16699471\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renovascular disease is an important, potentially correctable cause of secondary hypertension. The frequency with which it occurs is variable. It accounts for less than 1 percent of cases of mild to moderate elevations in blood pressure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/1\">",
"     1",
"    </a>",
"    ]. In contrast, the prevalence is much higher in patients with acute (even if superimposed upon a preexisting elevation in blood pressure), severe, or refractory hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The indications for testing, methods of testing, and interpretation of diagnostic tests for renovascular disease will be reviewed here. The clinical features and clues to a diagnosis of renovascular hypertension, as well as the treatment of renovascular hypertension and ischemic nephropathy, are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27991?source=see_link&amp;anchor=H3#H3\">",
"     \"Who should be evaluated for renovascular or other causes of secondary hypertension?\", section on 'Clinical clues for renovascular hypertension'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/43/29369?source=see_link\">",
"     \"Treatment of unilateral atherosclerotic renal artery stenosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8040?source=see_link\">",
"     \"Treatment of bilateral atherosclerotic renal artery stenosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/0/26631?source=see_link\">",
"     \"Treatment of fibromuscular dysplasia of the renal arteries\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/41/33433?source=see_link\">",
"     \"Chronic kidney disease associated with atherosclerotic renovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H517662\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testing for renovascular disease is warranted in patients who fulfill all of the following criteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The clinical findings suggest a cause of secondary hypertension rather than essential hypertension.",
"     </li>",
"     <li>",
"      The patient does not appear to have another cause of secondary hypertension such as primary kidney disease, primary aldosteronism, or pheochromocytoma. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27991?source=see_link&amp;anchor=H4#H4\">",
"       \"Who should be evaluated for renovascular or other causes of secondary hypertension?\", section on 'Clinical clues for other forms of secondary hypertension'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      An intervention is planned if a significant stenotic lesion is found.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are a variety of clinical findings that increase the likelihood that hypertension is at least partly due to renovascular disease or another cause of secondary hypertension (",
"    <a class=\"graphic graphic_table graphicRef56130 \" href=\"mobipreview.htm?41/38/42604\">",
"     table 1",
"    </a>",
"    ). These findings include severe",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    resistant hypertension, an acute rise in blood pressure over a previously stable value, and young onset hypertension with a negative family history. In addition, there are other findings that are more specific for renovascular disease. These include an otherwise unexplained acute and sustained rise in serum creatinine of more than 30 percent after initiating a renin-angiotensin system inhibitor (eg, angiotensin converting enzyme inhibitor), moderate to severe hypertension in a patient with diffuse atherosclerosis, renal asymmetry (eg, a unilateral small kidney) that cannot be explained by another reason, or recurrent episodes of flash pulmonary edema (",
"    <a class=\"graphic graphic_table graphicRef56130 \" href=\"mobipreview.htm?41/38/42604\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27991?source=see_link&amp;anchor=H3#H3\">",
"     \"Who should be evaluated for renovascular or other causes of secondary hypertension?\", section on 'Clinical clues for renovascular hypertension'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to estimating the likelihood that a patient has renovascular disease, other considerations should contribute to the decision of whether or not to pursue an evaluation for renal artery stenosis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Antihypertensive drugs can effectively control the blood pressure in many patients with renovascular hypertension, and it is unclear that correction of a stenosis (with either percutaneous or surgical therapy) frequently results in additional long-term benefit. The ongoing CORAL trial is evaluating whether or not percutaneous revascularization of renovascular disease is superior to optimal medical therapy in preventing cardiovascular outcomes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/43/29369?source=see_link\">",
"       \"Treatment of unilateral atherosclerotic renal artery stenosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other than an otherwise unexplained acute and persistent elevation in blood pressure above a previously stable baseline, there are",
"      <strong>",
"       no",
"      </strong>",
"      routine clinical, laboratory, or radiological features that consistently predict who will benefit from correction of the renovascular disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/4\">",
"       4",
"      </a>",
"      ]. Lateralization of renal vein renin measurements does predict a reduction in blood pressure after revascularization, but this invasive test also produces many false negative results. (See",
"      <a class=\"local\" href=\"#H16699573\">",
"       'Renal vein renin measurements'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Testing for renovascular disease is associated with potential risks, particularly in patients with impaired renal function who are at risk for contrast-induced nephropathy and nephrogenic systemic fibrosis, which is associated with gadolinium exposure during magnetic resonance angiography. (See",
"      <a class=\"local\" href=\"#H16699485\">",
"       'Diagnostic test options'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/22/31082?source=see_link&amp;anchor=H4#H4\">",
"       \"Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure\", section on 'Gadolinium'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/13/10457?source=see_link&amp;anchor=H6#H6\">",
"       \"Pathogenesis, clinical features, and diagnosis of contrast-induced nephropathy\", section on 'Epidemiology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Procedures undertaken to correct renal artery stenosis can be associated with morbidity and mortality, particularly in patients with underlying chronic kidney disease. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/43/29369?source=see_link&amp;anchor=H13#H13\">",
"       \"Treatment of unilateral atherosclerotic renal artery stenosis\", section on 'Procedural complications'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/43/29369?source=see_link&amp;anchor=H16#H16\">",
"       \"Treatment of unilateral atherosclerotic renal artery stenosis\", section on 'Surgery'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8040?source=see_link&amp;anchor=H10#H10\">",
"       \"Treatment of bilateral atherosclerotic renal artery stenosis\", section on 'Procedural complications'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8040?source=see_link&amp;anchor=H11#H11\">",
"       \"Treatment of bilateral atherosclerotic renal artery stenosis\", section on 'Surgery'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of the potential for harm from invasive procedures, we test",
"    <strong>",
"     only",
"    </strong>",
"    those patients who are thought to have a",
"    <strong>",
"     high likelihood",
"    </strong>",
"    of benefiting from the procedure. The following scenarios identify such patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A short duration of blood pressure elevation prior to the diagnosis of renovascular disease, since this is the strongest clinical predictor of a fall in blood pressure after renal revascularization [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Failure of optimal medical therapy to control the blood pressure in someone who has, based upon clinical clues, a high likelihood of having renovascular disease. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27991?source=see_link&amp;anchor=H3#H3\">",
"       \"Who should be evaluated for renovascular or other causes of secondary hypertension?\", section on 'Clinical clues for renovascular hypertension'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Intolerance to optimal medical therapy, including a clinically significant rise in serum creatinine after initiation of a renin-angiotensin system inhibitor.",
"     </li>",
"     <li>",
"      Progressive renal insufficiency that is thought be a consequence of bilateral renovascular disease or unilateral stenosis affecting a solitary functioning kidney. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/41/33433?source=see_link&amp;anchor=H10#H10\">",
"       \"Chronic kidney disease associated with atherosclerotic renovascular disease\", section on 'Revascularization'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Suspected fibromuscular disease in a young person in an attempt to limit the need for life-long antihypertensive therapy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/0/26631?source=see_link&amp;anchor=H3#H3\">",
"       \"Treatment of fibromuscular dysplasia of the renal arteries\", section on 'Renal artery revascularization'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Recurrent flash pulmonary edema",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      refractory heart failure. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/7/41079?source=see_link&amp;anchor=H16441210#H16441210\">",
"       \"Treatment of acute decompensated heart failure: General considerations\", section on 'Renovascular hypertension'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Testing should",
"    <strong>",
"     not",
"    </strong>",
"    be performed in patients who have a moderate or low likelihood of having clinically significant renovascular disease or who respond well to medical therapy. The existing randomized trials comparing percutaneous revascularization with medical therapy were primarily comprised of patients with moderate and low likelihood of clinically important renovascular disease, and showed no evidence of benefit from adding revascularization to optimal medical therapy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/43/29369?source=see_link\">",
"     \"Treatment of unilateral atherosclerotic renal artery stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16699485\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC TEST OPTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;We agree with the 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association",
"    <span class=\"nowrap\">",
"     (ACC/AHA)",
"    </span>",
"    guidelines on Peripheral Artery Disease that testing for renal artery stenosis is",
"    <strong>",
"     only",
"    </strong>",
"    indicated if a corrective procedure would be performed if clinically significant renovascular disease were detected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H517662\">",
"     'Indications for testing'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11700845\">",
"    <span class=\"h2\">",
"     Testing options",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gold standard for diagnosing renal artery stenosis is renal arteriography (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71793 \" href=\"mobipreview.htm?21/14/21743\">",
"     image 1",
"    </a>",
"    ). However, a variety of less invasive tests has been evaluated for testing purposes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The following noninvasive tests are reasonable alternatives for initial testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Duplex Doppler ultrasonography",
"     </li>",
"     <li>",
"      Computed tomographic angiography (CTA)",
"     </li>",
"     <li>",
"      Magnetic resonance angiography (MRA)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The choice of test should be based upon institutional expertise and patient factors. (See",
"    <a class=\"local\" href=\"#H16699595\">",
"     'Selecting a diagnostic test'",
"    </a>",
"    below.) If the noninvasive test is inconclusive and the clinical suspicion remains high, conventional renal arteriography is recommended.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/59/9145?source=see_link\">",
"     Captopril",
"    </a>",
"    renal scintigraphy (renography), selective renal vein renin measurements, and plasma renin activity (in isolation or after captopril administration) are",
"    <strong>",
"     not",
"    </strong>",
"    useful as initial diagnostic tests for renal artery stenosis, although renography is useful to determine the relative function of each kidney. (See",
"    <a class=\"local\" href=\"#H16699536\">",
"     'Tests of limited utility'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16699492\">",
"    <span class=\"h2\">",
"     Duplex Doppler ultrasonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Duplex Doppler ultrasonography primarily provides functional assessment of the renal arteries, as well as some anatomic information. Direct visualization of the main renal arteries (B-mode imaging) is combined with measurement (via Doppler) of a variety of hemodynamic factors. Stenotic lesions can be detected by comparing the systolic flow velocity in the renal artery to that in the aorta, since the velocity of flow increases as an artery narrows; end-diastolic velocity also may be increased distal to a stenotic lesion.",
"   </p>",
"   <p>",
"    Duplex Doppler ultrasonography can detect both unilateral and bilateral disease. It is relatively inexpensive and suitable for serial measurements to determine disease progression. This modality can also be used to detect recurrent stenosis in patients previously treated with angioplasty or surgery.",
"   </p>",
"   <p>",
"    A meta-analysis of 88 studies involving 9974 arteries and 8147 patients assessed the ability of the various duplex ultrasonography parameters to detect renal artery stenosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/8\">",
"     8",
"    </a>",
"    ]. Of these parameters, peak systolic velocity, with a sensitivity and specificity of 85 and 92 percent, respectively, was more accurate than the renal-aortic ratio and acceleration index. The positive predictive value was 84 percent and the false positive rate was 8 percent.",
"   </p>",
"   <p>",
"    There are, however, two important",
"    <strong>",
"     disadvantages",
"    </strong>",
"    of duplex Doppler ultrasonography:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      It is time-consuming (taking up to two hours to perform).",
"     </li>",
"     <li>",
"      It is technically difficult (particularly in large patients), has a steep learning curve, and is operator-dependent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As with many diagnostic procedures,",
"    <strong>",
"     a positive test is more informative than a negative test",
"    </strong>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16699507\">",
"    <span class=\"h3\">",
"     Resistive index",
"    </span>",
"    &nbsp;&mdash;&nbsp;When added to Duplex Doppler ultrasonography, calculation of the renal resistive index ([1 - end-diastolic velocity] divided by peak systolic velocity) may, in the hands of experienced operators, improve the ability to predict the outcome after revascularization. In general, a higher resistive index is associated with a greater degree of intrinsic (ie, permanent) renal damage and therefore a diminished predicted benefit from revascularization.",
"   </p>",
"   <p>",
"    The utility of the resistive index was evaluated in a study of almost 6000 patients with hypertension and clinical features suggestive of atherosclerotic renovascular disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/9\">",
"     9",
"    </a>",
"    ]. The following findings were noted in the 131 patients who had renal artery stenosis and underwent technically successful angioplasty, primarily without stent placement:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The outcomes were poor among the 35 patients with a resistive index above 80. Renal function declined during follow-up in 80 percent of these patients, nearly one-half became dialysis dependent, and only one experienced a blood pressure reduction of &ge;10 mmHg. Thus, a high resistance index may indicate irreversible intrarenal vascular disease or arteriosclerosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The outcomes were better among the 96 patients with a resistive index less than 80. There was a significant fall in blood pressure in 94 percent, while renal function worsened in only 3 percent. These patients had significantly better baseline kidney function than those with a higher resistance index (creatinine clearance 68 versus 33",
"      <span class=\"nowrap\">",
"       mL/min)",
"      </span>",
"      and were less likely to have a history of severe atherosclerosis (54 versus 83 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although similar findings have been found in some studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/11\">",
"     11",
"    </a>",
"    ], this marked difference in outcomes according to the resistive index was",
"    <strong>",
"     not",
"    </strong>",
"    replicated in other studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. In addition, determination of the resistive index is operator dependent and can be obscured by patient factors such as obesity. Thus, it is",
"    <strong>",
"     not",
"    </strong>",
"    a broadly useful parameter for predicting the outcome after revascularization.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16699522\">",
"    <span class=\"h2\">",
"     Spiral CT scan with CT angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;A spiral (helical) computed tomography (CT) scan with intravenous contrast injection (called CT angiography, or CTA) is a highly accurate noninvasive diagnostic test for imaging renovascular disease due to atherosclerosis but less so for fibromuscular disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/40/17032?source=see_link\">",
"     \"Principles of computed tomography of the chest\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    CT angiography combines the diagnostic accuracy of arteriography with the low risk of intravenous digital subtraction angiography. Multidetector, spiral CTA continues to evolve technically and has been reported to provide excellent sensitivity (96 percent) and specificity (97 percent) in small groups of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/13-17\">",
"     13-17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The performance of CTA was less favorable in a larger series of 356 hypertensive patients, of whom 72 patients (20 percent) had some degree of renal artery stenosis (defined as a 50 percent or greater stenosis detected by digital subtraction angiography) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/18\">",
"     18",
"    </a>",
"    ]. The sensitivity and specificity of CTA were 64 and 92 percent, respectively. However, the poor sensitivity of CTA in this study was probably due to the high proportion of patients who had fibromuscular dysplasia (36 percent of those with renal artery stenosis), since fibromuscular disease usually involves distal arterial segments that are more difficult to image. (See",
"    <a class=\"local\" href=\"#H282253371\">",
"     'Noninvasive imaging is less reliable in fibromuscular dysplasia'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Rapid developments in CT imaging with improved tissue reconstruction, multidetector slice acquisition, and higher resolution with less contrast exposure continue to improve the value of CT angiography as a diagnostic tool for renovascular disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16699529\">",
"    <span class=\"h2\">",
"     Magnetic resonance angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;While contrast-enhanced magnetic resonance angiography (MRA) can provide excellent vascular imaging, concerns about gadolinium-associated complications including nephrogenic systemic fibrosis have greatly reduced its application for renovascular disease, primarily in patients with reduced kidney function. The level of glomerular filtration rate below which MRA should be avoided is discussed below. (See",
"    <a class=\"local\" href=\"#H16699631\">",
"     'Patients with renal insufficiency'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/22/31082?source=see_link\">",
"     \"Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MR angiography is a highly sensitive technique for detecting proximal renal artery stenosis, as noted by the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a series of 37 patients with hypertension who underwent both MRA and digital subtraction arteriography, 12 had renal artery stenosis of at least 50 percent [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/19\">",
"       19",
"      </a>",
"      ]. Using arteriography as the gold standard, MRA had a sensitivity of 100 percent and specificity of 96 percent (one false positive) for the detection of stenosis of the main renal arteries. However, MRA missed stenosis in 9 of 12 accessory renal arteries.",
"     </li>",
"     <li>",
"      Similar findings were noted in another report of 30 patients: sensitivity of 100 percent and specificity of 71 percent for proximal renal artery stenoses of more than 50 or 75 percent occlusion [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Technical improvements in MRA, including imaging without the use of gadolinium-based contrast, have enhanced the detection of significant renal artery disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. As an example, the use of breath-hold MRA with paramagnetic contrast material such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/45/24277?source=see_link\">",
"     gadopentetate dimeglumine",
"    </a>",
"    substantially improves the ability to visualize some (but not all) accessory arteries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/18\">",
"     18",
"    </a>",
"    ], while phase-contrast MRA produces results similar to digital subtraction angiography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/23\">",
"     23",
"    </a>",
"    ]. In one report of 87 renal arteries, 20 of which had a stenosis, the sensitivity and specificity of breath-hold MRA for renal artery stenosis were 100 and 98 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282253371\">",
"    <span class=\"h2\">",
"     Noninvasive imaging is less reliable in fibromuscular dysplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of a false negative result from noninvasive imaging is much more likely to occur in patients with stenotic lesions that involve the intrarenal portion of the renal artery. Disease in these distal arterial segments is most common in patients with fibromuscular dysplasia. Sensitivities of only 22 to 28 percent have been noted with MR and CT angiography in this setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/18,25\">",
"     18,25",
"    </a>",
"    ]. The preferred approach in these patients is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/42/34471?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical manifestations and diagnosis of fibromuscular dysplasia\", section on 'Imaging techniques'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16699536\">",
"    <span class=\"h2\">",
"     Tests of limited utility",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other noninvasive tests, such as peripheral plasma renin activity (PRA), stimulated PRA, and the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/59/9145?source=see_link\">",
"     captopril",
"    </a>",
"    renogram are no longer considered suitable for initial testing patients with suspected renovascular disease because of their poor sensitivity and specificity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/7\">",
"     7",
"    </a>",
"    ]. However, a captopril renogram may help assess the hemodynamic significance of a stenotic lesion. (See",
"    <a class=\"local\" href=\"#H16699638\">",
"     'Interpreting the results of diagnostic tests'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16699552\">",
"    <span class=\"h3\">",
"     Plasma renin activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peripheral venous PRA is elevated in only 50 to 80 percent of patients with renovascular hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/26\">",
"     26",
"    </a>",
"    ]. This may partly reflect the observation that, in experimental models, activation of the renin-angiotensin system can be transient in the development of renovascular hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/27\">",
"     27",
"    </a>",
"    ]. In clinical settings, levels of PRA may be suppressed by a high dietary sodium intake, bilateral renal arterial disease, volume expansion related to intrinsic kidney disease, and various antihypertensive drugs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The predictive value of the PRA can be increased by measuring the rise in PRA one hour after the administration of 25 to 50 mg of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/59/9145?source=see_link\">",
"     captopril",
"    </a>",
"    , a rapidly acting angiotensin converting enzyme (ACE) inhibitor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/26,29\">",
"     26,29",
"    </a>",
"    ]. Patients with renal artery stenosis have an exaggerated increase in the PRA as compared with normal individuals, perhaps due to removal of the normal suppressive effect of high angiotensin II levels on renin secretion in the stenotic kidney.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16699566\">",
"    <span class=\"h3\">",
"     Captopril renogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radionuclide imaging provides a functional test allowing the comparison of blood flow and filtration between two kidneys. Markers of glomerular filtration, such as DTPA, or compounds that are secreted by the proximal tubule, such as hippurate and MAG3, have been used as radionuclides in renography. MAG3 may be more reliable in patients with renal insufficiency [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/30\">",
"     30",
"    </a>",
"    ]. Due to various limitations,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/59/9145?source=see_link\">",
"     captopril",
"    </a>",
"    renography is not broadly helpful in diagnosing renal artery stenosis.",
"   </p>",
"   <p>",
"    Nonstimulated renal scans have a false negative rate of 20 to 25 percent and are therefore of limited efficacy as a diagnostic test for renovascular disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/31\">",
"     31",
"    </a>",
"    ]. The predictive value of radioisotope scanning can be increased by administration of oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/59/9145?source=see_link\">",
"     captopril",
"    </a>",
"    (25 to 50 mg) one hour before the isotope is injected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/32\">",
"     32",
"    </a>",
"    ]. The efficacy of this test is based upon the expected ACE inhibitor-induced decline in glomerular filtration rate (GFR) in the stenotic kidney, often accompanied by an increase in GFR in the contralateral kidney due to removal of angiotensin II-mediated vasoconstriction. The net effect is that the difference between the two kidneys is enhanced. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/60/19398?source=see_link\">",
"     \"Renal effects of ACE inhibitors in hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An abnormal scan after an ACE inhibitor may be followed either by a scan without medications (to see if the abnormalities were more prominent with the ACE inhibitor, as would be expected with a vascular lesion as opposed to a parenchymal disease) or by arteriography, if there is a relatively high clinical index of suspicion of renovascular disease.",
"   </p>",
"   <p>",
"    The sensitivity and specificity of the ACE inhibitor scan vary substantially in different studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/31-35\">",
"     31-35",
"    </a>",
"    ], and have limited interobserver agreement and a poor correlation with the benefit obtained from angioplasty [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. An additional problem is the high prevalence of baseline asymmetry of renal blood flow, particularly in patients with a reduced glomerular filtration rate. In a study of 148 hypertensive patients, for example, one half of patients had a greater than 25 percent difference in renal blood flow between the two kidneys [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As a result of these limitations, the major use of renography is to determine the relative function of each kidney. As an example, some patients who have unilateral renovascular occlusion benefit from therapeutic nephrectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/37\">",
"     37",
"    </a>",
"    ]. This is most likely to occur when the affected kidney accounts for less than 15 percent of the total GFR.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16699573\">",
"    <span class=\"h3\">",
"     Renal vein renin measurements",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renin secretion should be increased in the stenotic kidney (as evidenced by a renal vein renin that is &ge;1.5 times the value from the contralateral kidney), and suppressed in the contralateral kidney (as evidenced by the renal vein renin from that kidney being similar to arterial renin, which is estimated from a blood sample obtained from the infrarenal inferior vena cava) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/30\">",
"     30",
"    </a>",
"    ]. This large discrepancy in renin secretion between the two kidneys is present in less than 10 percent of normal individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/30\">",
"     30",
"    </a>",
"    ]. Thus, the presence of highly discrepant (or lateralizing) renal renin values should indicate the presence of physiologically significant renal artery stenosis. The accuracy of these measurements may be enhanced by the prior administration of an ACE inhibitor",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diuretics, which will increase renin secretion on the affected side.",
"   </p>",
"   <p>",
"    However, the use of renal vein renin measurements to diagnose clinically significant renovascular disease produces many false negative and occasional false positive results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/33,38\">",
"     33,38",
"    </a>",
"    ]. Although more than 90 percent of patients with unilateral renal artery stenosis and lateralizing renin values will have a favorable blood pressure response to angioplasty or surgery, so will approximately 50 percent of patients with nonlateralizing renin values. The benefit of angioplasty observed in patients with nonlateralizing renin values may be due to suppression of renin secretion resulting from volume expansion, which is commonly used to reduce the risks of contrast nephrotoxicity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, renal vein renins have a limited role in estimating the physiologic significance of a stenotic lesion. Exceptions may include patients with bilateral renal artery stenosis in whom renal vein renin measurements can be used to determine which side contributes most to the hypertension or in patients considered for nephrectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/30,40\">",
"     30,40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16699595\">",
"    <span class=\"h1\">",
"     SELECTING A DIAGNOSTIC TEST",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testing for renal artery stenosis is",
"    <strong>",
"     only",
"    </strong>",
"    indicated if a corrective procedure would be performed if clinically significant renovascular disease were detected [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/2\">",
"     2",
"    </a>",
"    ]. Potential indications for testing are discussed above. (See",
"    <a class=\"local\" href=\"#H517662\">",
"     'Indications for testing'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27991?source=see_link\">",
"     \"Who should be evaluated for renovascular or other causes of secondary hypertension?\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Even though they are noninvasive, a spiral CT scan, MR angiography, and duplex ultrasonography are",
"    <strong>",
"     not",
"    </strong>",
"    useful for testing a population at low risk for renovascular hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/41\">",
"     41",
"    </a>",
"    ]. As an example, a test with a sensitivity and specificity of 95 percent will have a positive predictive value of only 16 percent if the prevalence of disease is 1 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no sufficiently accurate, noninvasive radiologic or serologic diagnostic test that, if negative, will completely exclude the presence of renal artery stenosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/18,23\">",
"     18,23",
"    </a>",
"    ]. Each test is associated with strengths and weaknesses. (See",
"    <a class=\"local\" href=\"#H16699485\">",
"     'Diagnostic test options'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    If a decision is made to evaluate for renovascular disease, the test of choice depends upon the local availability and clinical expertise with each technique and the presence or absence of renal insufficiency, because radiocontrast media and gadolinium are potentially harmful in patients with stage 4 or 5 chronic kidney disease (ie, a glomerular filtration rate less than 30",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per 1.73 m2).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16699602\">",
"    <span class=\"h2\">",
"     Patients without renal insufficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Duplex Doppler, CT angiography, and MR angiography all provide minimally invasive options for diagnostic evaluation prior to intraarterial angiography in patients with normal or near normal renal function. They are most accurate for proximal disease. In addition to diagnosing renal artery stenosis, these tests can identify anatomic abnormalities of the kidneys, aortic disease (such as abdominal aortic aneurysm), and whether the stenosis is unilateral or bilateral.",
"   </p>",
"   <p>",
"    A negative Doppler study does not exclude renal artery stenosis. Thus, digital subtraction arteriography should be performed when noninvasive testing is inconclusive. If the arteriogram is positive, endovascular revascularization, often with primary renal artery stenting, can be performed during the same procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16699631\">",
"    <span class=\"h2\">",
"     Patients with renal insufficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with renal insufficiency, an evaluation for renovascular disease should be considered in those likely to have chronic ischemic renal disease. In addition to hypertension, which is often difficult to control, patients with chronic ischemic renal disease tend to present with a characteristic (but not diagnostic) constellation of findings (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/41/33433?source=see_link\">",
"     \"Chronic kidney disease associated with atherosclerotic renovascular disease\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Unexplained progressive renal failure, with occasional acute deterioration or even anuria if the one functional artery progresses to total occlusion",
"     </li>",
"     <li>",
"      A bland urine sediment with few cells or casts or mild to moderate proteinuria",
"     </li>",
"     <li>",
"      A unilateral small kidney, which is associated with the presence of large vessel occlusive disease in 75 percent of cases",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The optimal approach to such patients is uncertain, although some will have recovery of kidney function or slowing of renal function decline after successful revascularization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. The primary indications for testing in patients suspected of having chronic ischemic renal disease are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Progressive decline in renal function",
"     </li>",
"     <li>",
"      Recurrent episodes of flash pulmonary edema",
"     </li>",
"     <li>",
"      Uncontrolled hypertension",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Both noninvasive testing and angiography carry",
"    <strong>",
"     risk",
"    </strong>",
"    in these individuals, including contrast-induced acute kidney injury, nephrogenic systemic fibrosis (due to gadolinium if magnetic resonance angiography is used), and atheroembolism with conventional arteriography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/44\">",
"     44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/22/31082?source=see_link\">",
"     \"Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/13/10457?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of contrast-induced nephropathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/13/13528?source=see_link\">",
"     \"Clinical presentation, evaluation, and treatment of renal atheroemboli\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We suggest the following approach to the evaluation of renovascular disease in patients with renal insufficiency:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If technical expertise is available, duplex Doppler ultrasonography is the preferred initial noninvasive diagnostic test since both gadolinium and radiocontrast media exposure are avoided [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      If expertise with Doppler ultrasonography is unavailable, we prefer spiral CT scan with CT angiography in patients with an estimated glomerular filtration rate (GFR) less than 30",
"      <span class=\"nowrap\">",
"       mL/min,",
"      </span>",
"      despite the risk of radiocontrast nephropathy. In such patients, preventive measures for contrast nephrotoxicity should be used. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/42/35498?source=see_link\">",
"       \"Prevention of contrast-induced nephropathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Although MRA with gadolinium had been widely used in the past mainly to avoid exposure to iodinated radiocontrast media, its use in patients with moderate to severe renal disease is now severely limited by hospitals because of the risk of nephrogenic systemic fibrosis, which is often severe. As a result, it is recommended that gadolinium-based imaging be",
"      <strong>",
"       avoided",
"      </strong>",
"      , if possible, in patients with an estimated GFR less than 30",
"      <span class=\"nowrap\">",
"       mL/min.",
"      </span>",
"      Opinion among experts differs as to whether or not one would expose patients with an estimated GFR of 30 to 60",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      to gadolinium since the risk has not been defined. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/22/31082?source=see_link&amp;anchor=H23#H23\">",
"       \"Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure\", section on 'Avoidance of gadolinium'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16699638\">",
"    <span class=\"h1\">",
"     INTERPRETING THE RESULTS OF DIAGNOSTIC TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testing for renovascular disease is",
"    <strong>",
"     only",
"    </strong>",
"    recommended when the plan is to intervene if a significant stenotic lesion is found. Potential indications for testing are presented above. (See",
"    <a class=\"local\" href=\"#H517662\">",
"     'Indications for testing'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    With duplex Doppler ultrasonography, a peak systolic velocity above 200",
"    <span class=\"nowrap\">",
"     cm/sec",
"    </span>",
"    suggests a stenosis of greater than 60 percent, although some studies indicate that a peak systolic velocity above 300",
"    <span class=\"nowrap\">",
"     cm/sec",
"    </span>",
"    represents a hemodynamically important threshold [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/45\">",
"     45",
"    </a>",
"    ]. With computed tomography and magnetic resonance angiography, a stenosis greater than 75 percent in one or both renal arteries or a 50 percent stenosis with poststenotic dilatation suggests that the patient may have renovascular hypertension.",
"   </p>",
"   <p>",
"    However, quantifying the actual degree of stenosis can be difficult. Experimental studies indicate that luminal occlusion less than 60 percent rarely produces any measurable hemodynamic effects, including a fall in pressure or blood flow across the lesion. Human studies using translesional pressure measurements have shown that a blood pressure gradient of at least 10 to 20 percent across the stenosis is required to detect stimulation of renin release [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/46\">",
"     46",
"    </a>",
"    ]. The corollary of this finding is that revascularization is not warranted if no translesional gradient is detected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16699645\">",
"    <span class=\"h2\">",
"     Incidental lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients are often incidentally discovered to have atherosclerotic renal artery stenosis. Radiographic evaluation for peripheral artery disease or coronary disease often reveals that renal arterial lesions are present in patients who are not hypertensive [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. Patients with incidentally discovered atherosclerotic renal artery stenosis do not require therapy directed at the renal vasculature since there is evidence that renal artery revascularization in such patients does",
"    <strong>",
"     not",
"    </strong>",
"    improve blood pressure or other outcomes in this setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/17/31001/abstract/49\">",
"     49",
"    </a>",
"    ]. The frequency with which this occurs is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/41/33433?source=see_link&amp;anchor=H3#H3\">",
"     \"Chronic kidney disease associated with atherosclerotic renovascular disease\", section on 'Association with systemic atherosclerosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/20/37186?source=see_link\">",
"       \"Patient information: Renovascular hypertension (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?32/54/33635?source=see_link\">",
"       \"Patient information: High blood pressure in adults (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/32/37380?source=see_link\">",
"       \"Patient information: High blood pressure treatment in adults (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/8/9347?source=see_link\">",
"       \"Patient information: High blood pressure, diet, and weight (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H760873\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Because of the potential for harm from invasive procedures, we test",
"      <strong>",
"       only",
"      </strong>",
"      those patients who are thought to have a",
"      <strong>",
"       high likelihood",
"      </strong>",
"      of benefiting from the procedure. The following scenarios identify such patients (see",
"      <a class=\"local\" href=\"#H517662\">",
"       'Indications for testing'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A short duration of blood pressure elevation prior to the diagnosis of renovascular disease, since this is the strongest clinical predictor of a fall in blood pressure after renal revascularization",
"     </li>",
"     <li>",
"      Failure of optimal medical therapy to control the blood pressure in someone who has, based upon clinical clues, a high likelihood of having renovascular disease",
"     </li>",
"     <li>",
"      Intolerance to optimal medical therapy, including a clinically significant rise in serum creatinine after initiation of a renin-angiotensin system inhibitor",
"     </li>",
"     <li>",
"      Progressive renal insufficiency that is thought be a consequence of bilateral renovascular disease or unilateral stenosis affecting a solitary functioning kidney",
"     </li>",
"     <li>",
"      Suspected fibromuscular disease in a young person in an attempt to limit the need for life-long antihypertensive therapy",
"     </li>",
"     <li>",
"      Recurrent flash pulmonary edema",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      refractory heart failure",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Testing should",
"      <strong>",
"       not",
"      </strong>",
"      be performed in patients who have a moderate or low likelihood of having clinically significant renovascular disease or who respond well to medical therapy. (See",
"      <a class=\"local\" href=\"#H517662\">",
"       'Indications for testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Reasonable alternatives for initial testing include duplex Doppler ultrasonography, computed tomographic angiography (CTA), and magnetic resonance angiography. (See",
"      <a class=\"local\" href=\"#H11700845\">",
"       'Testing options'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16699492\">",
"       'Duplex Doppler ultrasonography'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16699522\">",
"       'Spiral CT scan with CT angiography'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16699529\">",
"       'Magnetic resonance angiography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risk of a false negative result from noninvasive imaging is much more likely to occur in patients with stenotic lesions that involve the intrarenal portion of the renal artery, which are common in patients with fibromuscular dysplasia. (See",
"      <a class=\"local\" href=\"#H282253371\">",
"       'Noninvasive imaging is less reliable in fibromuscular dysplasia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/59/9145?source=see_link\">",
"       Captopril",
"      </a>",
"      renal scintigraphy (renography), selective renal vein renin measurements, and plasma renin activity (in isolation or after captopril administration) are",
"      <strong>",
"       not",
"      </strong>",
"      useful as initial diagnostic tests for renal artery stenosis, although each may have confirmatory roles. (See",
"      <a class=\"local\" href=\"#H16699536\">",
"       'Tests of limited utility'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The test of choice depends upon the local availability and clinical expertise with each technique and the presence or absence of renal insufficiency, because radiocontrast media and gadolinium are potentially harmful in patients with an estimated glomerular filtration rate (eGFR) less than 30",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      per 1.73 m2. There is no sufficiently accurate, noninvasive radiologic or serologic diagnostic test that, if negative, will completely exclude the presence of renal artery stenosis. Thus, if the noninvasive test is inconclusive and the clinical suspicion remains high, conventional renal arteriography is recommended. (See",
"      <a class=\"local\" href=\"#H16699595\">",
"       'Selecting a diagnostic test'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients without renal insufficiency, duplex Doppler, CTA, and MRA all provide minimally invasive options for diagnostic evaluation prior to intraarterial angiography. (See",
"      <a class=\"local\" href=\"#H16699602\">",
"       'Patients without renal insufficiency'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with renal insufficiency, both noninvasive testing and angiography carry risk, including contrast-induced acute kidney injury, nephrogenic systemic fibrosis (due to gadolinium if MRA is used), and atheroembolism with conventional arteriography. If technical expertise is available, duplex Doppler ultrasonography is the preferred initial noninvasive diagnostic test, since both gadolinium and radiocontrast media are avoided. If expertise with Doppler ultrasonography is unavailable, we prefer CTA in patients with an eGFR less than 30",
"      <span class=\"nowrap\">",
"       mL/min,",
"      </span>",
"      despite the risk of radiocontrast nephropathy. In such patients, preventive measures for contrast nephrotoxicity should be used. Although MRA with gadolinium had been widely used in the past mainly to avoid exposure to iodinated radiocontrast media, its use in patients with moderate to severe renal disease is now severely limited by hospitals because of the risk of nephrogenic systemic fibrosis, which is often severe. (See",
"      <a class=\"local\" href=\"#H16699631\">",
"       'Patients with renal insufficiency'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      With duplex Doppler ultrasonography, a peak systolic velocity above 200",
"      <span class=\"nowrap\">",
"       cm/sec",
"      </span>",
"      suggests a stenosis of greater than 60 percent, although some studies indicate that a peak systolic velocity above 300",
"      <span class=\"nowrap\">",
"       cm/sec",
"      </span>",
"      represents a hemodynamically important threshold. With CTA and MRA, a stenosis greater than 75 percent in one or both renal arteries or a 50 percent stenosis with poststenotic dilatation suggests that the patient may have renovascular hypertension. (See",
"      <a class=\"local\" href=\"#H16699638\">",
"       'Interpreting the results of diagnostic tests'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/1\">",
"      Dworkin LD, Cooper CJ. Clinical practice. Renal-artery stenosis. N Engl J Med 2009; 361:1972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/2\">",
"      Textor SC, Lerman L. Renovascular hypertension and ischemic nephropathy. Am J Hypertens 2010; 23:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/3\">",
"      Cooper CJ, Murphy TP, Matsumoto A, et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 2006; 152:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/4\">",
"      Ronden RA, Houben AJ, Kessels AG, et al. Predictors of clinical outcome after stent placement in atherosclerotic renal artery stenosis: a systematic review and meta-analysis of prospective studies. J Hypertens 2010; 28:2370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/5\">",
"      Hughes JS, Dove HG, Gifford RW Jr, Feinstein AR. Duration of blood pressure elevation in accurately predicting surgical cure of renovascular hypertension. Am Heart J 1981; 101:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/6\">",
"      White CJ, Jaff MR, Haskal ZJ, et al. Indications for renal arteriography at the time of coronary arteriography: a science advisory from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Councils on Cardiovascular Radiology and Intervention and on Kidney in Cardiovascular Disease. Circulation 2006; 114:1892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/7\">",
"      Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113:e463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/8\">",
"      Williams GJ, Macaskill P, Chan SF, et al. Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis. AJR Am J Roentgenol 2007; 188:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/9\">",
"      Radermacher J, Chavan A, Bleck J, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001; 344:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/10\">",
"      Ikee R, Kobayashi S, Hemmi N, et al. Correlation between the resistive index by Doppler ultrasound and kidney function and histology. Am J Kidney Dis 2005; 46:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/11\">",
"      Santos S, Leite LR, Tse TS, et al. [Renal resistance index predicting outcome of renal revascularization for renovascular hypertension]. Arq Bras Cardiol 2010; 94:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/12\">",
"      Krumme B, Hollenbeck M. Doppler sonography in renal artery stenosis--does the Resistive Index predict the success of intervention? Nephrol Dial Transplant 2007; 22:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/13\">",
"      Crutchley TA, Pearce JD, Craven TE, et al. Clinical utility of the resistive index in atherosclerotic renovascular disease. J Vasc Surg 2009; 49:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/14\">",
"      Zeller T, M&uuml;ller C, Frank U, et al. Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis. Catheter Cardiovasc Interv 2003; 58:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/15\">",
"      Echevarr&iacute;a JJ, Migu&eacute;lez JL, L&oacute;pez-Romero S, et al. [Arteriographic correlation in 30 patients with renal vascular disease diagnosed with multislice CT]. Radiologia 2008; 50:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/16\">",
"      Glockner JF, Vrtiska TJ. Renal MR and CT angiography: current concepts. Abdom Imaging 2007; 32:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/17\">",
"      Olbricht CJ, Paul K, Prokop M, et al. Minimally invasive diagnosis of renal artery stenosis by spiral computed tomography angiography. Kidney Int 1995; 48:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/18\">",
"      Vasbinder GB, Nelemans PJ, Kessels AG, et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med 2004; 141:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/19\">",
"      Postma CT, Joosten FB, Rosenbusch G, Thien T. Magnetic resonance angiography has a high reliability in the detection of renal artery stenosis. Am J Hypertens 1997; 10:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/20\">",
"      Rieumont MJ, Kaufman JA, Geller SC, et al. Evaluation of renal artery stenosis with dynamic gadolinium-enhanced MR angiography. AJR Am J Roentgenol 1997; 169:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/21\">",
"      Schoenberg SO, Rieger J, Johannson LO, et al. Diagnosis of renal artery stenosis with magnetic resonance angiography: update 2003. Nephrol Dial Transplant 2003; 18:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/22\">",
"      Schoenberg SO, Knopp MV, Londy F, et al. Morphologic and functional magnetic resonance imaging of renal artery stenosis: a multireader tricenter study. J Am Soc Nephrol 2002; 13:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/23\">",
"      Textor SC. Pitfalls in imaging for renal artery stenosis. Ann Intern Med 2004; 141:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/24\">",
"      Thornton MJ, Thornton F, O'Callaghan J, et al. Evaluation of dynamic gadolinium-enhanced breath-hold MR angiography in the diagnosis of renal artery stenosis. AJR Am J Roentgenol 1999; 173:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/25\">",
"      Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med 2004; 350:1862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/26\">",
"      Wilcox CS. Use of angiotensin-converting-enzyme inhibitors for diagnosing renovascular hypertension. Kidney Int 1993; 44:1379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/27\">",
"      Lerman LO, Nath KA, Rodriguez-Porcel M, et al. Increased oxidative stress in experimental renovascular hypertension. Hypertension 2001; 37:541.",
"     </a>",
"    </li>",
"    <li>",
"     Textor SC. Chapter 47: Renovascular Hypertension and Ischemic Nephropathy. In: Brenner and Rector's: The Kidney, 9th Ed, Elsevier, Philadelphia 2012. p.1752.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/29\">",
"      Svetkey LP, Kadir S, Dunnick NR, et al. Similar prevalence of renovascular hypertension in selected blacks and whites. Hypertension 1991; 17:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/30\">",
"      Derkx FH, Schalekamp MA. Renal artery stenosis and hypertension. Lancet 1994; 344:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/31\">",
"      Pedersen EB. Angiotensin-converting enzyme inhibitor renography. Pathophysiological, diagnostic and therapeutic aspects in renal artery stenosis. Nephrol Dial Transplant 1994; 9:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/32\">",
"      Setaro JF, Saddler MC, Chen CC, et al. Simplified captopril renography in diagnosis and treatment of renal artery stenosis. Hypertension 1991; 18:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/33\">",
"      Mann SJ, Pickering TG. Detection of renovascular hypertension. State of the art: 1992. Ann Intern Med 1992; 117:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/34\">",
"      van Jaarsveld BC, Krijnen P, Derkx FH, et al. The place of renal scintigraphy in the diagnosis of renal artery stenosis. Fifteen years of clinical experience. Arch Intern Med 1997; 157:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/35\">",
"      Krijnen P, van Jaarsveld BC, Deinum J, et al. Which patients with hypertension and atherosclerotic renal artery stenosis benefit from immediate intervention? J Hum Hypertens 2004; 18:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/36\">",
"      van Onna M, Houben AJ, Kroon AA, et al. Asymmetry of renal blood flow in patients with moderate to severe hypertension. Hypertension 2003; 41:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/37\">",
"      Kane GC, Textor SC, Schirger A, Garovic VD. Revisiting the role of nephrectomy for advanced renovascular disease. Am J Med 2003; 114:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/38\">",
"      Roubidoux MA, Dunnick NR, Klotman PE, et al. Renal vein renins: inability to predict response to revascularization in patients with hypertension. Radiology 1991; 178:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/39\">",
"      Strong CG, Hunt JC, Sheps SG, et al. Renal venous renin activity. Enhancement of sensitivity of lateralization by sodium depletion. Am J Cardiol 1971; 27:602.",
"     </a>",
"    </li>",
"    <li>",
"     Rossi GP, Cesari M, Chiesura-Corona M, Miotto D, Semplicini A, Pessina AC. Renal vein renin measurements accurately identify renovascular hypertension caused by total occlusion of the renal artery. J.Hypertens. 2002;20:975-84.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/41\">",
"      Pedersen EB. New tools in diagnosing renal artery stenosis. Kidney Int 2000; 57:2657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/42\">",
"      Elkohen M, Beregi JP, Deklunder G, et al. A prospective study of helical computed tomography angiography versus angiography for the detection of renal artery stenoses in hypertensive patients. J Hypertens 1996; 14:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/43\">",
"      Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation 2005; 112:1362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/44\">",
"      Scolari F, Ravani P. Atheroembolic renal disease. Lancet 2010; 375:1650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/45\">",
"      Chi YW, White CJ, Thornton S, Milani RV. Ultrasound velocity criteria for renal in-stent restenosis. J Vasc Surg 2009; 50:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/46\">",
"      De Bruyne B, Manoharan G, Pijls NH, et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol 2006; 48:1851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/47\">",
"      Leertouwer TC, Pattynama PM, van den Berg-Huysmans A. Incidental renal artery stenosis in peripheral vascular disease: a case for treatment? Kidney Int 2001; 59:1480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/48\">",
"      Choudhri AH, Cleland JG, Rowlands PC, et al. Unsuspected renal artery stenosis in peripheral vascular disease. BMJ 1990; 301:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/17/31001/abstract/49\">",
"      Marcantoni C, Zanoli L, Rastelli S, et al. Effect of renal artery stenting on left ventricular mass: a randomized clinical trial. Am J Kidney Dis 2012; 60:39.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3825 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-C0B5FDA9AB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_17_31001=[""].join("\n");
var outline_f30_17_31001=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H760873\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16699471\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H517662\">",
"      INDICATIONS FOR TESTING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16699485\">",
"      DIAGNOSTIC TEST OPTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11700845\">",
"      Testing options",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16699492\">",
"      Duplex Doppler ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16699507\">",
"      - Resistive index",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16699522\">",
"      Spiral CT scan with CT angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16699529\">",
"      Magnetic resonance angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H282253371\">",
"      Noninvasive imaging is less reliable in fibromuscular dysplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16699536\">",
"      Tests of limited utility",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16699552\">",
"      - Plasma renin activity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16699566\">",
"      - Captopril renogram",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16699573\">",
"      - Renal vein renin measurements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16699595\">",
"      SELECTING A DIAGNOSTIC TEST",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16699602\">",
"      Patients without renal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16699631\">",
"      Patients with renal insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16699638\">",
"      INTERPRETING THE RESULTS OF DIAGNOSTIC TESTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16699645\">",
"      Incidental lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H760873\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/3825\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3825|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?21/14/21743\" title=\"diagnostic image 1\">",
"      Arteriogram in RA stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3825|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/38/42604\" title=\"table 1\">",
"      Features of secondary HTN",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/41/33433?source=related_link\">",
"      Chronic kidney disease associated with atherosclerotic renovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/42/34471?source=related_link\">",
"      Clinical manifestations and diagnosis of fibromuscular dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/13/13528?source=related_link\">",
"      Clinical presentation, evaluation, and treatment of renal atheroemboli",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/22/31082?source=related_link\">",
"      Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/13/10457?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of contrast-induced nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?32/54/33635?source=related_link\">",
"      Patient information: High blood pressure in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/32/37380?source=related_link\">",
"      Patient information: High blood pressure treatment in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/8/9347?source=related_link\">",
"      Patient information: High blood pressure, diet, and weight (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/20/37186?source=related_link\">",
"      Patient information: Renovascular hypertension (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/42/35498?source=related_link\">",
"      Prevention of contrast-induced nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/40/17032?source=related_link\">",
"      Principles of computed tomography of the chest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/60/19398?source=related_link\">",
"      Renal effects of ACE inhibitors in hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/7/41079?source=related_link\">",
"      Treatment of acute decompensated heart failure: General considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8040?source=related_link\">",
"      Treatment of bilateral atherosclerotic renal artery stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/0/26631?source=related_link\">",
"      Treatment of fibromuscular dysplasia of the renal arteries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/43/29369?source=related_link\">",
"      Treatment of unilateral atherosclerotic renal artery stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/21/27991?source=related_link\">",
"      Who should be evaluated for renovascular or other causes of secondary hypertension?",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_17_31002="Modified Epleys Left";
var content_f30_17_31002=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F50861%7EPC%2F62612&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F50861%7EPC%2F62612&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 530px\">",
"   <div class=\"ttl\">",
"    Modified Epley's maneuver for self-treatment of benign positional vertigo (left)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 510px; height: 435px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This maneuver should be carried out three times a day. Repeat this daily until you are free from positional vertigo for 24 hours.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from Http://www.charite.de/ch/neuro/englishL.htm",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 539px\">",
"   <div class=\"ttl\">",
"    Modified Epley's maneuver for self-treatment of benign positional vertigo (right)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 519px; height: 443px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAG7AgcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6poorD8WazcaRa2Uen2ZvNS1C5WztYydsYcqzl5G7IqI7HGSduByRQBuUVxk+ieN5UJXxlp8Mh5/d6ICinIPAaYnGMjk55zmnHRfGuwhfGGn7toAJ0QHnuT++/SgDsaK4pdD8cAfN4008nAGRoYHTqf8AXd6jTw/47CzB/HVkWb/VkaEo2fX97z+lAHc0VxR0Hxud/wDxW1mMjC/8SRePf/W896YugeOgzZ8cWJBHA/sJeD/396UAdxRXDp4f8ciVWfxzaFATlV0NBkemfNPPvTbzw746k837L48tYNzZXdoaPsHp/rBmgDuqK4BPDfxA8mZJPiBZl2QKki6AgKHuceaQc+laFvca/wCHZ7Fdfv7bWLG6mS2a5itfs0lvI/CFlDMrIzbV4wVLD7wJ2gHX0UUyaVIYXllYLGilmY9gOSaAH0Vw1mnjDxFbw6pBrFtoNncKJILBtOE8yRn7plcyY3kc4AAXOPmxkzyeH/FzLhPG208c/wBkwn+vWgDsqK4keHfGY8vPjsHb97/iTw/NyOvzemRx61R0nSvFGoB5rP4mQX1uk7o5ttLtmClSQYyQTgjoe/FAHolFcP8A8I5402YHjwbv7x0aH/Gj/hG/Guwj/hPRvOOTo0OB+GaAO4org08M+NwgD/EHc3y5I0WADjrxnv8ApSp4Z8bDyt/xAJ2gh9ujQDefXqcUAd3RXDP4b8bFCF8fKrdm/sWE/n81D6X440oPeQ+JbXWhEAxsLnTkg85Rjcqyow2McHBIYZPI7gA7miq+nXcd/p9reQBxFcRLMgcYYKwBGR2PNWKACiuY8SXmu3Gs22jeHRBaboTcXWp3MfmrAmdqpHGCN8jENySFUKSdxIFUZvDnjBg3leO2TOMZ0iBsc/WgDtaK4b/hGvGu8keP/lLZx/Y0HA9OtUxpXiiC/gsLn4mwf2jKhlS3Ol2yvIgOGZUzuIyQM9BxQB6LRXCnwx40Kn/i4MoYgDI0e3wOeSPrTR4X8bbs/wDCw5Men9jW/r/+ugDvKK4P/hF/G3zY+IcnLE86Nb8DnAH/ANfPSnDwv4z+bPxCuCSR00i2wOe3H880Ad1RXDQ+GPGSLIJfiDcSZ+6f7ItgV6e3Pf8AOlHhnxkMf8V/KQMZzpFvk46/n/h+IB3FFcj4b1TWbTxJP4c8SSW97P8AZfttnqNvF5QniDBHWSPJ2urMvIOGDZAUgiuuoAKKzfEV/cabo89zZWn2y7BSOCAvsDyOwRQzc7VywycHAzwelcw/hvxrPL50vj37OWBzDa6RAIlPt5hdsD3agDuaK4NvCvjMkFfiLdj5skf2Ra8jHT7tSN4Z8YbHC+P7gMWypOk2xCjHTGOfWgDuKK4KXwt42Zsx/ESZBuzg6NbEY9Oled6f4t8baj4xk0+PxLEnhlpra2tNZh02N2meeIyRlgflwdu35cHMicDJwAfQNFcLD4Y8Zq6mT4gyyKBgj+x7cZPrTn8M+MiU2+P5QBnP/EotyWoA7iiuEHhnxqECn4guSDnd/Y1vkj0PP8sU8eHPGm0Z8eDdzk/2ND79Pm/zigDuKK4hrnxL4WuLOXWb+LX9KubmO1leGyFvPaNIwVJOGKvHuKhhgFQd2SARXb0AFFFFABRRXENdeI/E2o6gdA1S10bS7G4ezDy2P2ia4mQkSMMuFVAflAwSSrHIGAQDt6K4Wbw746Y/uvHlsg466HG3/tSoT4b+IJI/4uDZjnkDw+nT/v7QB6BRXBN4d8f4+Tx7YjnvoCn/ANrUp8PePt5I8eWAXHC/2Av/AMe/zx+IB3lFcMdB8e9B4403GQcnQRnHcf6/vz2pToXj0u5/4TbSwrdANA+7x/18UAdxRXCf2D8QOf8AiuNK6cf8U/8A/dFOXQvHvG7xvphA640DBPH/AF39eaAO5orh/wCw/HqkFfGmlORk7X0Hg+gOJwcVveFdTvNRs7mPVrRbXUrKc2tyI8mJ2CqwkjJ5KMrqeeQSVOSpNAG1RRRQAVgeJGI1vwou1iG1KTkdv9Duetb9c94mGde8JHaTjUpOfT/Q7mgDoaKKKAKGuavY6Hpsl/qtwLe1QqpYqWJZiFVVUAlmJIAABJJrK0fxx4c1fU302z1NF1JGKNZ3Mb284I6/u5ArfpzXBfHfSfEeuaj4dsLK4uLbw+1yktxLaMIpFkUk5aY58rC4KHGC2QxGVrotH8FXk3gbUNG1fULmC5nvGuIJoJCxtTHIphePcWxkxLKVJPzOw6UAd/SMwVSzEBQMkngAVyng/wASanfznT/E+kDSNU2yPCFm8yO6SN9junAK4JU7Tnh1IZucbPiWCK60W4tbmNZbe42wSxsMq8bsFZSO4IJBHoaAOdb4p+DEtY7qbXIoLSVnWG4nhliin2HDGJ2ULIAepQkY56V2FtcQ3UKy20sc0TDKvGwZT9CK81m+F1xdm5j1TxFe38L6fNaxfaSWSOWYuskiwghFAiby1C4ABbijwj4dh0H4hXX/AAjN3c3GnmS5/taB3YQ280iW7QhOMMypGoxksBLkkZxQB6fXOeOmxpmnj5udVsRx/wBfMddHXN+PMf2dpgIBzq1j17f6QlAHSVS1wE6LqAHU28gH/fJq7VHXf+QHqOOf9Hk/9BNADPDn/Iv6Xxj/AEWL/wBAFaNZ/h4bdA0welrEP/HBWhQByvxTOsH4ea/H4bsGv9VmtHghhSURt842l1J4JUMWx324HJFeb/CvQ/CWv3mvaNf6N4dvLjTVt0jeHSlhmETxKRI0qoAC7AsoGHXvgivcq4xLBPD/AMSLjUY0iSz8SQxwzyHAYXcKny+/IeIsMdjEP7xoAp3Nx418NTeRb2NhrmgWsEkguprxorzagyI2BUh3xwGzhtvzFSc09NTufHV1bx+H9budJ0hbO2v5ZraNPtMwnVmjQeYrCNQoBPBJzjjBza+Luoy6d4HuhFHKwvZ4NOkeL70Uc8qxM49wHOP9oiqYMml+ItWs9AhVLeyttNJjtYlcrGsjq8JHXd5IBA7AgjrQBcs9M8X6ZCjXXizTb6KFSpN3pflGQFjhndJQAQCBwoBx0Ga53QvidAmp6RDf3F1qOm65dNbWOoppUloiS8bY9jks6HDfvAMLgbjzkdT451CSRbbw5pOoWll4h1UM1pJcRiUQpGVMkwQ4DMgIKrnlsHorEamhaKdPCz315LqWqtGI5b2dVVmAAyFVQFRSQDtUDJ5OTzQBr1FdZ+yzYODsP8qlqC/x9huMkgeW3I7cUAUfCf8AyKujck/6FD1/3BWrWV4SAHhXRgM4+xQ9ev3BWrQBmQvJ/wAJLeIQfKFpAQf9rfLn+ladZUG3/hKb7lt5s7fI7Y3zfrWrQAV8665byf8AC0NSuPF+laalrqOuW9qkeoWCagrWaxCOLy/l3gzP0KnEb53L82T9FVzXxC0E694dK20EE2pWM8Wo2AmUFRcQsHQewbBQn0c0AZeoeE7vw8Zr74bwaTYTujefpk0bR2ly3y7XAjIEcg243AEMGO4dCKE3j3V9F0TVR4p0m0ttdsrCG+WO1uDJBJ5rtGiFiAVYOMMPmGMEMeQO48P6vZ69o1pqmmyrNaXKb0ZSDjsVOOhBBBHYgivKPEurf2h4f+JepXMMcd7aXyaLbJIFUyRxiJ40XJ+ZneZyP95R2oA7AeFfFEOoLd2vjm7PmqwuoLmwilhLfwmBRtMWOeCXyCM8jNZ2p6v4ijS5h03W7PUtR0+1luTDa6dtiuCj7RHLM0hRGJVlIUgr8xIAAFddBdSaPpusXevXZ+yWcs9z9pkUALb48zovZASvqdlc/oWiX+uXR1jVNd+0aBeMt3ZaRZxIluI2GVMkgG6XdneRkLuY/eAFAG14E8VWnjLw3b6zYW95bRSlkMV3EY3RlOCPRhnupI/EEDoKKKAOVuUY/FPTX2tsXRroFuwJnt+Prx+ldVXNTyv/AMLJsYgI/LGk3DE5G4nzoQOOuOv510tAGX4kyNPhwAf9Mtep/wCniOtSsjxQQNNg3HrfWY69/tMda9ABRRUF9dwWFlcXl5KsNtbxtLLI3REUZJPsADQBPXl3hLwfaxaX4u8N5soo1ljjtbaNQWt0SNfInYbj8xZdwOB8yE9c4ty/FrRY9Xitns9RSxMfmSXrxABN0XnR4iBMr70BOAuRwCATxL4Z1rRtT+JNzfaNcQXMGs6LBJDcwsCspt5pRIp9HUXEQIOCM4PTgA6fwlq8ur6SGvrd7TVLZvs97bPyYpgBnB6MhyGVh1VgcDkDargfE3h/xLZ+I28R+E7y2upmZRcabfM0azwhCDGsq5wc4ZNynazPztYius8O6xb69pEF/ahlVyyPG+N0UiMVeNsfxKysp9xQBpUUUUAYHjj/AJAKZJA+3WWcDt9qizW/XPeO/wDkAxf9hCw74/5e4a6GgAooooAK5nwCMWGrH5udXvjzj/nu9dNXMfD9Sum6pnvq9+ev/TzJQB09FFFABRRRQAUUUUAFFFFABWRog/4mfiA9/tqf+k0Fa9ZGhgDU/EGD1vlzx/07QUAa9FFFABXO+JWI8Q+ElA66hKSf+3SeuirmfEx/4qjweMZ/02c9en+izf40AdNRRRQBS1yKyn0XUItWKLp0lvItyXfYoiKkPluw255rmfhFrUWs+CbVI5JJX05m055JEdTL5WAkuG5+ePy5Of79b3i0Wx8K6yL+D7RZmymE0OceYnlncv4jIrzvwp8M5oPBOnwWHiDXdCnvrC2XUreGSOZWcQKjbfNRmjbAxlCAMDjgYAOk0a9i1r4oa8fPjJ0C2hs44ByQbhVmaUnHGQsajB/gb145r9pLXJbPwP8A2Jp8Woyarq25oDYKxkiWDErOdoztyqKcdA5POMHY0zw1Y+E/GegLpMk7T3trPBezXEhkmu1jVCjyMepT7o7BX2gAYAueMdOkf4heANUjkIEFzeWbpgYZZbWR8/gYF/M0Ac54l+NGiWHhqIeHr228ReKbiMxW9hYRPIWnC8l4xl1TPY8np6kaPwBvdSuvAJg8QhBr9lfXFtqWCpbzw+4lypILbWXkdsV6MI0Ds4RQ7cFgOT+NcP8ACWNZbHxJqqSK8eqa/e3CbU2gLG4tx9ciDdn/AGqAO6rmfHwBsNKyR/yF7Hr/ANd0rpq5fx9u+yaMFAOdYs8+wEoP9KAOoqh4gONB1IjGfs0vXp901frO8Rts8Paow6rayn/xw0AP0EAaHpwHT7NH/wCgir1UtEUpotgrZytvGDnr90VdoAK8r+L+hX3inxf4N0e1eJbQC5vp/OaUKDC9uUI8t1IbLEBs5AY+teqVx91cm5+Lmn2awsRY6LcTyS54BmniVF/HyJD+FAHF+PtK8UDwB4h06UCCC1SXVH1o3xmlmaDE0IjjZcod0aBhnaoX5dxORb+EqT3nijxnq0d2qXmoLpks8Jj3RRyGyjdiBkHJ3+vpxXcfEQA/D/xOCcA6XdZPp+6asX4NiKbwtc6jAjLFf300ibvvMseIFJ+ohGPbFAGX8SPDck+t+HfEmo3zzT6bqdpBYw2yNAsXn3cKSM5DMXJT5cEhcMeOa9PrnPH2P7CtSwBA1XTTz2/02CujoAKr6h/x4XPGf3TcevBqxVfUf+Qfdd/3TfyNAFXw0NvhzSlGOLSIcf7grSrO8OLt8PaWvHFrEOBj+AVo0AUIdn9v3mP9Z9mgzyem+XHHT1q/WfBn/hIL3n5fssHH/A5q0KACsTxxdzaf4L1+9tZPLntrCeeN9u7DLGzDjv0rbrj/AIwTiD4X+J9zqnm2EtuGJA5kHljr7tQByfhTwprmiW1lrNpDYaoZ3e9/s2GWSwhheYbt6pl0Zl3bMkAlfm+9nPNeLPC97dSeING1e6ButVvdG1R2s22rY3E121uxgYrniKFRuYZJBOFzge92dulpaQW8WfLhRY1z6AYFeWeIfLv/AI46VakyyKPIMkKNwvkRXUokbHbfPCOeM4oA7LWfD+q6p4cfR5fEMiLOnk3N2lognkjOQ4B+4rEHG4Jx1A9MP4G2MeleEtR0y0LixsNa1G1tY2Yt5USXLqq5PJ6Hr616HXn3waufOs/F0Rj2Nb+J9SjPBGczFwfycUAeg0UUUActcFj8ULADy9q6NcE/3iTPBj8OD+ldTXIzEf8AC2rMF/m/sOfC56fv4ucfl+VddQBkeKSw06324/4/rPOR2+0R1r1jeK9xsLTbj/j/ALTOfTz0rZoAKQgMCGAIPBB70tFAHkOofDbQ18cXFtAj2E+ppcajZ3Fq2GjkCRxSo4PVMvE6KCADuxt4y3xFp9r8OX8K3YXzlk1a2tTcW1mWm3NamGQuqbmkDiMHAGQ+D83buNXUp8RvDczB/Kawv7cEDjezWzgE+u2Jz+Bqz400a61nS4Bps8MGpWVzHe2rXCFomkQ8K4HO1gSCRyM5GcYIBl658QdJtvh5rHinSbmK8gsI3Uq4aMpMMARyIwDI2SuVIDcjjkVe+HMWnr4TtbrSdQfU7a/eS/N66bDO8zs7NtwNoyxAXHAAByck4em6N4b8eW58QTaUsOsbjb3kDzsRFdQMV2TIjbJWjYfKzA8bSuBir3wZYt8KfCm5GR106JHD9d4XDZ/EGgDs6KKKAMHxsQuiRFhuH9oWPH/b3FW9WD41AOjW4YZH9pWHH/b5DW9QAUUUUAFc74GGNMv8YwdUvzx/18yV0Vc/4IBGk3mcc6nfnj/r7loA6CiiigAooooAKKKKACiiigArH0NidT8Qg44vlHH/AF7QVsVjaFj+1PEWAAft6Z9/9FgoA2aKKKACub8RqG8UeE+Cdt1O2cdP9GlH9a6Sue14k+KPDCgjHnTsR6/uGH9aAOhooooA4/4wXbWfwx8RvGzI8to1srKu4qZcRggd/v8ASuvACgBQABwAO1c18S7aW58C6v5DKssEQuhuGQfKYSY/HZj8a6agDhtQmuf+Fz6NDdoi6aNGuWs5Ap3PcmWPzVJzjiMIQMc5b0qTV5ptX+J2h6baSqLbRIpNUvxtDfvJUeC3TPUEhrhj/uL60/4kQGOTwvq8caGTTtat8ueGWOcm2YA/9twSO+Paovhcgv7XWfEsoVrjWtQldWwMi3hYwwJkdtqb8esjetAHb1xnwrjNlpOs6U8MsTadrN7H+8IO9ZJjcIwx2KTp6c5rs647w0v2X4jeM7fzmP2lbLUPKY8KWiaEkcdD9nHryKAOxrnfGiK8WjBgT/xNLYj6h8/0roq5/wAYAk6IACf+JpBnnH96gDoKy/FRA8MawT0FnMev+wa1KyfF3HhPWj/05T/+i2oAt6OAuk2QBLAQIMnv8oq3VbTONNtOAP3ScD6CrNABXHaLdJcfFfxTErFmtdM02MjHClnu2x+RBrsa5fT7cQ/EzXJY4Y1WfSrEySAfMzLLdAZ/A/pQBseItNGteH9T0tpTCt9ay2xkC5Kb0K7sd8ZzXH/AHB+D3hdvtH2kvbF2l55YuxbOecgkj8K9AriPg0IovAkVpAAEs76/tQoP3Ql3MoB/AA/jQAz43Tz2fwz1a9tUWSWxktr3YzhQyw3EcjDJ46Ia7quf+IdrPfeAPEtrZqrXM+mXMcSt0LmJgv64q94Z1H+1/Dmlal0+2WkVx0x99A39aANKq2pHGnXRPTyn/kas1V1bH9lXu7OPJfOP900AQ+Hf+Rf0z5t/+ixfN6/IOa0KoeH8HQdNK/d+zR4/75FX6AKEJH9vXgwMi2g57/elq/WfAT/b96McfZYOc/7c1aFABXFfF63F54Qhsyu8XOq6bEU/vA3sJI/IGu1rkPiwufA9y4Ul4rqzmjwcHel1Ey4/ECgDr682e3nt/wBoqCb5lsrvwzLtXPytOlzEGP12Mg+mK9JrgfFt1NafFz4fiPaYruDU7WTPX/VxSgj8Yf1oA76uJ+H7RReJPHtjHkPFrKztnv5tpbtn8935V21cV4Zt1tPih41H3WvIbC7APVvkkiJHqP3QFAHa0UUUAclMP+LsWpxz/Ykwz/23irra5OV/+Lr2qEf8wSVgfX9/Hn+ldZQBieLHKWNltBOdQtBx/wBd0rbrG8UhTaWW4Zxf2pH181a2aACqOu6nFo2j3mo3AZ47eMvsUjdIf4UXPVmOFA7kgVerm9EuP+En/wCJnIFbRxKG09OCJwp4uG9QSMoOwAbqRtAOItrDxZpXivw1feLdYe50ua+kmdIkXZaXM0Txw25AGfLUyugkLHcxjG1etdprPjG0069vNOSzvbjVYjElvapCR9raQEr5bdNo2tvY8IBk4GM72pWMGpWE9neIXgmXawBIP1BHIIPII5BGa8r8D6rrV38a9ds9R1W31bSbexkWwmVER4ts6rIjBe+/KFuNxhHAxQB3/grRJNC0UxXbwyajdTy3t7LCpVHmlcs2M84GQoJ5worL+Fojs9I1XRY0ljOkardWuyTOQjv58eCeo8uaPFdlXLeHEa28beL4CSVnktb4ZxxuhEPGOcf6P1Pv6UAdTRRRQBgeNlLaNbAf9BLTz+V5Ca36wvGf/IIt8f8AQRsP/SuGt2gAooooAKwPBJzo9zwB/wATPUOnf/TJq36wvBgI0e4z/wBBG/8A/SuagDdooooAKKKKACiiigAooooAKx9CBGp+Ic45vl/9JoK2KyNEGNT8QYPW+U/+S0FAGvRRRQAVhaxn/hJ/DwHTNwf/ACH/APXrdrntaYjxh4cUZwVuifwRf8aAOhooooAyvFk8Nr4W1m4u4HubeKymklhjba0ihCSoPYkcZqfQo7qHRNPj1Fi16lvGs7FtxMgUbjnvzmud+MOs2+g/C7xPqF2GaNbGSIKBnc8g8tB9Czrk9hUnha68Z3U9rP4g07RrSwmt1aSGK5ka5gk2gnd8mxsnggEbezPQAvxPjSXwmI5A5RtR09SE683sHTFV/hFBHp/gqLR4gwXSLq504bnDErFM6oSR3KbW7daPiiWi07RbmeaeDSbTVre71KWIj93BEWdWbI+4JVh3Y6LuPQGn+CI4rbxH41trSPbbDVEnZzKWJmktoXcAHoMFD/wI0AdhXGaMTdfFXxJc2su61ttPs7C4XJGLgNNNjGOcRzIc/wC1jqDjpdcur2z0yafS9POpXaFdlqJliLgsA2GbgEAk89cY4zXIeB9SXUfH/jJreO5SJBZrcR3S7JILkI4aIL0KbBE4cEqS5wWHQA72uf8AFpHnaCp/i1OMfkjn+ldBXN+MHC3nhkMpO7VUAIGcfuZTmgDpKyPGIB8I62Cdo+wz8+n7tq16yPGP/Io65zj/AEGfn/tm1AGhYLssbZR0WNR+gqeo7ZdtvEvXCAfpUlABXnkGtx6V8TfGA1i8htbcabZzQ3U0q/Z7eFTIuJTkbGMkjkBiNy9D8px6HXIfDPyptL1a/iIkN7rF9IZ+8qrO8aHPcBI1UeyjFAGn4P1SbVtH8+5u9IvZUleI3GlTmSF9pxnnOxuxXLYPc1wXwUup7a/1SwvDPCNUjHiCCC6VQ2biaUyeWV4ZFHkZB5VnOTgivU7e1t7YSi2gihErmR/LULuY9WOOp4HNeW/CNhrmoQ3Goxq1z4bsY9MszuyAGAWWQ5GQ7+Sv0XA7kkA7/UvEmh2moppN5qlkmozqwSzMy+c4CbjhM5+7zWZ8JRKPhb4RFwQZP7JteQc8eUuOfXGKvTeE9KuNbn1a7hae+dXjjkcj9wjxqjqmAMbgoyTk++AAMr4OXhvPhtogYEfZEewBIwXW3kaEN+IjB/GgDs6qav8A8gq97/uH/wDQTVuqetDOj349YJB0/wBk0AM0DH9habtxj7NHjH+6Kv1T0T/kDWHT/j3j6dPuirlAFCE/8T+8Gf8Al2g4/wCBy1frNgOfEl8O4tLc/wDj81aVABXF/Fy8g0/wlFd3eHtrfUbGaSELueYJcxsEjX+JyVGF74rtK4rxHbz3vxR8GrHcYt7G3v72aDzMZbbFCj7e5AmkAP8AtNQBaHiiGfxrbaVYazoU0ZEkdxYtKVvI5EXcSnJD4BUMhVSuSdxxtrjvjJNKfFGiTaWb1tW0GyuNZijt4/MVh5sEJDrjLr5bzEqpDEDg9j6y8UbvG7orPGSUYjJUkY49OCRXlnxWmuvD/iGPW9NlKz32nLpsvzYMSfbIVDp6Ni4cZ9dh7cgHf3niXRbLQYdbutTtY9KmRHiuS/ySBhldvrkc8VzPhrXNO8RfEJtQ0ac3FnLoUMiS+WyB1a4mCkbgD1jft6etdO3h3S20K10b7KBpdtGsUdsHYLsVdoQ85ZccEHOe+a5dbVdC+LmlW+lwpDY6nokkM1vEgVIxaSR+SR/dAFy64HHI9BQB31FFFAHJvu/4WtDx8n9ivz7+eldZXINj/hbkfzvuGht8m0bf+Phec9c+1dfQBj+JwTb2AAyPt9vnj/poK2KyfERAisAwzuvYQOe+7P8ASp9b1a20e0We6LFpHEMMKYMk8h+6iAkZY4P0AJOACQAYXjeV9TnsvCtsQG1VZGvXDYaKyQASkd9zF0jHpvJ/hxXUwQxW8EcNvGkUMahEjRQqqoGAAB0AFYmg2F0+pXWtarDHBfXUUcCW6srm3iTcQpcAbmLMxPYcAE4yd6gDmvFuoXzX2naDozeVe6j5jy3W4A2lrHtEsigggyZkRUBBGW3HIUg5HhS10yH4j67baXEUXSdLsbEkDKhmeeVlJ6l8NGxyc/OCetJ4eCX/AI78T+LLuOKOysoV0aznI+Zo4WaS4fPp5p2f9sTW94EsJNO8LWcdzD5V1LvuJwQQzSSMXYtnncc85oA365rQDb3fjHxRewMTJCbbTJfTdHGZuOfS69B0rQ8V6jc6R4Z1TUbCz+23VpbSTRW+7b5jKpIXP4VV8CWUVn4U08xXcN/JdRi7nvoQAt3LL87zDHZixI9BgdBQBv0UUUAYXjMZ0i3/AOwjYf8ApXDW7WH4xONKtvnKZ1Gx7Zz/AKVFxW5QAUUUUAFYPglt2jXBAP8AyEtQHP8A1+TVvVgeB/8AkDXPH/MT1D/0smoA36KKKACiiigAooooAKKKKACsjRD/AMTPxB/1/L/6TQVr1kaG2dT8Qjji+Uf+S0FAGvRRRQAVzOuH/iuvDC4H+qvGz9FjH9a6aub1hf8AiuvDbY6W94M/hFQB0lFFQX93b6fY3F5ezRwWtvG0ssshwqIoyWJ7AAUAcV8VF07XF0XwZqE9uRr14qzWzE+ZJbwq077cHK8xKu7tu45xXeV88Rarf+KvHemavazmwij16eS6uLgriKwsYANqnOPLZrmXLHnMoPQCvfNL1Ky1azW70u7t7y1ZmUSwSB1JUkEZHcEEEeooA5j4wXkVj8O9WluiRZOYYLvC7j9mkmSObA9fLZ8VW+FsSxXvjkBmZj4imJB/h/0eAKB7BQuK0/idpbax4F1W1S2+2OqJcLaliouTE6y+USCMB9mzr/FVD4Ya5ZeJW8S6zpMjS6fdaihhlIwHAs7YNj1wwZTjupoA7euH0wJB8ZteU3UQe50WylW2GdzBJp1LntxuUdzyOnFdtI6xozucKoyT6CvnHWPGWoXGm33jTw/FeQXtprsPkWczApPaXdtbKjTFAwCsVXGGG0nBO7AoA+kK5rxiQL/wsGBOdWUDAzj9xMf6VoeFtai8Q+H7LVIYzEJ0O+JmDGKRSVdCR1KsGU/SqHjAoNR8LBxknVgF9j9nn/pmgDpKyPGIB8I64D0+wz5/79tWvWN40z/wh+u4GT9gn/8ARbUAa8S7IkXGMADHpTqQAKAB0FLQBm+JtUj0Tw3quqzHEdjaS3LcZ4RC3Tv0qHwbbG08JaNA2/elnEHLjDFtgLEjsScmuT+L3jLTdGsU8PTpNNqGsp5CBE/dwRyOsRmlYkBUDOo9SSAOuR6JQBW1O4e0027uYonmkhheRYkGWchSQoHqeleffBC3xpus3KxJFGbiC0jVOcrDawoxz3Jk8yvSq89+B0BtPCOoWru8ksGs6hE7uMMxW5cAkduMcUAehVzPw+v47rRZ7JWY3Ok3UunXIZSP3iHIPPUMjI4Powrpq881/XofAniPWdQvLXUbqy1WSy8uKziEjG4KSo7YJHAjgiz9BjNAHodU9az/AGPf7Tg+RJj/AL5NZvgzxXpfjHR/7S0SSZ7YP5bedC0bBtqt0I5G1lIIyDngmtHXMf2LqGcEfZ5OvT7poAXRsf2RY44HkR/+girlVNIx/ZVltOV8hMH1+UVboAzLcD/hJb855+yW4x/wOatOsy3bPia/TB4tLc5+rz/4Vp0AFcvoqpeePPEl7uQvZx22mBR1XCGdifr56f8AfIrW8Sa1Z+HNBv8AWNUdksrKFppSoycAdAO5PQe5rl/hHcHUNN17VHtZrOXUNYuJ3t58ebFgJGocAkBtsakrnjOO1AHdV5B8SXgvfidoWkXRlnaaTT/It0IAVRNcTyue+P8AQ4fyr1+vO/HGnqPit8OdUEnlgT3lrIMcSFrWRkBOeoxJgf7RoA9Eri9bi+wfFLw3qjxyyR39pc6QGBG2KT5bhSR1+ZYJBn1C12lc18QIYP7Dgvp4FlbTb22vYyW2lCsqhmB9djOPoSKAOlorzDQ/i1aXvi2TR9TsH07zrhYLFXYtNKpxiaRNo8uNmYIpyfmBBwcCvT6AOUO0/FRcISw0U5bPAHnjAx74P5V1dcgW/wCLuIgUf8gNiT/28DH9a6+gDI8Sf6rTxxzfQdf97P8ASsjwpIuta5r+oX1uTcafqUljaeamDDGsUYJXt8xZ23dSHx0AFa3iX7mm8Z/06H8PmrMuLltE8eQLIUTTddj2BjkYvY14GemZIQR/2wHrQB1dYniuS+kso9P0gtHeXzeSZ1ODbRf8tJh/tKPu/wC0y54zV3XNJsdd0ufTtVgFxZzY3oWKnKsGUhgQQQwBBBBBAIrkbP4YaTY3K6hZ6r4iTXlhFv8A2vJqck9wYw27YyylomXP8JQjvjPNAGrrVrYaH4TstItYfLsXlttNSJWIyjyIjDPUnaWJPU8+ua6evMPEk/ivTIdMg1qxbW7SDUrWX+09KtyZRGrjcZrUZbIGfmjLZ67V6V6Do2rWWtWIvNNm86De8ZJRkZXVirKysAVIIIIIBoAvVyPwptzZeCoLIPvis7y9tIfaGK7mjjUewRVA+ldFrWoRaTo9/qNwVENnBJcOWbaNqKWOT24HWszwFp0mleDtJtbjaboQCW4IOQ0z/PI2fd2Y/jQBv0UUUAYXjMgaZZ5xn+0rLGSR/wAvMdcL8QfiRe2PiG48NeHktYtSANuJZ28yZ55IDJF5MC5ZgOpd9qZUrkmu78Yf8gu14z/xMbLtn/l6iqv4p8PJe3VrrWm28Q8Q2BBgm3+UZowfmt3cKT5bAtwQQGIbGRQBTttT8WaXtt9U0RdbVY1P2/TJI4S5x8waGVxtbI7MQc9ulOu/iDodpp0VxcDUUupMldO+wTG9wM5JgC7wvH38benPIy9vF7aZPp9v4p0ybS5b+c29vJCxuoWk42oXVQVZsnAKgfKec8VDYvBD8WtXjufJ+23Ok2r2rEjeYY5ZhIo46BnUn/fHpQBVs/G+sT6ja6XN4L1W21O5xMBJIhtooCSN8k65VWGDmMAtnHUHNclo3jHxJc2eoW3hKw0horLVboXeo387GyKyTySbo5VxuCbgrD72SOMc17DqEU89hcxWlwbW4kjZIpwgcxMQQH2ng4PODwcV4ja/Ce11rQ49BtfFccttpUcumX1iNOMcBcxgLKYN4AnGTIJm37mYMOMUAeiIPGv2ZZLDUvDepRyKXSSS3lgHLZGNruCADgdzj8a5y6m8bweKdL0bVfFNlbTavFPLbnTdJVlhMOwurGWQkghxg469ccV08ngW0vYLaPXNW1zVmtnjlhea9aAo6fdbEHlhjnnLAnNVj4M1Gz146tpHiKdpgkkUUWrwm+S3R2VnWIh43GSifeZvujGKANK18N3v2NodT8T61fM6bHcGG37g5UxRqVPGOD0qOTws9pA39keIdb08gEgzXX21c/7X2jexHsGHsRTZrTxuEuDDrPhtmH+pVtJnAPHRj9pOOc8gH6dqo6tDq954O1CDxzpugXNosBluhb6hLBE6p8/V0GwZXqXwMcnGaALQ0TxXHp0UkfimFtYEjvK0ung2kinO2MRBg6hcjBEmSQd24YAujUfEcGnGS40K2uLuOMlo7W+GJWA6JvVevbcR7msDwd8V/D3iS6vbRxc6Xd2nlb1vlCRusq7o3SQEqVccrkgsMYFd7DLHNCksLrJFIoZHQ5DA8gg9xQBk+HvEVrrRnhEVxZajbnbcWF2oSeL0OASGQ9nUsp5wcggbNYHi3w9BrVtFcRv9k1eyJlsb9OHgfHQnvG3RkPDDr2Il8F64niXwppWsoIx9st1kZYn3qr4wwDdwGBGfagDarH0L/kKeIuc/6en4f6LBWxWNoIA1XxHjqb9M/wDgLBQBs0UUUAFc1qwz498OHJwLS9OMcdYK6Wue1QA+N9AOBuFrec+2Yf8A61AHQ1R17T4dW0PUdOuY/MgvLaS3kTn5ldSpHHsavU2VikTsq7mUEgZxmgDyLw14Hs9W8C+GrnSryIRSXNnqU0zgktCsUImhwRkBzAoIOMY56Yrr/hTp0mmeD1gkaaRZL28uIprg5lmikuZJEkkPdmVgc+44HSuM0HXL+z+F9vZy6VrOqz61YPeWUunWRMSi6DSLCzB/3flmTbucqNoBBzkDs/hBe6jqHwy8O3GteX/aBtFSUoMAlSVGffAGccZzjigDsK4L4H20dt8PoUhVUiOoagURRgIv2yYAAemAK72uR+ErtL8OdDmlgS3mnhM8sSKVCyOzM/B5HzMetAGh4/DHwJ4jCEq/9m3OCCQQfKbuOlcmPC0Ok2Or6hcaXaXGlJZWt1ZafDI4aO4ggaPygDhdmNm3J6liR0NbnxbkZfhvr8EZRZL23NgjOSFRrgiEMcAnAMgJ47VzOrHV9d8G3HgaLw9qFlfG2j0+e9kUGyii4VpopWbdJ8gLKvL5Kh9pyQAd34P0VfD/AIcs9P3tLMoaWeVjkyzSMZJXP+87Mfxqv4rx/aPhjcM/8TTj6/Z56b8OZ7i58BeH5b2eS5uGsYt88jbnlIUDex7k9SfU1J4n/wCQp4XBGc6me2f+XW4oA36x/GWP+EQ1zJIH2GfJHb921bFZHjDjwlrfCn/QZ+GGR/q260Aa9FFFAHyN8T/EOlyf8JZrHiqGWa/utek0OxSIEiGzs8ndgkDDSE5znnJXBUY+uEYOishBVhkEdxXkFp4KtfGXh7xEuovY3AkXUtOjdowwiuPtlwTNgj5SpK4I5+9V34bfEU3HgnRjr+ia7b3gsov3tpp019BcjbgSJJbq6jOMlWwVJwc4yQD1OuQ+G0MUNr4haKNU83XL52wc7m80gn26U8674onDSWXhELFvIUX2pRwyMn97aiuBnsCQfXHSsnwl4l0vR9T1vRdbnj0i/WY6n5V86Rbkny7bGJ2yBH3qWUkDC5IPAAPQq8j+MbTt4u8PWcUlwFlsry8ijtow7tc2piliOMZ4BkAx13EdxXd6X428KatfxWOleJtEvb2XPlwW1/FJI+Bk4VWJOACePQ1zE+ob/wBoC0tLpQLaLQpFs5GXg3LSq0qK3QuIhG23qFOehoAwvgZHPput65p1lo8Gn+G7ie5vtNntiDFdwmUCNxySGCnByANoQDpXq+uts0TUG/u28h/8dNcf4LOjRePPEekaO0cbaNFCksCRCPY1wWlPQAMAqxKMdAuD612GvAHQ9RB6fZpP/QTQA/SSW0qzJIOYUOR/uirdVtLGNMtBjGIU4/4CKs0AZ0AH/CRXx5z9lt+/H35u1aNZtuT/AMJHfDHy/ZLfBz/tzVpUAeX/ABv1GaBvC9gfObTLi+e51CK3BMs0NtE0+wAc4LIuccnAHcg5f7LuoWGp+DdduNOsXsQ+tTPLA5JKO0cRI5JPH3cnk7ckAk10Pj+3tNR8d+HNIvm2f2lp2o28EiH94j5tmcqf4T5QkG78O/POWN83gD4w+J9Os9JuLzRdXtLXWDBpkal7KQsYHYQL88gdlDMyg49DnNAHs1cT49UP4q+H6mMSf8TiRsHtiyuTu/Cpz4s1K/cx+HvC+p3DKwDzakDp8KggngupkY8D7qEc9RWN4s1PVdMj0nX/ABPoTLBo85u2bR7hrzZvV4WDo0aMVWOXeWUHlTxjqAekVx/xi3/8Ks8VeUSJf7Om2EHBDbTtx+OKfP8AEnwTCyq3i3QmZhkCO+jc49flJrC+NmtRXHwR8Q3+hSpqMd3a+VbvZuJRIHcIWQqedoLHjptPpQB5NLZ60dCTW/D9i+p65Z2Vpq1vPfXIedbS4hk89GZztbZcQmZR/CzZUAcH6iGcDcQT3IGK5HxbqujaZ8PHkurqGHSbqCO0Wa3YMojlATemOoVWL8fwqT2rr6AOQLJ/wt0Kc+Z/YZI+n2jn+ldfXF7j/wALm2eXwNAzvx/08dM12lAGP4kGV0zr/wAf0J4Huasa7pFrrenm0vAwUOsscsZ2vDIpykiHsykAg/nkZFVvEjFTpIwxDX8QOBns3X8QK2aAMHwxql1MH0zXPKTXbVAZvKRlinTOBLFnqp4yMna3B7E71Z2taNZ6zDEl4jCSF/NgmiYpJC/ZkYcg/oRkEEEiqLahqekyKmp2zX9q8wjju7OPLxqQfmmj7YxgsmQc52oKAN+sm88O6Xd3c11JbMlzNt82SCV4WkwMAsUI3EDABPIAxV3Tb+01SxhvdOuIrm0mXdHLEwZWHsas0AcP4j8OatZaRfjw5cy6nDLB5UujarctJHPHjDrHO2XjkZSeXLpnGQOWE/wz1m51DQ4rXUnZ7u3QBJZU8uWaIEqDLH/BMrKySKOAykjAYAdjXmniq5k8M/FnwxqErrHo2tmTTZX28pdsqmIE56SCMKBjgoOmTQB6XRRRQBgeNM/2bYgGMZ1Oy++ev+kxnj3rfrA8asF06xDHG7U7IdOv+kR1v0AVNW02y1ewlstTtYrq0kxuilXcCQQQfYggEHqCARzWLfeCNEvnsHvF1GWWwkEttK2qXXmRPtK5D+Zu5BIPPPfNdLRQBzl94fvIE8/w5q11a3qnOy+mlvLeUcfKyO+V4HBRlIJydw4PJWyeNNb1M6zpdn4e0p1d7C7aS5mma8SGWWMghUXZhtzI2Sy5OcgkV6hXP+BgRoc2SCTqN+cj3vJqAMGyHjfQXnvtRa11vTnfJ060Ume1TjLRSuR53clGG7+6xPynrtB1rT9f0yPUNIukubSTIDqCCrDgqykAqwPBUgEHggVoVyvijw54fl3ahdzDRbzcSNRtbj7JJvIxlmGFc4HRww68UAdVXEfEOP8At+90fwpCqyC7uI77UFdcoLKGRWdWz18xwke3uGc9FNc9deJWltdPtNC8VHXIHvrOK6uFiVZYoTOiMxmjKIMnA+6SdxwMdOv8NrG3jTxdJPs+3iW2iXHX7KIQ0f4ea1z+OfagDES3ufEXgPTH1SK2upLzUYX1GJLZWjuEE4Qq6kcgKqAk9kra8c+KtM8F6EHmnt7Zwh8iERlyI0GXZY05KogJ7DgDIyK0PCpsks7y2022NtDbXs8bJv3guXLswOTwS5OO2cdq4+W1lh+MOsf2nBfvZarpMVvaSmPfZAAsHicnIWQkggEEMPXoQDI1XRtO8d+D9cGpeJ9Ta0sr4xX0t8VEDRQ/OV8uExqEZXVtwIfoCeMV0/wx0pE8M4k0uTSo/tMzQJb3E0cc8TOWWYRM+6PeDko3IOc1gXGix6zrWntZT3ev+GbSCKOe0sbyO3Et0Bv+0TqojS4V1MR4YKCh+U5IHpGh6xa61aPPaeahjkMU0M0ZjlhkABKup5BwQfQggjIIJAMW6ku/DWtWLG7mudD1CcWsiXLmR7SZhiIo2CzIzfKQ5OCykEDNX/Dn/IS8Sdf+QiP/AEmgrK+LUIu/BptFkCXFxf2SQDdtLyC6iZVHI/u/kCa1fDYI1LxJnvqII5/6d4KANyiiigArndT/AOR80Ebc/wChXp3Y6fNb/wCNdFXP6iD/AMJ1oZA4Fje55/27ft3oA6Cs3xJqcOj6BqGoXLqkdvCz/N3OPlX3JOAB3JArSrlPHLG4v/Cull2WG91ZGmwm4MsEUlwF56ZeGP8ADNAGpoenHRvCen6YGANlYx226FeBsjC5UfhxXN/BzVdPk+FPhIpc20YXTIEKmVcgqgU598g1u+PLuay8Fa5PaTGC7FnKtvIOomZSseOvO8rineGfDOlaDoVlptlYWUcdvEsZ8qBUDMB8zEAdSck+5oA3KoaLYy6dbzwy3AnV7iWaP5Nvlq7lwnU5xuIzxxjgVx+ueGLfRLe5n0rWPFNjDcSAx6dpTJMvmfO22JJI3EYbJzyqDA+6BWLf+H7LSo0vvFfh+TVNHjTM+oapqrXlzaDu7xMPLVB1YxscdcHHAB2PxPgE/gHWmLMPs0H2wbSASYWEoGTxzsx+NdQDkZHSvHfHOk2fhKHVbHQY0tdK1vQtQWWwDYhNxHGojaME4VmDspUfewp6rz7CihUVQAABjA7UAch8JrWbTvAtnpt08Lz6fNc2TNESQRFPIinkkglQpwfWtLxLn+1PDGOn9pHP/gLPVDwjes/i7xxYGEotvfwSo4HDiS0h/XcrZ+taPiHH9r+GP+wi/wD6SXFAG5WP4xGfCOuDGc2M4x/2zatisrxYC3hXWQCVJsphkdvkNAGrRRRQB5t4Z8J/brLWLC8vry0tU1y+mntLGYJHdJLKZVWRiu8ApIoKowB6cjit74aQ21l4dn02ygFvb6fqN5bJCBgIguHKAe2xlxVnwbJLK2vNPD5T/wBqzLjHVQFCt+KgGqfg+cJ4t8b6eysrpfwXaZOQY5bSFQR6fPFLx7UAddVDVtG0zWEjTV9Osr9IySi3UCyhSeCRuBxVXxV/a0mnx2ugtFDd3UqxPdSAkW0WCXkAH3mwMKDgbmBPAINzRNMtdF0ey0zT4/LtLOFYIlJyQqjAye59T3NAFfVPD2k6ppA0y7sYDZJgxxouzyiOjRlcFGHYrgiuL8C6KdbtvFr65Nc3kc2vzfY7lyI5U+zpHbiRDHjYweKRdwwTjJAyRXa+KdXi8P8AhrVdXuMeVY2sly2e+xS2PxxVP4faR/YPgnRdOIUSw2yGYqmzdKw3SNjsS7MT7mgDmfh3oemw+OvGmu6UHMc0sOnSSySvI000IJlclu2XWPjvE1dr4kJXw7qhBwRaynrj+A1S8Dvby+G4Li1jMaXEs1w6kEfvHld5Dg88uzH/AOtVzxKSPDmqkdfskuP++DQBZ03P9nWuevlJ/IVZqvp4xYWwyDiJeR9BVigDMt9v/CS3+D8/2S3yPbfPj+tadZ0AH/CQ3pxz9lg5/wCBzVo0Aed/EjRV1Txx4ClF9eWM8dxeRRT2m0SKWtmbqwIx+75BBB71AuhReFviN4Tlst91NqUN7ZX9/eHzLq4OxJYyz4HA8lgBgKAcACug8VLu8ZeCvu/Ld3Lc9f8Aj1lHH50zx8qw33hLUDIY2tdZjUcZ3CaKSDaRn/pqOe2KAOupCw3BcjcRkDPP+eRS1yvhKzuNQu38TavFLDf3MbQW1q4K/ZLbfkIR3dtquxPfCjhckA6GzsLOyLmztLe3L8sYowm764HNec+LtBsYPH/g200w3dm19q0mq3MFqAIGMFvJulYfwszSRKccNnnJ5r0+uZsILW/8fanqSvI9xplqmmBS3yxmTbNJgerAwZ/3KAOX+JXgfw7e6ZHYvprzPq+pQxpbCeUQJISTLMsYcKriIStkDkjnJPPp1cvrpjfx34VilQttjvJ4/RXVETd9dsjj/gRrqKAOMEf/ABeV5MHnQAueMD/SD+P/AOquzrj0Vf8Ahb0r/Nv/ALCQe2PtDfrXYUAY3iRgJdHB6tfxgf8AfLn+lcdcfFjTzrtppdnaszXN5NaJdTyeXakJGHWVZsFGViwXAO7J6V2HiRS02igBiPt6E49kc15TP4ZOk+JptIh1Zb+bUZmt0TyHuoreIs9wIru1dzGYwo2q6eWwDKAMGgDt/CnjS6urqC08TWcOnXF4f9DaPzdkh5zE+9FMcmAGCt95WBXPIHc15VBotjHpFsmlWkmk+DYxM2rx6pFMk8yLEI4kTzMuqoDuUjp5aKuOalsp/iFolhPe6ncaTc2FpcJbql3vjZrFAd13LIgYiZ/lyu3aoBJ70AWrDWb/AMO+NfFllc6Y7+H42tr6BrKPzJIvPEnnSugO5lMkbH5ASCScEEkXn8ZXOv3CWHgqyuZJZFDvqt/YyxWdsuefvbGlkx0RcD1ZRTbXXJ7r4g6ZajQ5oZ5rKaSS+WdJLaW1BUq0bKcufMZAAyggOxxg13VAHJT+CIr+Xz9Z1zxBeXGFx5Woy2caMBjKpAUAzk9dx965L4heHLiI+Fjq3iK9vba18Raa+m2zQJ5hkEoDebIATJhPMOcLgDLFsZr1quN1BTrHxQ0y2If7NoNm2oPydpuJ90MX1Kxrcdc/fHSgDsqKKKAOf8aqGsNP3DONUsj1xg+eldBXOeOGC2Wl5yc6rZgYGf8AlsvvTNe8R263b6Rp19AuorLFDcurKxsRL9xnXnBbomRgkjPHUA6asHV/GHh3SLRri/1myRA2wKkgkd2/uqi5Zm4PABPFZ2seFL7UpHW+8TavNpWQ7WEawxebjnY0iIHKEjkAjPQkjIrnPhPoPh3SNO8O6nHbLfeJtbsxcT6i4EkuBGpk5/5ZxqWSMKgAGUGO4AOig+JXhC4sre4ttbhnNxnyraGN3uWwSCfs4Uy4yD/DWb4O8YaXbaIbedrwam99deXp72csV1IZJpZUxE6q2ChB3nCjuRg46zX54NItLrWk037XeRRCMmIRpIybuhkcgBFJLHJwACazvBniG51mFzqEMCbiJLa5tyfs91G+WXyWfDSbU25faFJPy8UAUdH1rXfFheTT7RtC0lJWT7XcGOae5AOMwqpZFHX523dOFI5rU0fwfo+m3C3Zge+1ILsN/fubi4I9N7Z2j/ZXA9q6BVCqFUAKBgAcACmzzRW8Ek1xIkUMal3kdgqqoGSST0AFADbq2gu4fKuoYp4tyvskQMNykMpwe4IBHoQDXM+I4Bo/iLT/ABDa25d7iSHSr4K2N0Ukm2JyCcEpI/12yP7VZXxnok6htOuZdUU78NptvJdIducjfGpUcjHJ68daz9U1r+39IutPh8L6teC5/wBHeK8iNnHtbqzSNyqgc5UFuOBnFAFXwfqlp4b0XW7bxBOlpdadeXV3dyOSd8UszyJP7qVcAnopUg4211HiXRo9c0l7R5PJmV0mt7gIHa3mRg0cgB4JVgDjvyDwa8+u/AHijxLopsPFmv2MM9tHLb2t/p1pm4aORArF3k6ZGVZUA3AZJzjb6lBGIYY4wWYIoUFupwO9AHkWu2vxA8M6UJfDOi+Ho1CCC5k04S3dy0a58tooJDGo2l2O0yNgNxnHN34X+MdGmmj8PaH4f1+0vvKe+vF1KJY7gEy+W0s7O2WkcgnvwvbAA9TrmdAUar4jv9fjfdYmBLGyZXysiqzNJKAOzMQoPcR5HDAkAsWWlXt1qYv/ABBLaytbys9jbW6HZbZDLvLNy8hViN2FADEAdWM2gjF/rxwOb4H/AMgQ1sVkaDk3muE4/wCP7t/1xiFAGvRRRQAVz9+R/wAJ3ogwN39n3uD/ANtLaugrCvP+R50gZH/IOvf/AEba0Abtcv42uBZXvhW7kgeWKPWEidkx+782GaFWOTyN8qA49c9q6iub+IVmbnwxNcRWourvTZI9St4tuS0kDiQKvoWClc/7VAFD4qaNq2teHkj0qe38i2mjvbmzkXDX6wusggEuf3QYr9/DHp0Gc2vBialLpun3gTStP0y4iE66da25Zow67uZdwBO5skhOeevWulhlhurdJYXjmglQMjoQyupGQQRwQRVfSNMtNHsIrHTofItIs+XEGJCAnO1ck4UZ4UcAYAAAxQAupy3cFo0mn20d1OvPkvL5e8egbBAP149xWBc+JLu6sglp4T1i7kmeSCSC4WGBUCnaS5d8FDnIKb8jPFa+r69pujiQ6hdLEY4muHUKzskY6uQoJC8HnpwaxtE+I3hHW5bSPTdes5Hu8i3Dkx+cQcEJvA3HPYc0Aef+J7rWNKa2tNV0O6h0y5ngWzsozFqNr5/nRrHCrsiG2JJG1mJjUZ2gEAV7TPJ5MEkux5NiltiDLNgdAO5rE8QaTearrWgsstuulWVw13cxtuLzSKhWFQPu7QzFyTn5o0wO4176A3VlcW6zzW5mjaMTQkCSPIxuUkEAjqODzQBznw7mTU9MvtfjyE1q7a7jVo9jLGqJCgYdc7YlJB6FiO1XfEX/ACGPC/8A2EX/APSS5qn8MtO1HSfBttZa5cm71KO4uvPuSMecxuJG347Bs5x2zir3iDH9reGs4/5CD9/+nS4oA26yvFmP+EV1nOMfYps5Gf4DWrWV4sbb4W1hvSymP/jhoA1aKKKAPNh4o0vwb4h8d3Gt3wi0WCazvJLgbpBbzTRiMwlFUtn93G/GeJh07v0vxNYW/ii613UEm0vTNW0aO6SS/UQlRbSyhty9iUmjYAnOOoGMCxpGm2upfFnxPqMlnGv2G2srHkkieUZn81lxglQ8So3LDD8ik8eadF4m8b+EtCuvJ+y2ckmvSB4/MMjQFYkjweFBNwW3H+5gdyADQ0+PVfFN1bX+q28+kaPBKJrfT3OLi5ZSDHLOQfkUHkQ8nIBY9UF7xr4Y/wCEq01bJ9a1nSos5ZtLnWF35BGWKkjBHbHU5zXQ0UAeV/E/QdVsvhDrlimrz3VnZ2In+0SlmvCIGWVt0hbEm4IwOQPvHr0r1GCZLiCOaJt0cih1OMZBGRXF/GS9hg8DXFjJ5Tz6tPBplvDI20SvNKqbffClmI9FNb3ivTYNQ0WcyvcwyW8cksE1tKY5In2MAy44JGeAQRnHHFAFT4fceHGjHmFIr++hQySbyVS7lVTn6AfTpV/xZk+FdZxnP2KbGDj+A1mfCyIQ/DLwmgVFP9k2pYJ0LGJST+JJNaHjH/kUdc6n/QZ+nX/VtQBpWQC2cAHQRr/KpqitRi1hABA2Dg9uKloAoQMp128UH5hbw5/76lq/VCByddvFzwtvD277pf8A61X6AOV8eW9q8nhu7uLgQXFprED23ODK7homjBz3SRzj/ZrmfFPi7R/FunaxYaELi8fQLqG7vLvyWjhtpLW5jkdN7gbn2o5GwEYB55Gei+J32OfQbPTb5Hb+09RtbSEpgMjmQNvU/wAJVUZgRyCBir3jRWsfAuv/ANlwKsy2Nw0UcUYwZGRjnA9WOT+NAFPVNf1C/wBVn0XwnBE91blVvdRuQTb2RIDbdoIMsu1lOwEAAgsw4B2PDmjR6Jp32ZLi5u5Xkaae5uX3STSMclmPQdgAAAAAAABVD4eeF18HeELHRftkt/LBvea7lGHnldy7uevdjjJJwBknrXR0AcZpPgiXQtQvNQ0rxDrNxd3OS8eq3LXUGfZMrt5A5HOBjpxVT4aQTWXiTx/a3DMztrC3fLbgPNtYTgH0GMAdcAV31cT8NZDfXfi/VvPhuIr3WpFheJty+XDFHCBn1zG350ASeKpJYPiD4HeIRss0l5bSKSdwU25k3AegaJQc/wB4V2VcXpeiWulePoItPjSKzh0yZkiLs5R5bgO5XcTgEjkD0A4AFdpQByEaL/wty4feu4aHGNmOcfaJOc+ldfXKRIP+FqXT9xosQ6/9N5K6ugDI8QZNxowH/P8AL2/6ZvSw+HNJt4bqO1so7YXVy95M1uTEzzv96QspB3H1zmna2M3Gk4XP+mD8P3b81Jr2qw6JpM9/cRzypHtVYoIzJJI7MFRFUdSWYAfXnA5oA4DVPD6Wni/wxoOnavrE1rJcPqd7Z3V810PJgX5GLSlnC+e0Pyg4PPHy8en1z3hLRrqy+06nrciT67fkNcMnKQIB8tvEcA+WmSeerM7cbsDYjvrWTUJ7GO4ia8gjSWWEN86I5YKxHoSrY+hoA5K/0qbQ/HGkaxayE6NJHLYXFuxAW0MnlGN4/RS8KqV9ZM+tdtUF9axXtnNa3C7oZkKMM44I7HsfesTwJdX8uh/Y9alE2r6bK1jdzAY85lAKS/V42jcgcAuR2oA6KvPnv7/TPivKyJazaPqn2fTZW8zEsFwkM84IGMFSuAVOD8ykdxXoNeZ+KIbeTxJFo9pF5moXWv2OqFpZR+7VEDOyjrjZalfTMnvigD0yiiigDm/HAJtdIAKj/ia2h5HX96Kx/HnhKefXdK8V+G7S2bX9OciaJmEX9oWxHMLSYPIKqyluARjjJI2vGpYQaPtzzqtqDj0310VAHPW+oeIL+OdI9GXSpVePy5b6ZJldCRvIWJicgZwCRzjnFc5qvgPUrPWIdX8I6wsE8N5JdrYX8Ie2CyrtmiRkAeJHIEhHzDeu7GSa9EooA4G4h8WnRPsXijRdC8SWeUjuRbSsklxHu5kEMibAwwG2b+SDgg4FeaaNfWerS22j67a6je6vp1zcxwTtF9nuzbsXhWfyGIS4R0zG5jG5SORnDD6Jrz3SPCOgeMfBFlb+ItNivooby5liLMyvG32iTlXUhh+B5oA0ZvBUN9pmmxnVNW08wbS6adcyW8cyD/lk0Ts+FI4IByOcEVS+HnhXSdI0e5sru0trufTLyaEXt1ChldM742dyOWEbqC3cgmt+HwlpcJtdramy2yskaPql064YEHcpkIbgnG7OO2MCsHSPhF4I0ud5o9EW6ZzKWW/uJbtD5hBYlJWZcnA5xnjr1oA7tEWNAsaqqjoFGAKzPElvYzaasuqXf2K3tZo7oXPnCLymRgQSx4wehB4IJB61ia78NPB+uLEt9oVsoiBCG1Z7UjPXmIrnp3rRsvBvhuzgiih0TTysTb0MkCyMG/vbmyc++aAKsPj3w/cPAlncXd1JO4SNbexnkLZ/i4T7vfd0x3rT1HUbwXEFrpVjJPNI+JJp1aOGBB1ckjLn0VepxkqMsNaigDDuNDn1CZG1fUpp7deTZwIIYJOMfOMlmH+yW2nuDW1HGkUaRxIqRoAqqowFA6ACnUUAFY/h8f6VrZyTm/PBHT91H0/z3rYrH8Pf6/WcA4+3N1HX5EoA2KKKKACsC9I/4TzRx3/s2+7f9NbSt+sC9z/wn2jccf2Zfc5/6a2lAG/TZCwRii7mAJC5xk+lOrjNSv8AXNQ+IP8AYek31rZabZ2Ed5eyiDzZ2eR5ESMZO1BiNmyQTxQBa+FwQfDzw/sPJs0Mg27dshHzrjthtwx2xWx4h1i10HSJ9Rv2K28RRTjA5ZgijJIAyzAZJAHeuXtNA1/wve3lx4fubfV7S+nNzdWN+wtnWYgb5IZI0KjdjJRlwWJO9cnMVhDc+MfFl7NrlgYNF0gC1i064ZJRPdMqu0sgRmUhEZFUHOCznqBgA5nwCkPi+31vTfEGoSTalC0V5PPZIUtWkYyqJYpHB+0KpRl+YGNTEoVflzXRwwrJnSf7Ml1PQtSzFBqv23+0o0fYWV5InG2Nc5AKblyFBwCMXdVs9fTxbqOsafplpPJFYxWOm77ny1cu5eZ5yASFUrHtADH7+PvHGfp+sazptx4vhktdKvJ9Nt4LlptNsZIfNndXd42QuxdgoR+GyRIoxk0AM8EacfDvjFdJiuYL3zdKEl5cQFYQ1xFKE3Nbqdqsyvjcv9zDfw13Wtagmk6PfajKrPHawPOyL1YKpOB7nGK8s8Jzw6Z4/wBfbWL22htfDKHTbKOJD5ksVz5NwC4GS7L8q5GScsTzyet1qwufHCR2NzbyWnhRxuulmVori9Kv8sYXho4/lDMThmBC4AySAbHgjT59L8JaTa3wYXy26vd7pDITcP8APKSx65dmOfejxB/yFvDXT/kIP1/69LjpWO/w70W3DPpt3rWkLtIcWWqTxoR1yVLFc9ecVmeFL24vfDPw7uru7nv3ubt3juZk2ySxm1ujGzjjkptyccnnvQB6NWT4tDN4V1hVAJNnMMH/AHDWtWP4yYp4S1ll6izlx/3waANimyyJFGXldUQdWY4A/GnVwHxM0rTtY8R+BbTVYLe+t31ObdYXK+ZHIotJj5hQ8HYQvJBA3+pFAE3grUbW7+IHjy3tZopXjmspmMbBhh7ZQOR/1zNXZFk/4WtAyqDENFkDNnofPTaMe+G/KsXwDolvoXxO8dw2NlbWVnNBpssENvCIkCCOVOAABjcjDj0ro/Dem3kWv+I9U1JXWW8uUhtlMgZVtYkATAH3cu0rEdfmoA6OiiigDjfi9p4v/AGovsYy2Bi1GMoAXVoJFlyue+EI9cEiuuikjuLdJIyHilUMDjggiqfiKxl1Pw/qdhbSrDPdWssEcjDIRmQqCR3wTmmWM507wzb3GrpDZG2s1kuVVsxw7Uy4DdwMHn0FAHC6D4u1PQPCejW+peC/EdwkEEVr9o01YLtH2KF8wKsvmbDjIymcHpXRXGtWPij4dapf2HnLbTWl1EyXELRyRugdHR0OCGVlYEe1XfAJlbwP4fe53/aJLCCSXepU72QFsg8jkng9K5PwTIJPgMl0UWNrnTLm7dU4AeTzJG/Hcx/GgD0eFdkSKOgUCn0DgUUAZ1um3xDftkndbQcY6fNLWjWdbMp16/AVgwggySeDzJ0rQZgqlmICgZJPAAoA4r4g32nPPoFu+qWcV5DrVowtzMgkcl9m0Kec/NnjnANa3xBga68Da9BH/rZLKVY137Nz7TtXPu2B+NefeC/C+ixfDDwrqdvpVhDfyz6dcy3rW6Gecm5jO9pMZYtnOc967/xbpl3rF3oNrHGraal+t1fFnx8kSs8agfxZmER9MKc0AdFRRRQAVxPw8sW0fW/GmmsQI21Y6hAoXGIp4kYke3mrMPqDXbVi2NlfweKtVu5zBLYXMEAgcALLEU37ozx8y5beCTnLsMYxQBz/AIqvL7SviHodxpumXOqtdaddwyW8DxRlAjwsH3SMo6ttxn+LParOieO4tQ16HR7/AMP+INGvJ94hOoWqiKUou5gskbupOMnrztNS3ZkufinpsY2CGx0i4kbk7i0ssSr7YxE9S38gl+I+jW0gjIi027uY853B/MgTI56bXI6d6AI4kf8A4WpdPzsGiwjpwD58vf8Az0rq65WBX/4WlfNubZ/Y1uAO2fPm5+vSuqoAyddP+l6IPW+9M/8ALGU1meImkn8aeFLPzZEgU3V6yrjEjRxhFVvYecWx6qPStHX5PLvtBGQN9/t57/uJf8KxdWvrQfFPRLa5uord4NNuHRZXC+e0ssSKEyfmI8tsgdN6+tAHZV5BBNY23jX/AITBdTt21a91ZtDezkvAP9DWb7MqRp3YTIJumcM4r0nxRfvY6RcC0mii1KaKRLLzeVMoRmBI/ujG4+wNc34M0Cw1b4WaXDPb20U2q6ZFNdXFrGqM88sSs8wbGS5Y7tx5zzQB3VcjAG8PeM757rYbHxFdRGCXzPmS5W32mNlPRSkClSM5YsCBxm94Z1uW4kfSdaQW+vWqDzU6JcqMDz4T/EhJGR1UnaexN7xHpf8AbGjz2iTC3uDiS3uPLEhgmUho5Ap4O1gpweuMUAaVeRy3+nQftEXNxqmp6fbR22hiG3WSVIz5jSAvknBJ27cAEgDJ4Jr0Lw7LrkWmzN4t/spJ4jnzrB38t0CglirjKHO7jLcd64f4V6OuoeJvEvirUhZXN1d3I+yhQDJZRsinyW9HKeSW9zjtyAehx61pclkLyPUrJ7Qts89Z0Me703Zxn2qWDUrGe9ks4Ly2kvI0EjwJKpkVT0JUHIHvVC88K+Hr3URf3mg6TcXwTyxcy2cbyBcEbdxGcYJGPc1zHivRdD8JQ6Rr+lWNhpB068gtma1txErW9xMsTxsEAyu6USAY4ZQfWgDf8ZqrQaRubGNUtSPc7+ldDXPeMldotHEZAH9qWxbPoGzXQ0AFFFFABXLfDL/kTrbjH+kXX/pRJXU1zXw5Zm8I2xcYJmuP/R8lAHS0Vy3jfWdRsbvw/pehTafHqer3rQBrxWcRwpDJJJIqKQWI2KByBlxkjNRtoni1oz/xWEKy46rpKbc+uC5OOvGe/WgDraK5U+EJLu5tbnWvEOu3c0KkeXb3j2ULEnOSkBUn0G5m/WrQ8I6aDxc65+Ot3p/9q0AdBRXPr4WtoWMlnqOt28p/jOpzzgf8AmZ0/wDHazrHwv4jivQ95481a5tQSRCLGzjYjsGcRdvYDP6UAdjRWA/heGeVZL3VNbuHVdnGoSQDH+7CUUn3xmlfwxbieKe21HWreaIYBGozSqR7pIzIfqRmgDerJ0Agy6rjOftrg5/3Vqj4B1SfVdDmlurn7Y0F9dWi3PlhDMsU7xhiBxn5cEjAJGQBnAvaB/rNV/6/X/8AQVoA1qKKKACuevv+SgaL/wBgu+7/APTW0roawb3P/CeaPyMf2be8f9tbSgDeriPh5Ef+Eh8e3FwWN2+tCNt3BES2sHlj6YbI+tdvXn13eap4c+IGt6le6Pq1/pF/b2kVrJpiCdYmTzPM8yIMHDksvzBSNoUZGMUAeg1yelzvpPjnV9PuoSlrqpS/s7nGEeURrHLBn++BEsg9Qzf3DUupePfDGlL/AMTfWbXTpNqsYrwmGQbhkDYwBzjtiqGs+K/AOtaB5up69odzpjOCjm7TKyA/KUIO5XB5BXDDGRigDtq858d6drGl66Nb8KXOk2t/eW5sUhvS+2e5d4yrbFIDtsixu6qqk8gEVnrrlhDBYWeifEO8WJQUzdWgvZJeeMyFM8Zxk5J7nNbNtP8AZdRDponiHxBq8G/ZfXUMcKRkjDeWZCiopwAdikkH+LBoA6jw1osGg6Z9lgO+WSR7i5nIw087ndJIeTgsxJx0AwBgACtWuGsr34jo11PfaJ4WmgKl7e1g1OdJk7hGdoSrNjjICjPtVqbxhf20SG68FeJVmZC3lwrbTcg/d3JMQCe2ce+KAOm1SNJdMu45JfJjeF1aT+4Cpyfwrz7wPPLP4G+FEk/+sZIQSc/MBp8+D+IAP41f8Uar4h1Xw3qen6f4P1eG8vLeS3iknu7NEiLqVDMVmZgBnJ2gnjitrVreK0vPCVtboscMN6Y40UcKos7gAD8BQB0NYnjb/kUNY/69ZO+P4TW3WJ43O3wjq554tn6fSgDbrl/EETr448J3QiLx/wCl2pcD7heIOM+xEJ/HFdRXOeNdP1y+j0ibw1PYQ3tlfrcP9uDmN4jHJG4whB3YkyO2QM0AUtbePRPH+lavcSzR2mp250iU4/diYP5luWPbJaZAe7Oo7iuwrmNb0vxBf6PcWslx4fvvNTaYLnT5Vifnv+9Yj8jzWToPhfxZotmhh8VC5dQz/YLyAzW6kr/q1mY+dtDdGZmOOoNAHT6/rS6VCqQWs2oajKP3Fjb48yT5gpY5ICoCw3OcAe5IBqS6jrljCbvUdNtJLRFZ5Us52kmjAGeFKDzPwwfQHpXI2Gu65onjbUH8Z2WiQ20mmyXi3WnyyTSokbwosPzIpxueRuBgl+2Oer+ImuX/AId8I3uoaNYLqOqBooLS2ZtqyTSyLEmTxxucE8jOMZGc0Ab9pcQ3lrDc20iyQTIskbr0ZSMgj8DWH4uuYLhbfw+yGafVsxvCF3D7MMeez+i7Ttz/AHnUd6yNOl8VazpkVgdNfw3b/ZlilvZpomuQ+0cwxIZEUdeXbI/unrVfw/8AD7UdElk8jxnrVxHM26aS6jgluJf9kzMhYKOcAY254oA7PXNRi0fRdQ1O5BMFlbyXMgHXailj+grktKtZbT4LiK4Cib+xnd1jOQGaIsQDxnGcZ4q3dfD7Sb5BFqd5rt/blWV7e41a4MUoJ5DoHCsOcYIIxxWt4oiWHwfq0VsqRIlhMsaqvyoBGQAAOw9KANmiiigDKsgf+Ei1QkAfuoMHPX79XNUs11DTLuykbalxC8LHGcBlI6fjVOxVR4h1Vh94xwZ+mHx/WtWgDz7TrG71f4H6faWsML6iNIg8iLdtRp40UouRjaN6D6fhXXeG9Zttf0a31G03KsgIkicYeGRTh43HZ1YFSD0INc34Y8P+KdH0iXTRq2jQwRXEptXWxklcwtIXUvmVQG+YggAgYGDVSPwTrU2u3Woya3Bo0rSlxLoNuYTdAgjNxHKZI3YDb820tx1A4oA725uIbS2luLqWOG3hQySSyMFVFAyWJPAAAzk1zllrWr69Gt3oFraQ6S6B4Lu+3h7nPRliABVD2ZiCf7uME8d8SoPHNp4fmmGo+GbjTNPK3TPfwzI92EXKxSRxnaSX2/dI3EAbecH0XWNYj0TQ21HUVYrGIxIsWM7mZV43EDqw7/nQAaNqUtzNcWeoQJb6jbBWkSNy6OjZ2uhIBKnBHIyCCOeCb17dQWNnPd3kqQW0EbSyyyNhURRksT2AAJrzsap4iuPGmr6noeh22qafsGl2twbpbcRSRSOJjNuBYr5hIBQH7jcZ62Nc+Hd54h1G31PVfFutQXcQUrZ2nkmwjYZ5EEkbByCT8z5PTpgAAG54Lie7+3+IbmGSGfVnVoo5Yyjx2yZEKsDyCQWkIOCDKQRxTXme5+J0UC25Een6Q0jzkjBNxMAqjv8A8uzk9uR17Rt4Kju0A1vXfEGpsUCNuvTaow7gpbiNSD3yD6Vf8NeE9F8NNcPo1mYpbjAlmkmkmlcDJALyMzYGTgZwM0AZ8ES/8LZvpiTv/sS3RRgYx58xPP8A3zXW1yNs2fi3qS4bK6HanOeObi4/XiuuoAxvEDbdQ8Pjn5r8jgZ/5d5qyLKz0bxsmuXN9Yw3llK8mkgyrkSRROQ+D2/eh+Qf4FPUCtjxAzpeaIYyN32x8AjO4/Z5sD868y+H3xHDeEb/AHWdpFNpUNtey29uzSN9mkKtPM3G3dzMwQMTxg88UAHxFh1S30fXVvb5ZI9E07yNPYviWdrqP7OJ7h+xQmUYAAPLHsB63pVhb6Vpdnp1jGIrS0hS3hQdFRFCqPwAFc1bwJ4i1HxxpWpRH7Mxj07fGu1mge1RyN3chppOe2RVbwpq3i20s9KsvE3hqV2SFYbjULa/inJkUAGR0whwxBPy7iMjj0ANPxlYyS3nh3UbeFXk0/Ukd3ztZIpEeJ8HuPnUkei56gV0tcJ8Q/FFpHok2jJDf/2jrUTafZD7M6AzTRuEySBtA2kk/wAIBzUKarrXhbQtOt9TW4uJohBBIwsrm+D4UeaUkhV3I4ODKgYnqTQB3GqSQxaZdyXSb7dIXaRdu7coU5GO/FcV8IoWjtNceS3lt3+2xRMrqBuZLSBWbgDnIKnOcFcewj8T+IZfF+gatoXgOdv7cZUt7l7hHtW06OVWIkkV1DglVYKApOWU4A5q7oMfijw7pwtbjSdO1Czh2JBHptwyzhf4mczkB2J5LFwSSSeTQB2tcZ8TXmmi8N6VbJbSPqOt2iuk54MULG5kIHc7YOPrWjL4jvFjzH4X12WTAPlgW6nPplpgv61hSt4g13XvDV3d+F7jTRpmovLI017BIvltbTRlhsJJOXHHFAG541LhNE2FRnVbYNkZyNx/KujrnvGRG3RQSwzqluOB15J/pXQ0AFFFFABXMfDVVTwbZhDlfMnIP/beSunrmvhyAPCFoB0Ek/b/AKbPQBVlguJvi3bzXCL9jttEkFqxAz5kk6+djvwscP0z7119cT41Gr2vjHwtqun2N/eaZaR3iXqWPlmQmRYxGGVmUlMqzHbk5Ve1WpPiH4Xt757PU9UGk3CqX26tDJYhwDglGmVVfH+yTQB1lFcqPiN4IJwPGXhvP/YUg/8AiqD8RvBIJH/CY+HMgEn/AImcPH/j1AHVUVykXjrTbyESaLZ6zqwZtsbWmnSiKQZxuSaQJEy8feD4PbNVR4h8ZTuXtvA6wwBjxfavFHKVzwQsayLnvgt+NAHa0VyLeK9WtbSR7/wXrn2hMny7OS3uFcBsAq3mr2OcMFPWn3PiPU7yzkXRfDOrvK6gJLdGO0RSRnJ3tvGM9kPI/GgCv8JYhB4TuIY2EkUer6mscgOd6/bp8HPf/wCtW14bGJNYwc5v5D/46tL4P0ptC8KaRpcvledaWscUrRZ2vIFG9hnk5bJyeTnJ5pnhgkvrG4Y/4mEuPphaANuiiigArBvQP+E70c7uRpt6Mev7215/z61vVh3n/I8aRz/zDr3j/tra0Abmecd6KKKACoFs7Vbk3K20IuD1lCDcfx61PRQAUUUUAFFFFABWB4jJ/tzwqB0OoSZ/8BLit+sDxEf+J94WHy/8f0p56/8AHrP0oA36wvHJ2+ENWPpA1btYnjYbvCmpqOrQkD6k0AbdFFFABRRWF411mTRNBea2QvfXEsdnaKF3ZmlcIhI9AW3HPYGgDldS06x8S/FC7huLn91YWdmPL24EkyXDTmMEjDgBIiwHTcnrXX65pNzqkiRjUPJ09kKT2v2dHEwJ5+Y8g46Y6deeMcf4T0uw034l3VlPbzm/sdJhg0+eWMv5lsG3SzGTJHmPLIQwOCfLzyCcdjZa7Fe6/eaVHY6kn2eFJReSWrrbTBiRtjl6Mw4yPcYzg4AOM8I+JIdO8e/8IMNZ1PV5YbJ5y+pWpjmgMbRqB5gjRZUYMxDAHlT8xBGPSq8tSLR774meG59K1ySW60qS/spbWe5ed5gY1ErAsxKhHVFPqSfQE+pUAFZHi/H/AAiet5AI+wz8Hv8Au2rXrG8anb4N14kE4sLg4B5/1bUAbNFFFAGXYpjXtVfK4ZYRweQQG6/mK1KzbFca1qbZb5hF1OR909B2rSoAKKKy/FcmoQ+F9Yl0Vd+qJZzNaLgHMwQ7Bg8fex1oA8s8MapH8Sr3TdXGreJLWeC7l8i2g08iwhK+YF8xniKu4UZ3buHYbcHAr0m+8NpqvhS50LXL651GK4QpJcSLGkvXII2qFBBAIO3qK4r4Ix+HI9FsLDRNan1GfTLOMKw1F2SWGQbhIYA5RCG3JtIyhUjoQT3Hh/xFHrU13GNO1SwaCaSJft9sYPPVTjzI89UPUHg46gcUAYHwnvbaWy16ygnErwaxeTgr9x4p53mjdDk7kIcjI43K47V3VeL6RdrpNpqPiLSrK4i0jRtcuYiJV8pntJpB9rAjB6Rz7pF3AHCEADPPtFABRRRQByNqB/wtvUyOT/Ydrn2/0i4x+fP5V11chaIR8XNVfMm06HZqBn5eLi5/XkV19AGTrZA1LQAVzm+YD2/0ac5/SvnKztdd8OeIfiT4f1WP/RxoWp6lD5RASSOWRPIVW6kLiYcgYLMOmK+i9c/5Cnh7gf8AH8//AKTT1zfxM+H0PjCfTbu3NraanbeZbPeyRF3FpKjJKijIBbDZUsGCnOByaANnwNp9zZabez6haPa32oX9xeTRvKJWAZyIwzAkZESxrgEgBQK2NXne20q9njdUeKB3VmGQCFJBPtVuue+IdjqmpeCdZs/D8vlapLbOsHIG84+5k/d3DK7sgjOcjFAGN8P9O0GTQ/D2pvbWdzrOpWMN8b+eFTc3L+WhaQsRnPzA47ZwAAK208WabcSummC51PY7xu9jC0saOpwylx8u4HtnPBrnNAvdM1fwr4P8V6U8qw20MdpHCzYVFleOGVX/ANpChGc4yp65zWz8N7dLHw7JptvG6WOnXlxaWjM27dCkhCgey8p6/JQBz3gTxFFB4p8Q2niWCXRta1bU3ls4LuDyhcQRxxRIscoJSVsIGKqxI3njAzXpVZ3iLRbHxDo11peqwrNaXKbWBHKnqGU9mBwQeoIBHSsr4d6vc6v4bH9pSifU7G4n067lCbBLLBI0ZkAHA37Q+BwN2O1AHTUUUUAYHi7H/ElyM/8AEzg7fX8q3657xiCRouGwBqkBI9eTXQ0AFFFFABXNfDn/AJE+zyu395Px6fvnrpa5v4dHPhCzO4tl5uSMf8tnoA6SkZQylWAIPUGlooAyZvDWhTzebPoumSS5zve1jLZ+pFaFpa29nCIbSCKCIHISJAq5+gqaigAooooAKKKKACsXwzn/AImuRj/T5cfTitqsXwwAF1Q9zqExP5igDaooooAK5+8Y/wDCf6SuDj+zLw5zx/rbWugrmPE8s2la5pet/ZZbmwhhntLvyQXeBJDG4lCAEuoMQUgcgPnoDQB09FeezfGb4fwlhL4kgQjcCDDLnjrxs96li+L/AIElYKniGDJIUBoZVyT25WgDvaK4BPjF4DYQ48QR/vs7M28wzgZ/ue9Pi+LvgWXb5evxNuGRiCX/AOI/SgDvKK4GT4v+BkxnXN2W2DZaTtz+CfrUP/C6fAJhWVddZkZtoK2NyefwjoA9EorzsfGjwCWCjXWLE7cCxuDzzx/q/Y0//hcfgY4xrExyMgjT7kgjGf8Ann6UAeg1z3iIE+I/CvIwLyY49f8ARpawn+MHgdNm7WJRvGR/oFz6Z/551d0vVofGGs6VqGjxXLaPZebN9tnt3hWaQq0QjRXCscAsxfG3gAE5O0A7GsXxkN3hm/GCcqOg/wBoVtVleKrG51Lw7f2mntAt7JEfINxny/MHK79vO3IGcc4oA1aK4Vfidolpa2//AAkEOp6PqLpmWzn0+4kaNskEBkQq4yDhlOCOajT4veCpHRE1S5Z3DMqjTbokhevHl+x470Ad9XHfFSR7Pw3baoIxJDpmoWt7cDOCIUlXzH9PlUlvoprOHxl8DmV4hql4ZEGSn9lXm78vK96bdfFnwJcwSW1ze3M0MytHJE+kXbq6kcqwMWOQcYPXNAF/XHn0HxhplzpUKXc/iG9itbtJF+aOCKCVt6OCNqrjO0gglzjBbNRQan4E8MeLDY2k1laa1fzJavFAGbEj7nSN9uVjLbWIB257V5vrvirw0dHXSNPvYNY021Obaz1Sx1GGWFGBUxi5SMnaEYqAVJKnaSetZ417wtr+n6Pb6xrLaBp+myPMNP8ADmlX8CEMrIyNKYl4KkglVU8sAR1oA9U0nSbOb4v6tq1ulrObWwW1aSO3VGt5XYO0bSD77EBXweVD+jiu+rzDQfiJ8OfDmlWumaK89hYxjbFDDo92o46n/VZJ9WOST1JNaTfFvwcrEG91HPB40e9Oc9MfuuaAO9rI8YAHwlrYJIBsZxkdf9W1c0vxa8IM5RbzUtw7f2Ne+3/TH3FRan4ytPFel32j+E7bUr29ugbOSWSxntobVXUgyu8qKCFGSFXLMcADByAD0GiiigDM0/H9targAHMWTkc/J6Vp1yWr6zdeHPENxcahp9xPoFzCrC8soHuJLeVcgpJEgLlSMEMoODuDY4JqD4peFy2A+sn/ALgV9/8AGaAO4orij8T/AAyF3b9ZxjPGhX3Tjn/U+4pg+KnhY9JdYP00K+/+M0AZPw5+weB/B/iCXWbi0txpl5dSXEUFosZs7cOzRoAihnUqfMDEEnzD9K0be80CHSfEmq+ArPTZvEcVtLK1uY/KmMu0uqSo210DNt4O3Pt1rl/HmqfD7xtbbdRPiG1vkjMUGpWWjX0VzGjAhkVxDyrAsCrAggnjvXO6zrdubfR7EWVlrtvp0CwRXmreHdTiu4goVQdywtvJAO7BQEnpigDqNchWT4UzmwmivNU8czweURCYI3kuI41LhF3FQkKGQ5JJ2MSa9fryTSPFXhuHVoNS1q51O6v7WI29nFb+Gr+G3tEPB8uMxsQ5AwWz0GAFGQenHxL8OHoNdPf/AJAF/wD/ABmgDtKK4w/EnQAcCHxARxyNAv8AHIyP+WNIPiVoLAlbfxC308P33/xmgC1ZlP8AhaerASNvOjWeU2nGPPusHPT14rqq4/wjHfan4k1fxJfWM2nW9zBBZWVvcDbM0UbSOZZF/gLNKQFPICjIBOB2FAGVrIJ1HQjkDF4x5OM/6PN+datYXi5NSW0tL3RrVL27sbgXH2RnCGdCjoyqx4VtrkjPBKgEgHIy5fiFpkTmN9K8UeYCVKroF43I68iLB+oJFAHY0Vxn/CxtJOQumeKGPYDw9fc/+QqafiTo4zjTfFBGcceH73/41QBwZju/Dx1rwra+HLiSw07UbfV4TBevPJc2r3fmv5FvgbVjUGNkQnnHynfk+3QyLNEkibtrqGG5SpwfUHkfQ15zrvirw3rSW73Gm+K4by1bzba6h8P3qz27cHKt5JGDgAqcqwGGBHFYepePfEdsllFo1xJegkCWXUfCOppIVzyR5ahWbGeAqj6UAeu6jewabp91fXj+XbW0TTSvgnaqgknA5PA7Vh/DyyubTwrbSajCYdQvnkv7mNhhkkmcyFG91DBT/u1xF54k0zVb+CTxHP4jvLSB0mj0638M31vAZEbKvKCjNIQcEKW2ZUHaSAa6Z/iVogHy2XiR/wDd8P339YqAO1oriv8AhY+kEjbpnihs9Nvh69/+NU4/EXSVyG0zxQDjOD4evc/+iqANLxhv3aFszj+1Id2D2w3/ANauhrh01G98W65pX2DTL2z0OylN1cXeo2z20ksiqQkcUT4fq25nZQMDAySSvcUAFFFFABXOfDz/AJE+w+snfP8Ay0aujrg9N1t/Btl/ZOu6dqkyxTSfZrvTrCa7jmiLFlLCJWKOA20g4yRkZB4AO8oriz8R9JUKX0zxQu7nnw/e8D1/1X+c0h+JGlBsf2V4qPfP/CPXv/xqgDtaK4r/AIWRpO7A0vxSfp4evef/ACFQPiPpZQN/ZHivnoP+Eevef/IVAHa0VxR+I+mgZOjeLOmcf8I9e/8Axumt8SdLDYXR/FjjHBHh685PpzH1oA7eiuGf4k2Ck48P+MWx6eHrvn/xykPxLsAAR4e8ZEnsPD13x/45QB3VYnhXJi1PP/QQuPx+asKP4jW00ixW/hrxhJKxwitok8QY9hvkCoufViAO5FdD4Wtru30hX1ONIr64ke5mhjbcsTOxbYG/i2ggbu5BPGcUAa9FFFABRRRQAUUUUAFUtY1Wy0axe71K4WCBeM4LMxwTtVRksxwcKoJPYVdrltMWTWPGepXtyqtZaQws7JGQcTMgaaUEjOcOsYI6AP8A3jQBZHidXsRdQaNrkqEAhPsTRyHP+w5Uj8QMUtj4s0y51NNNmN1Y38gzHBe27wGX2RmG1z14Uk8Hit+vN/iy2qLqXhq1tXtLrTdXvRp09hcZiZW2PKtxFOvzxyJ5RwcHnaQARmgD0iiuV+HniGXW9NvbXUJYJNY0i7fT74wNuQyLghgcDqrKTwMNuGOK6qgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArlvDF7DB4m8RaJNIq36zjUEjPBe3lUAOM9QHR1OOhA9RXU1geKfC9pr7Wtx59zYarZNutNRs2CzQZxuXkFWRsYZGBU+mQCADfryebzW1CXXL+4hS48P+I7iS7kuZSfs1i9uUAQN91SjQuQuASCRk5ztfDi88W6zoVvf6rq+jTQGaWNHh0yRHuIkdkWUkzbVL7d/C4wwxmrmoaBpCWV7oWpahdzXviTzFe4mA8yZkjHTYojXaijAwMhSeTk0AZFjeweHvjZqmlnfcP4mtoL5SqqWt3iSSNtxA3eUViXGSQHJA+/XpNc7pxgl8e63JHtaaPT7KGRlwdp8y5bZn1wykj0ZT3roqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKo65fnS9Fv78QtObWB5hEvVyqkhR7nGKAKera1JBef2fpNn/aGqFQ7Rs5iihU5w0sm1toODgAMx7DAJGVqOn+Nr945LTXtH0cIWzAmnNeBx23SNInbnAVeT1I672gWEun6bHHdzC4vpP3l1PjHmSn7xA7KOAo7KFHatGgDh9B0Txf4a0a10611XS9bjhJAlv4Xtpdh5wWQspwScfKOMD3qpr3w3/4TCaR/HGrT30KqVtLPT99nDbblKsxw7NI5DMuWOMEgKMnPodFAHCaFb3PgCwi0+TTLe40JFZze6TZCJojkf622TJbI6yR5yRyijmu1s7qC9tYrm0mSa3lUOkiHKsD3BqauYsG/sXxfNphY/YtVWS+tgW4jmUr5yAejbhJ9TIaAOnooooAKKKKACiiigAooooAKKM8470UAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFZPi048NakdqtiBuGbAPtmtasbxo2zwhrTZIIs5SpXru2Hbj3zjHvQBbv9Tgsr7TbSQO01/M0MQTBxtjaQs3ooCYz6so71erB1GWNPGmiI8KNJJaXYSQtgphoCQB3z/St6gAooooAimuIoZYI5XCvMxSNe7EAsf0BNZHiu2eRNJuoZGSWz1GCRQBwwdvJYH22St+QqvqbeX490FmRXEtndxKScFDmFsgd8hcf5NHido59f8AC9i/mMXvJLoqM7SsUL4LY9HeIjPcCgDpKKKKACiiigAooooAKKKKAOL8NkH4peNODkW2nDr/ALM3+Nclc6n4/tNfhuNVFybUasiJpdhaGRLiKSGLAFwq/IkT72Zn2h/mGVGK6bwo+74r+PRx8kOmr/5DlP8AWu7oAzNDtNQtRejU71bvzLl5ICF2lIiflU/TpWnXMeLPEk1hcRaNoEMN/wCJ7uMyW9rI5WOGPODPORkrED+LkbV5yRtaLZ3FhpdvbXl/PqNygPmXUyqrSsSSThQFA5wABwMCgC7RRRQAUUUUAFFFFAGDoniOO+1i+0e+t20/WLUmQW0jhvPt84WeIj7yHIB4BVuCOhaH4hNfR+F7iXTZLxZY2Vmjso2eeZc/6uMqCVYkgbsEAZJwMkS+L/DkevW1vNbyLaa1YOZtOvwm5raTGD6ZRh8rpnDKSOuCIfCHiVtXa407VbYaf4isQv2yy3ZGDkLLE38cTYOG7cg4IIoA5jwXL4ybXmtPEL3Iuo7cfaJRB/oYBgi2eW3AdxL5u7HJ56LsFXPEWs634E8A2JnH9uavJcLaG62GOC38xm2yzFmJESDCli2WOMkbsj0CmyIsiMkihkYEMrDIIPY0Acovjm0t3dNY0vXNNEYO+e409zCCDg/PHvUDvknGO9dLp99aajZxXen3MF3ayjMc0EgkRx6hhwasVwnidNP0DX7e68P2TSeKtRLmOwtp/IjvSFw0tyPu7UyCZCN3RRkkKQDodb8QQ6Zf2GnwwS3up3rjy7WDG5YgQHmcnhY1zyx6khRlmAO1WH4X8PjRknuLu5a/1i7bfd30i7WkPOEUc7IlyQqZOMk5JJJ3KACiiigArIu/EujWkl+lzqVtG9iivcKz8xg9PqScDA5yQO4rXrh9U+H8F14gvNZs737FdSeS9vGkWYYpVlWWSVk3AO0hRAx+U4Ud8mgDpbfXtLuJtPit76CV7+H7RahGz5seMhgR2I5Hrg46Gua1fWtQ8G69Lda5cNdeEr6QYvGUBtJkPG2TA5gY4w55QnDfKQV2fD3hiw0TT9MR1Se7sITGLt12sS2S7dTgEsxA/hDEDisjxh4jEvh24l019OXSJFeO51bUCGtYk+6dsfW4JJ2hRhWPG7PykA6fXNVttG0m41G8MhghUHbEhd5GJAVEUcszMQoA5JIHeuJ1fxx4k0/T/wC0JfCEVtbOdtvBd6mq3dyxBKRJDHG481scLu45yRg15jbaJ4l0DWNAsdPudU/4QZLgR2ep69C08lhcNH5cJWAOP3W4gRmVAEZvmHyqW9w03wjY22sx6xfT3eqatGpWO5vZd4hyMMYoxhIiw6lFBI4zigDKg8T+LxYi8vfArxRKu+SCLVI5bgL32oFCs2M/LuGeldfpl/banYQXtjKs1tMu5HH8iOoIOQQeQQQa59/H3htb82v2+RwH8prlLWZ7VX3bdpuAvlA54OW4PBqv4DhOkat4m0EiUpDfNqMDuPvRXTNIcHviUTr9FGfUgHY0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWN4zCHwlrIlufsq/ZJf3+CTGdpwwA5JBxwOtbNVNY0+31bSrzT7xBJbXUTQyKSRlWGDyCCPqCD6UAc7bTNqninw/PdxNZ38GlSXU1mXy0TTGIbSRwcFXB9wK62vKvhHLf3mrRG+llupdM0S3069uLiUSSi9WaXzY2bqSAqNyM4ZSeTXqtABRRRQByviGM3vjrwrbKGAtftWosy8fdjEIUnrgm4zgddvPTl3ihxb+KfCM/+rL3U1q0xYAbXgdvKxnks0aEcfwY78s8dRNaSaR4hheRDpNx/pG0nDWsuEm3AdQvySZ4x5ec9QaGqWYl1qw059Tu9XvJLq3vFjkEQWxhiZn807EGN/wBwE5LHGOFc0Ad1RRRQAUUUUAFFFcve3Wp63rt/pWl3TaZZWKKl1eoiPM8rqGCRBsqu1SrFmVs7lAHBNAGd8SPHtt4Sn0vT0eL+09QkGzzELrFCHUSSFAQzkBsKiZZiRxgGsRfiZr2n+F7bU/E3gm60qVjHHIJr2FUeRzhVjUEyMx4+UoCOeuCa7TRPCen6XfjUXku9Q1XyvJ+3X8xmlVM5Kr0VASeQoGcDOcCsvVbaDxT45j0q/tkl0/QVt9TG7+O7ZpBF+CKjNjuXXsMEA8t0Lxn4mj8S+Odet/Ct1FefaLGC60hYvtV3FEsEhEpAkQbT2Cg5OR71ueO/iFrvgfS4bpNRsNZkntHuTaXdjJb3Nv8AvFXzXEedsKFsEMNxKgBiSSIPEkMs/wATvFNr4Xn1CDxRdpaRyTw/LBbWqxqxkmcqcDIYAIQ7EkDA+YU/D3hG+f4cQ+LNL1Bf+ElnmlvP7Y1ZpHludPZvlSZVzkNEkZEY4U424bmgDf8ABmoXvhrxTeWF/Z2dylxcxnVPEE+phrqeWVmS3zAIxsjJ2IiA7FWQYJIevXq4LxD4FXx14O0K08T3F3pmpQJbz3L6XIiHzlUEpudWzGH+YD1VT2q5Lea74e1/RrW+uotW0fUZntTcSRrFc28uxnjLbMI6EIy8KpBK9eaAOxooooAKKKKACiiigBGYKpZiAoGSTwAK+f8AxT4z1XUHu/EH9lWtnDpViNW0q+tJGlvZLdyNqyxAYEbLy6Oy5BBU7kLL6OsWo+PtI1eOTUJtI0Oee4sYvsUa/aZ4VzE7l5AwUMwfbtUHbtO7njO1bwrYeCPhdqVjZPd3lkJ1urye9kMswi8xDJISoUvsRcgE9ExmgDj9L+IXifVPDtzqWr3tzYazZypGfDvh/R2urrLAMvniTf8AI6EMrKUGCRuLDaNK28X/ABGsTounf2Pb6pql3EZbm2udsdzZQhyonmMTGJlcA4UBGyrABsHGZ4g8GajoOj+DtQudZK63Pq6x6vren8S3JuCVi3EspeIOYVKgjCjKgYro/DGqt4fe402Wwubz4i3pijuYZp/ME0cY2R3JlCgC1Ayd23duZlIMhIIBm3HxQ8Y3+k6VH4a8OaPf6rqYeSGeK+eWCOGNtsskkRRJQFb5CMfe4BJIU9d8I5ra90y+vbi7tbzxM85j1eWGdZtkq9I1I5SNR92M425bPzbiY/hxoNr4X8SeItLzFNfzLDqRmWJYxHFMZFFvGo5WJHikZVyQPM6kkk7mu+CtI1e9mvwLzT9UmVVe+026ktZn2jC7yhAfA4AcMKAOlorkPD2rXtn4vvPCuq3UmoSRWMeoWt88AR5Imdo3SQqAhdWVTlVUEOPlyCT19ABRRRQAUE4GT0orN8S2c2o+HNVsrVgtxc2ksMbE4AZkIB/M0Ac1rOo2F/p6674hvY9P8IWw81UuGUR3wYYV5QRnZkjYnVjgkdBXHaX8VPB+pavpVxrwaOJp2Gj3QtpPskCuQkayN91ZiAGyQAitjI+Ymv4k8V6ZfWsmvwvHNNpusQaFp/2qBmh0+dgnm3Lw5GXQO/XBGzAI3NnRtzpWrW2mjVb3xC/9sQ3lxO8mqSGOCCE4Z5I1AiVSSo27duWx8wFAHpXiu50yz8MarceIAh0iO1kN2rruDRbTuGO+RkYHJzivENZ8Y3Vik3w0g1WdtR1VIbfS9Qv1YPbCXaZLW6fOTKsTqAyHcfMXOGwx0PCX9ifErV/DdlBcrqGleFrFzOYpCI5HaUR2ySIT8x2W7u2R1KkYzVb4Z6TZ6h4w8aWPiSOw1PTvFiSXdrKHYLNEk8kbxqp6OCFkbYcqWToQMAHpCfD+2u9Oey1/Ur++snhMBsLaU2NmiEYKLFCVJXHGHZ64jxVpsfwjuoPEHhm7v9Tb7I1inhy7u3l8y1jPmZt2wWXycsxL7wEJX5SVrV1nxTq3w5mtNBuidbhvFSDSb64k2tAxcRqt8+fuAsuJQMtgggty3ZaXoltoralruu3aXepTxE3d7MoWOGBQT5Ua/wAES8nGSScliTQBZ8Jafd2unm61W/j1HU73E09xEoWIcfLHEO0Sg/LkknJJJJNblcf8HjdN8KvCTX7BpzplucjH3dg29P8AZxXYUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFcb4pVda8ZaT4au5JhpkthdX91DFIU+0bHhjSNyOdn71iQCNxUA5GQQDU8cyavF4Yu38PJK1+Cn+pCNKI948wxB/kMgTcVDcFsZrmtGibxHFHdeFvHOrQm3UQXlpPFBLJHIM5Escib4pc5BBwOOneto/DzwcTk+F9GJ682af4U3/AIVz4KySPCWghj1YWEQJ+p280AZUfgzxPYXU1zovjdo5Lmf7RdJeaRbyxzNsCZxH5TA4VOd38NakPhbVJDnUvGOt3J8vaFhS3t1Vsct8keSfQEkD0NOPw68GFSp8K6IVPY2UZ/pT0+H/AIORGVfC2h7W6g2MZ/pQBXbwprTRtCfHfiAREbQVgshIB/v+R19+tXl8LKIwra1rrkD7xvWBPvwAKhb4feDnXa/hXQ2A/vWMR/8AZaU/D/waSSfCfh856506E/8AstAFPXvAcWq6Tc2Uev8AiK0a4jeOSVL5pNyuu0gpJuTGPQAjqCDzXN/2Jrfg7w+w1Hx5oelQEp9p1ifT8XNyyqFUu807Juwqj7p6cAV1j/DrwU+N3hHw8cdP+JdD/wDE0g+G/gcZ/wCKN8N8/wDUMg/+JoAzfhzrfiHV9Rv1vTHe+HoIkFpqz2TWcl3KWJbbGWO5Au0eZhATnaCOR3tc2ngLwfGFCeFNAUKMADToRj/x2syy0S28MeOrGHw7FBp+lanbTteWEEQSEyx+XslRVwEchmViPvALnlQaAO3oorn/ABjYSatbWGmC+ns7a7ugl0bdykksQjdzGrjlNxUAkYO3cAQTkAFP4k3WsW2hQDRfPijmuUivry2QSTWdsc75Y0P3mGAOhK7i21tuK5fwjokw1TVZ/BnxJTVLe42NeRXiRahLFMFCqwdGTZlFUbWU/dJzk11sXw98GRRoieEvD4VRtH/EuhPH120kfw88FRtmPwf4cU9MrpkA/wDZaAKUGm+P7GDjxHoGquH3bbrSZLdmXuu+OYhe+DsPvmuCu/Fup+GPGt0bnStMs/EfiyC2jt7V9TEsVpNG0kQkuHwuI2QoUCDLsjIMMcjvPEPhLQrOwVdG8FaDd31xKIow1hCsURIJMkp252KAenJOAOTmoPDvwm8HaVpoguvD2i6ldu7S3F1c6dCTJIxyxC7cImeiLwowPcgDPAVhH4b1DxdNq2sC9uBNDLe6jdskZYi3QszAYWNBk4Xoo/OuLm0R/EF3HY/D+61y10WDU4r+3uX8o6OuHMkqxxjbJNGWwQu7buIKFVXnu9O+H3gyW+1fzPCPh59t0qjdpkJwPJiOBlemST9TWgPh34JAIHg/w4Ae39mQf/E0AVZ7X4hRzRCDWvCk0P8Ay0Mmk3EbZ7AYuWHPAz29D0rM8Z2viO4urDUr/X/DXhzStKkS7JuImuVkl2uh8x2eEKg38Y5z37Vvf8K88FE/8ih4c/8ABZB/8TSH4d+CiMHwf4cx6f2ZB/8AE0AN8Ba/qWuWFzcarbWsdskuyzvYGKLfxjrMsTZaNSeACzZxkcEE9UrBhlSCPY1zQ+H/AINCbR4S8PBfT+zYcf8AoNYWr6RpXgzxJ4ZvPDdpbaQupagNNvLazhWKG6RoZXUsijG9WQENwcFlzg4oA9DooooAa8iIQHdVJ6ZOM1x/jbxPcaPeWUcV9o+mafKH8/VNQzLFBIMbY2UOgXcC2HZwMrjBJGcP4aaDo/i7wdp3ifxPo+n6nrOrRm5mmvbZJigLErEm4HaijCgDHTJySSeqPgPwgQwPhXQCG6j+zoef/HaAOY8M6d4o0HS5bPS/EPhnVLSeWS4tp5oJIvs5lkaRgFSRhIg3fKNykDjJGMb0UPiWaFluvE2g4dCpNvpTKQSpGRuuGHBIPII4xjmrA8BeDwAB4U8P4HQf2dD/APE1m+I/Beh2mjzSaD4G8N32pkqkMUtnDFGCzBSzttztUEsQASQMAZNAHkceu2/w0m0LS/EKahdarDaR2+lT6lrKSadNOWCy3HJLQogKhSw4UMqgEEt6TF4Isl077c2vxnxoW88+IflMm/8A557M4+z4+Xyc7cc/e+arvhb4V+F9J04rqOi6PqmpTu011dzafEN8jHJCJghEHRVHQAZyck7Y8DeEh08L6F/4L4f/AImgDzX4f+ML3xZ4p17W7H/hGY57ZYtGn3X5c7YTK4uI8L88Ujy4XJXIQnJ6V1d3Y+KLgbj8RNOtJQgULa6VEI855JEkjsfQYYD60/xR8MfD97bw3OiaFoFlq9mTJbPJp0Zhk4wY5VC8owJGRyucjkc6th4L8MzWVvLdeD9Ctrh41aSA2UD+WxHK7guDg8ZHWgDzjVINCtNZ1HU/E3xKvNT8RCyayt7PRbiO1nRMbgI4ImLPKXBbLZUkgEYAx6X4E1DUJfDGmp4mubY62VKyhWQM+GOwsqEqHKbSwUlQxIHGKlHgnwqGJHhnQwT3+wRf/E1DeeAfCV5aTW03hrSBHKpUmO0SNxnurqAysOoYEEHkEGgDpqK534fy3UvhOzF9cvdzwvNbmeTl5FjleNWY92KqMnucmuioAK4r4geLF0zRIptH1vRLSRruGGe6vHWSO3idwpcqHXOCVHUDnn1q9480063a6Zo8tzPBYX96IrwQOUeaFYpJDFvBBVWMaq2OSpYcZyJ4/BXhWJQsfhrREUDaAthEABjGPu0AeO+O/DN3Cl54q/tPwbqt7bxs15bWlgLKbULfKmWMziZyHKJgHBPOM4Ncvonh/WPHfh3S0sfEmiaJoSWsVlMv2jzZrpR++kweMK0rlGU4yYu4wD9GL4M8LqwK+G9FBHIIsYuP/Ha5Y2vhez8Ua7p/iHw9oNtHDANQspmsov3tqsaiUn5fvJIGz/sulAGbb+HptKntJvC3iTwn4f8AKs/scsVvYiSOZN5ZG2mYYKs0hBycmRs5rxyy8TxfCq+0qxu7jR/ENz4aju7W1QTfZ5vPvGEu87sqVVY+XDdJ1XGQa9/8VaZ4T0e3toLXw1oFxrOosYdNtDZR/v5NucsVQlY1HzM+MAe5AM3hj4beHtLsX/tDR9Hv9TuH866uWsIwGcj7qLg7I1AAVewHJJJJAODsdas5vCepXTxaVqF5qVp5+qX/AIhvIYI512sUhWJHcrGM7VB2qAd2XYnPFL41utauNP8ABE2tx2HhW+uEWW9vZknuYYmhEi2UjBsMjMGQSE5deuRy30T/AMIX4W/6FrRP/ACL/wCJpJvBXhaa3eCXw3ozQupVl+xRgEHr/DQB5lqNv4b8H6HDp+s/FrVrXTLONI7K3guraOaOKNQAv7qLzJOnp0wMHuaZ4wabWLFtA8Zyz6OJibq+8Qz2kULRqRuSGIJHMz9RubaoweW6V6D4a8A6BoelxWI02wuliLLHLNZxeYI8/KhIUbtq4XJ5O0E5PNaDeEfDbMC3h/RyRxk2Uf8A8TQBq2V5a30Pm2VzDcxZxvhcOufTIqeuD1Lw5p/h/wAYeHNS8Oww6U95dNZX0NrGscN5F5Ezr5iAAF1ZAVbqMsOQSK7ygAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACuU8W2GqQa1pniLQLVb+7s4pLOexaYRefbytGzFGb5RIrRqRnAI3DIyCOrrH8Sa7Hoq2KmISz3tx9mhVpFjTdsZ/mduBwh9STjAoAx28W60qgt4C8R5zghZ7E4H/AIEc0g8Xa0engHxIOM8z2P4f8vNaMPieBdTs9M1G1ubPULmCS4EZAkVVRwvLoSOcgj264PFSHxZoqW09xPei2jgMYk+1RPAV3khDtcA4YggHGDg+lAGP/wAJdr24/wDFvvEO31+02P8A8kUv/CW+IDnb8Ptf4/vXdgP/AG4rZ0HxLp+uXt/bWBmL2bqrs8RVXDRRyBlPpiVRg4OQeMYJZc+KdMij1BopWlaySRpMIyodh2uBIwCEq3BAPB4OKAMkeLPEO3P/AAr7Xsnp/plh/wDJFKPFfiHHPw+14HPa8sOn/gRVibx3o8LTCRbwGHUP7NfFuxxJzyMdV+U9OfarUvi7SLeJnu7gxHfOAio0jMsLBZGwgJAG5Sc9Aecc0AZn/CV+Ivm/4t9rvH3f9NsOf/Jjik/4SvxJkf8AFvdbxg5zfWHXHA/1/rW9P4i0qC+itHuwZpGjVSiMyBn+4C4BUFuwJBPapdY1vT9H8r+0LjyjIGZVCM52rjcxCgkKuRljwMjJGaAOY/4S3xTvP/FudZ29j/aNjn8vOqTQY/EOt+J49Z13Tf7CsbGB4LWwa4Saad5Cu+SVkJRVAVQqgkkliccCt1vEmkLqKWP21TcM6R4VWZQzqGQFwNoLAjGTz2zWvQAVgeMbHVLqxtbnQJok1LT7gXUUM3EVzhHRonPVQyucMOjBTggEHfqrqd/b6bbJPduUjeaK3BCk/PLIsaDj1Z1FAHHDxb4t+Xd8N9Vzj5tup2JGfbMoyPfj6Uv/AAlvizHHw41bOO+pWPX/AL/V2E9/bwXDxTyCPZCZ3d+EVAcEljwKWK+tp7D7bbTx3FrsLiSFw6sB1wRwelAHGjxd4ty+fhvq2B9z/iZ2PP1/e8frSv4t8WAfJ8ONWY++pWI/9rV0em+JNI1DRxqcOoWq2gjSSRpJlHk7wCA/OFPI4NWZdY0yK1gupdRs0trggQytOoSQnoFOcH8KAOOi8TeKIbi4ZPhtqwE0gd2/tOyJY7QucGbjhRxTpfF3i8IvlfDbVHfjIbVLJQPx8011um6vaagH8mTYy3EtsFkIDO8bFW2jPI4P4VNcajY213Da3N5bQ3M3+qhklVXk5x8qk5PPpQBxR8X+M8DHwz1LPcf2tZf/ABymyeMPGoQmP4Zaiz9g2r2QH5+Yf5V29xf20FtJO0qsiI8mEO4kJ97AHXFVNS1/TdOgne4u4vNhtnuzbh184xqpYkITk8A0AcsfF/jHjHw01M899Vsun/f2ksrXxB4u1vS7zxNoKaDpuj3TXdvbveJcT3E+xkRyY/lRFWRzjLEtjoB83VXWv6fay2EcswD3knlqMj92fJkmy/PyjZE/NaSyxtJ5ayIZNofaGGdp749KAH0UUUAea6Wni/wRb/2JpnhuLxDosDsbG5gv47aaOEnIilSTALLkqGVsMoXIBzWinirxeU3H4eXynONp1W0z/wCh4rbsfFNjeX89osN9DJbjdO09s8aRAqWBZiMDgGtiW6t4d/mzxJsxu3OBtyMjNAHDP4s8bDOz4b3TYPfWLUZH/fVA8WeNtjH/AIVvdbxnaP7YtMHHTnd3rs49UsJLtLWO+tXuXXesKzKXZcZyBnJGKnkuIY/N8yaNfKTzJNzAbF5+Y+g4PPsaAOFXxX43LNu+HFwF42n+2bUk+ueeKVPFXjUn5/hzcr9NYtT6+/sPzrtP7SsftM1t9ttvtEKeZJF5q70X+8wzkD3NSvdQJnfPEu3bnLgY3HC/meB60AcOPFPjXDlvh3PwpKgaxbEk54HXuOahHi3x2dx/4VpMABkZ1u1yevH8q7HVNastNsIL24mU2s0scSyoQVy7BQxOcbeeT6VI2saYlrb3L6jZrb3DBYZTOoSUnoFOcE/SgDiT4t8feZgfDOTZjqddtuuPSppvEPj64RYbPwNbWk8oKrcXmrxvFAx6O6oNzqOpC4J6ZGcjsxqVi2otp4vbY36ruNsJV80DrnbnOOaq2Gv6dqGsXOm2NzHcXFtEsspidXVNzMu0kHhsocj6UAO8N6UNF0S2sPOa4eMM0kxXb5kjMWdsdsszHHbOK06KKAMHxhpF9qtnaTaPeiz1XT7gXdq0gzDI4R0McoHJRldgSOQSGHIweYXxV8Qw0of4bQfLwjJ4hhIf84wR+VdvrOpw6TYtd3Mdw8KZLeREZCoAJJIHbjrTNK1i11K0S5i82GN1LoLhDEzIApLgNzt+Yc+9AHGjxR8QiwH/AArm2A7k+IIvXt+7/wAK5rx7Z+MPG+jPp2r+A57eHDbTZeI4EclhtOWMXAILKeoKscg5xXr739mjBXu7dWI3AGQDjGc9emOaWyvrW+hM1ldQXMIYqXhkDqCOoyO4oA8b8CWHjjwzJLdaj4Lj1XWpYI7Z7865GEWGMYSGFCn7uMdSOSzEsxJwR1D+KviDj5PhtGTjvr8AH/oFd615arEsjXMIjaMyqxkGCgxlgfQZHPuKbbX9ndQxy2t3bzRSqWjeOQMrgdSCDyBQBwn/AAlPxBBP/Ft4cDp/xUEPP/jlSv4l8fB3C/D23ZQAVb+3ovm55H+r49a7j7ZamSNBcw75ACi+YMsDkggd87W/I+lUv7e05dcl0mW5jhvUWNlSR1XzN+7ATJyx+Q5H0oA5YeJfHZlRf+FfwhCCWb+3IuD6Y2VHL4n8fqhMfw6hkb+7/b0Q7cfwf5967ePULKW4uIIru3ee3GZo1lUtEP8AaGcj8ap6R4h0zV7i7h0+7in+zyiEujqyuxQP8hB5wDz9DQBz2jW/ifxDq+naj4osLbQrPTmaaHT7e7+1STzsjJvkkCqFRVdsKM7i2SRtAPb0yKRJU3xOrrkjKnIyDgj8wRT6ACiiigAoqvqV7b6bp9ze3snlW1vG0sj4JwoGTwOT9BVC116GYN5tpqFqweNALi3Zd3mHCkHkHkc85HcDIoA16KoaPrGn6zYi80u7iubYkjeh6Edcg8j8asNeWypva4hCbQ+4uMbScA/Q9jQBPRUNnd219bJcWVxDcQPnbLC4dTg4OCOOoqGHVLCeOaSG+tZI4X8uVkmUiNv7rEHg+xoAuUVXtL21vLQXVpdQT2xziWKQMnHXkccYrFh8aaBMNOkj1GD7NqFq93DcO4SPYpiBDFiCrHz0+UjPXOKAOioqs9/ZpfpYvd263rrvS3MgEjL6hc5I4PNWaACiiigAooooAKzPEGn3Gp2YggkslUt+8jvbT7TFIvoV3Lz75/A1p1y/jzWH0u2sIobw2Mt1OUW4aSOKNcIzYeSRHC5xxhSTjjuQAU7DwTJpyWosNTFsUt7q2k8q32hVnkEn7gBv3WwjCj5gBj61W0z4ftaXMk8l9aCR2sGb7NZGIObaWSTc2ZGLM/mYLE8be/So9X1a41P4NJqt3JHDcz2kE0sicIrFkyRnoOprNvfFmqRsYLbVIZdLN88Ka0zwxqyiGNwnmFDFnezru24Owr94E0Ad5pekzafrWsXa3KPa6jMty0JiIdJBFHFw+7BXbEvG3OSee1c9f+BZbu41lhqUdtBqEM8RhtrdkQtIwbzJFMhV3GD8wVCdxyTmud1XX77UYrGHUtUtYLiO90ZktrRlMd6HuoC8qMw3Mm7IG0gfKc5zXU/ETXJ9JSzgtL37DcXCTSJNJJHFESgX5GZ0f5juGEVdzYbkYNAElx4Uuma6+z6lDGraiup24e1L+XIMblfDjep5xjaRnqabF4MK3MszX4LSQ6jEQIMY+1yxyZ+9/D5eMd89sc4dv4p1i7jg1D7SkUSyaQrWqRLtf7W8SSZY5bjzCVwRyOcjineFdWm1bxxpFxdaj5ty+mah59iNgFk4ntB5ZAG7IHB3EngkYBxQA+bwxqttq1tZWCu+nPeWV7c3EscYXdAkaHa3m7xlYUG3yzyfvYJx1Gv6Hc399De6ffR2dyltLaOZYDMrRyFCcDcuGBQYOSOTkHjHL63rV7pHiPxLINVKrELKWKzm2lVhLKssqg87QN5JHAPXpUi+JdR1fUktdH1K1jgm1eW0juVhEw8pbQS/LyATuzz/ADoA1IPBcVtE0NveMsP2uyuUVo9xVbZYlCE553CLr2z0NddXC6BreqXGuWRursS215eana/Z/KVVjW3uHSNgQNxbCYOTg56AjJ7qgArE8Yadd6poqwaeIDcx3lpdKs7lEYQ3McpUsFYjIQjoeSK26yfFGrHQ9KGoFFaCOeFZyxxsieRUZ/8AgIbcfZTQBzPiTwvrHiCdrqc2VpKIIkWKK5d1do7hZQC+xSAQuMgEg84OMVt+HtGmsNGv7eWKOGe6lklYC7e4BZlA3F2VTk45AH51zS+N7+9srgPYmyubX7I1zHv+eMz3IWNeR3jG48fxAcdaistW8R3k+kD7faCSbWtStVJibb5cTXKqHVSN2BGuOR0BJJ5oAfZeEfEEOn2u19Otbm2srOw8u3uH23CRPucmTygUJ/hwpI+bnnIl0Twjq+kSx3CQ6ZeOReRtbXN3KyxrNP5oIkaNmY44YEDPBzxzu2+vX154CttasbJJdQnto5Vtg3y72wDjJGcZJAyCcY4Jrmp/E2rXF9YzafdWxkh03VJLiOW2liQvDLbYDRFtyuAxHLEDcSMjggGp4c8J3+j+K7rVZJbW6iu5bkssjHfao8rSL5Py/wAWRvU9wpDEKBUHi3RNSXULi6tbeG7tr3U9KmdgW8+ERXUO4BQpBQBS5O4Yy5xVi08X3l1cpcR29uun/bbewaA7jOWlijkDg9MDzR8uOVBbI6Vman4xvL/wY08KC0ubnw6mrb4nO6J3A+UewyefagB8vg7WZYJrQtp626WupwQSiZy7m6fchZdmFC9Dgt7VbbwvqqafrunRx6ZNFqSyst3JK4ljd7fygpXYcgEY3bh8pxjjmhrfi3ULe5t9V+T+y7W61KM2UQYTTfZoZ87mzg7mjyBt4+U5OauJ4q8QLbRiXTLXzri4toreaQmKJxLvzwGcnbsB3cBtw4GDQA3SfBN7Zy6fb3T2V3Z22ovey3EjHz7lZLSeFlkG3aSGlUA5A2DGBtAN/wCG2kXVhYXN1qLSvcSsLaAzIUkW0hLJAGB5yRuc55zIc1Jo2v6lJ4lbTdYigtdwkECJC5E2zbl1myVPU5QgMvvg11tABRRRQBymseGbjUbfxjB50Uaa3Z/ZYm5JjPktGSwx6tnis648K6lqt/NdaxBpYSa+tLl7dZWnTZCpBGWjXJJII4rG1PW/EeiNfGUXr6gun6ldOkpjeA+V80LxAEkAZReQM7vmy1df4Wlni1rV9Oa9mvrW3jt5YppnDtukVty5A6fKre2/jjFAFOLwpPDqguYvsiINaGoDbkEQi18kL0657dMd+1N8Z6FNqviPR0tg6290rQ6mRGSklqjLIFZugJf5AO6yykdOMnUvFuoQ3cGrvsOmQrqZ+wwhhLJ9mDD52zgklCQNo25xk1etfFGuu1ra3NjbwT308UNtdumIfnimkbKCQltohwDuUMZF6YNAEd94Lv71J7N5LOO1+0X9yl2rMZ5Dcxyr5brtA2r53XcciJOPQn8JarqcV6NVi0tRcvpYaFZXmRo7a4EkgbdGudy5AGMZ4OBzUlj4v1W6axWO0smzBd3F0wZwdkE4iIjXnJYcgE8H1qjF461v+zbS4l0lcakYBZzKo2KZMnaR5mZMADDApuLAYWgDrvEei/2jp1jaWqW8cVveW05jYYXZHIrFQAOuBwOn0rk73wLqD3Uswa3uYpXvka1N5JbL5c83mD51RuSOGXbg8HPHNuXxZrdsbJtT0+Owtt224neFpQSZtighHJhDLhtzbgC2D0JOz4hvtSg8T+HbTT54I7e6af7Qkqbt4VQRg9QetAHP3Xg/WrvVrV5bqFbe3ufNimS7lDRx/Zmi2iLbtLAt99mLEDtnFa3hDQNR0zUVnv47CKOLTLfT0W1kZ9xiZzuIKLtBDDjnHPJo8KeJb3VbnTBdxWyw6pp76jAsIbdbqrRjy5Mnlv3o5GOVcY4zXXUAFFFFAFPWLZ73SL61iKiSeB4lLdAWUgZ9ua5bV/DmqPBpR0/7FJPb6TcaXKs8rxqPNEP7xSEYnBh6EDO7qMVv+J9TbS9L82F1W5lljggDRGXc7MABtDLk4z/EB6kCuQi8Z6zc2sSQ2tnb3q2+pTTmdSy5tJY48BUc43eZ/eO31bHIBJP4Fmm0vXI3TT2vb3T4LOGZgSUKRbGBbbkKTnpn6V1Oi6VJp+ra5cExCC9njliRM5ULDHGcjGAcp2zxiuTn8Tajqt3p81o8VnYJqtrayRYYzSb4VlOWyAF/eAbdpzjOR0rR8Zalqlj4ksP7KmhVV0jULqSOcM0bmN7Xb8qkc/MwBzxuJ56EAx9P8H3dzbayuQsdvdJBpUVzGUUW8Vws7I3BOx3Hl5wcxxoRnPN4+F9ZTUpdVhXTftdxLctJam4cRRLLFDHlXEeWOYAxBUZLtz6rD4z1G81dlsdM3WFvJapcbgNwWaOOQyb9wwEWQcbTu2sAQap2/jvUTIY2toXW7jtZbC5aIwoyzziIMy+YzFRuBBOwnpgZzQBs+FvCjaZqlve38dnNLBo1jp0cijc6SQmbzCpIGFPmJjHJwcgYFQ6/4Z1LUdc1GSFbEWV+lmjTvKwmh8iVnJVNhBJyMHcMHntzd8HX1z/Z+ty6xdpK1rqFwrSqpVFRcdFJJAHPGTisCDxxqvlzpLZwPI39nvayvGYVdLq5EOSu92wM5BO0n+6O4At14H1O6s3smlsYooYrxIbhHZpLnz5A+Jl2jC8fNhm3HnjpS63oetR2Oq6lDDbQ61LqFtdaelqWuFicRpAd5KL8pUuGOOFYntV228Tatc3SaZGNPjv1kvBJcyo4gZbdoxgLuypYSr1Y4CsecYrDufFGt6lo2uX9vKlta/Y7C5toCCssLTKjFS49yQcigD0bQ9Nh0fSLPT7YsYraNYwzfecjqx9STkk+pq9Xn914v1eHUJNHS2gm1NL2S286KEmNlW3hnyIzIDuxMBjf/Cze1auga9q+qa2LWfT7Wzihs4Li7R5S0qSSCT5FwNpAZOuenagDq6KKKAKmrW5u9MurdYLe482Nk8m5H7qQEYKtweD0PB+hri7Xwjqin70FpardWU6WIvprqOPyZd7srSKCpYYUIAF+UHvx0HxBuZ7LwF4lurSV4bmDTLmWKRDhkZYmIYHsQRmsQeK9YutVv47HTlNhb3E1m0rL/q2RCRIzb+QWCjZtzhg27tQBseFNEuNK8OyaVdJaoFaRElt2J8xGJIZgVG1sHpk9OtcZqHhfXLfQGFza2VzJFZabp8UNvLJJ5vk3IZnbMY2qQcnAbAB61e+HN5rsmo2MF9fxXFtPo9tqEok3u5klL5ZWYnH3Vyo+UdgM1vXmv31r4vhsLiKO302WRIYZWheTz3ZCxHmKcRsCMBWXnqDyKALOiaNdQ2utm9eK3uNVuHnKWrllgzEkfysVUk/u9xOB8zGubXwXqU+neRcppkDR2tlZLHA7NHMkE4kZ3BQYyAQq/MBk/Mc1nW3irVtW8NaPcW86W6JJogumfLTzG4lt2bDAgBdr7T8p3ZYcYrofCfivUdYnW6u7BbfRpopZUnbCeTsYAKzFzuJG4n5V2lSOetAG5oGly6dPrTTGJo72+a5jVMnCGONcEEdcqx4z1rlNM8FX8Ol6PaXKaaDp2h3Wkhkdm8x5Ft1SXBQYyIX3DnG4AFsnHoYIIBByD0IooA8903wVfWmrRzXJhu4TPbXTOb2WMxPHEkZxGEIk+5kEsvDYI459CoooAKKKKACiiigAqCe8t4Lm2t5pVSa5LLCp6uVG4ge+AT+Bqeub8faRc61ocdtpzSRXwuYmhuYnCtb/ADbXkBP/AEzaQY6nOO+aALQ8U6K0lsi36N9oCMjKrFcOxVCzAYUMwIXJG49M1O2vaWsIla9hEZSaQNnjbCcSn/gJ61i3fg1WleGwuo7TSp47aKe18gs22A/KI33DZlQFOQ3A4weapv4FuJEngfVo/sn2e/ggQWhDoLptxLNvw209MBcigDc1DxNZQ+EdT8QWDrfWllbTXI8tsCXy0LYDY7468ipF8T6Q1tNOLptsUqwMnkv5hdgCoVNu5sg5G0HI5Gadrujf2r4S1HRPP8r7XYyWXnbN2zfGU3bcjOM5xn8ax9f8Fpq1/c3hu0WZriG5hSWDzI1aOJ4iHXcC4KyN0KkHBzxQBrSeJ9Jjt7e4a5b7POMiZYZGRPm2newXEeG4O8jBBB6VDN4osl8Q2OkW4eea4mkgd1RgkTJGzkb8bWPy4Kg5Gea5zVfh09/YfZftunxxNbtCYhp5MUTmR5DLChl+RyXwzHcTtHI5zsWfhSe21i0uF1CNrG1vrm+jgNufM3TiQuDJvwQGlYj5emB70AX/ABN4ks/D62v2lJppriZIkihALAM6oXbJ4QFlyT3IHJIFV9M8TDUfEt/pMMNuDZSmKUtdL5v3FbcIsZ2/OBnPrTPFXg2x8QGSZ5bm2vJPIVporiVQUilEgUorqv8AeweoJz2qeXQ7m51+wvru9ge20+V5raKO2KyBmjaPDyFzuGHbgKMnaT05AN+iiigAqtqYszp9wNTFubEoRMLjHllO+7dxj61ZrG8VaZPqenwJaeS09vdQ3SxzkiOXy3DbWIBI6ZBwcEA4OKAFurjw+tubu7l0oQXeyQzStHtm2Fdjbjw2DtwexxjtTdSXQNCzql7BY2bSXCA3JhUMZpD5aksBnJ343dgTkgZrm4/Bl685nuPsIaS01SNoVYskUl1JCyhCVGVAjfc2ASWPHJxsa1oV1e+D7LTYzbveWr2c371j5cjQSxyFScEgN5ZGcHr07UAS2GoeHtTW40KJbFooW8j7C6x7ZFCq+Uj7phhzjFWtNttBk8y202HS3+yLJbPFbpGfJDkF4yB90MVBK9yoz0rAj8KXhvBck2kEjax/aDeU5JSP7J5O0HaMkMTjoMflS+A/Cl14flg+2JC7W1mLJLhLySQyKCCP3TKBGDjOAzYJIz3IBupb+H01uHZDpQ1iOPZHhYxOqAYwv8QUA9BxzWHZ3nhRbxbS10e2jbUlhD7bJEEonSSRQ/GTkRNkEdcVU0/Q9Ru/E2oSSWsFtYw659uW5ZmE0uLZEARdmNpJILbugYYqnpfgHU7e30aKa6tk+yWlhbyPC7bgYbaeJ2TK/wB6VSM44BzjoQDsrWHw9cahLqFrHpMt8svlyXMaxtIJCNu0uOd2DjGc44p1hpGg2r7NP07S4WZ/N2wQRqS8Zxu4HVS2M9ifeuUj8Ham+lTxyDTba7g0+2tbMW7sY3lt5PMjkk+QFQHC4UbtoLcnNaXg7wjL4f1a6nkuEnthbpFbdd6s3zTs3b53Cvx3JoA2LaPw/b+IJ1tU0qLXJFLTCMRrcspwSWx8xB4PPtVuHV9NmS4eHULORLdQ0zJMpEQIyC3PAI55rlbrw1rFz4vtdQnmgktLbUPtcbfapFKxeQ0ezyQuwtlvvliSPTpWbb+BNRttI0S3iksPN0/TbG2kTcwjnlgmSRgTtzsba3zYzk52nkUAdxoes2Wt288+myiaCKZoPMUgqxXGSpBII561o1h+E9Nu9Nt9QN+LdZru9lutkDl1UPjjJVcnj0rcoA5SHXvClpJ9ptWsIzfXstncXEaJH+9jWZn85jg4/cycnOeCMg5rUsDoOjxW1vp50uxivW3wRweXEJyQOUAxuOMdM9q5+w8KXkF1pqypYfZrLXLrVA6sS8iTLdFQV2YDK1wgHJGFJyDgVjx/D/UIkjSQ213FJaJayxfbZbdYwksjqVKod4/eDg7cFeDzwAdpcQaNp+vWUh022XUtRldEuEt03lhGzMWfr91SK57X18IWvhuY2Q06G2uLqOBv7NhtW86YHKo3mKY8jk5bGOTkVreN/Dtx4jitIbe5W1VFuUeXneglt5IgyjuQXB6jpWHZeDLwyQSXdvZRyx3No7n7bLcK8cPmcAPGAn+s4HPHBPAoA3fA6aCdJgGgNDKtn5tsXIXzUbzD5inA4zIpPHynAK8YpdNsvDd2NRS30jT44ZZXgmZraNVuihy/++FbIOR1B+tTeEdJuNFt7+2njtRE97c3MMsLHc6yzyS4dSo2ld+3gtnGeOlc/P4dutX8O2mmLutLvTb543kkVlEsLh43ZGx8xaKYsMcB+CQQcAG7Jp3hm1ksCNM0sNG4Fu0dtGfJzukDAgfICVY545qs/iXwrrB0ozz2FzBcRC+tJ7gJsUgqFxv5WT94MDAPXpWbpXgu6sZLcma2dINVW4QZOVtI7doYounLAHPpyeap2fgXUE0G20+ddMElroE+jI6OzCR2WNVlOUG3IQ5HOM9WoA7Ozh0TT9Vlgs49NtdSuR5skcSok0oyTuIHLDJPNS6lrWm6bp7317eQx2ioshk3bhtYgK3Gcgkjn3rmU8LaiNUJZrNrWS/g1FrrzG89WjiRPLC7cEHy8btw+VyMdzkQeB9ZbQ0065bTQLXR4dLgZZXcStE6sruCg2BtgyBux70AelQyxzRJLC6yRuNyuhyCPUGn1DZiQWsQmiihkCjdHE25FPoDgZH4D6VNQBleJptNi0srrNsl3bSyJELdoRL5rlhsUKRgnOD7YzxjNYa6v4ZsrCB7XS1AK3MX2aCxHmRIrD7QGQDhdwTcP4jtxu4re8R6eNT0t4RAk0quksQa4eDa6sCGEiAspHsDnoeCa5O38IarpsdvdWElpcakY76Odbq4k2D7S0bZD7WZivkoOQN3J+XgUAdP/Z+glYdXNlpoEcSPHdtCgKRgZUhyOAB09KrQ654e1K1l1KWew+zxSSWAurhowjBtpZVcnBVtq8Z52jjio9S8PSt4Q0/SbGSN5LA2jIJyVSbyHRtrEAkBtnXBxnODjFc9N4M1eS4S+Y2huBc3krWkd5JFGVn8vnzRGTuHlkY2YIdulAHV3dr4b/tWxW8g0j+041X7IJUj85VB+Xy8/MAD0xUBsvCVhbXjG20K2t2XZdExwohBPR+2CQeD3FcadEvdO1O00mzsfOie9065MgWdhbJBHEhQStHsZQIiwJcNlz8uTzot4FuILDT2sxaLfW9/c3cwjlaATiRpdpMqqWDKsg5Kn+Id80AdhaNo2mGCws20+zNzmSG3iKR+bxyyqMbuO4qppWneGPMuYNJs9F8yF08+O2iiyjo25N4UcFWGRnoRkc1ydl4CurS8QrFBJZubZzCdSmX7MYWBUL8h80AgMM7OcjoeN3wZoGo6LeXInaCLTfKEdvaxzmfyzuYkh2jVlXkfKS/1HcAsyz+E9St9QW5GkTQWdy32oXEabYpujM24Yz23d/WtNtM0m+dbtrGxuWkiEYmMSOWjzkLuxyueQOlcu/hfUob6W4totOkEWrnVIRJKyefujdCkmEO3aX3KRu5UcCui8K6ZLpGiR2k5jMvmzTssX3EMkrybF4Hyrv2jgcAcCgCzeaPpl7HNHeadZ3CTSiaVZYFcPIFCh2BHLBVUZPOAB2qW0sLOy/487S3t/kWL91GE+Rc7V47DJwO2TVmigAooooAiureG7tpbe6ijmt5kMckUihldSMFSDwQRxg1Vl0XS5dR/tCXTbJ77GPtLQKZMYxjdjPQkfSr9FAFNdL09ZrSZbG1Etonl27iFQ0KYxtQ4+UY4wO1I2k6c2pjUW0+0OoKMC6MK+aBjH38Z6EjrV2igDMOgaMXtXOk6eWtUjjgb7MmYVQgoqcfKFIBAHQjig6BozTXUx0nTzNdo0dw5tk3TK33lc4+YHuD1rTooARVCKFUAKBgADAApaKKACiiigAooooAKKKKACub8YanJYT6TD9uXTLS6mZJ75gn7vCFlUFwVBYgDJB6EDkiukqhrOs6dosEU2q3cdrHLJ5UbSH777WbaPU4VuO+KAPKdH8S6vZaNoNrb3tnaRJpdtPC97MkS3jszB1JZSWwFUYQhgXBOQQK2f+EtvxqUg/tGI3JOoiXTiiZthBu8o4xv+YAMSSQ2crgV1sni3SYLd5rqcxKsky4VWlIWJtruQgO1RxknAGRnFZdhqWgp4xvUk+0LfpMsEMs0800ZMsaSfIGJSLdnAAxnbgelAHPar4k8RWUGnLNqmnwPc2AvUurjZawySnH7k7w2VXgkAhyG4IxT7jxXrravqMcd9pNjLC88aWl7OqgIsLNHKE2+YwLBWLA7dm4YBGa7vwzr1n4j0tb/AE8TCFmK4mjKMCDj/OKq+IvEo0a9W3FhcXZFpLeyGJkXZFGVDH5mGT8w4oAq/D/WJNZ0u8aW6muZIJzF57GF0PyK3yPF8jqCx5wCDkEcc8do3iO9t/DWjR3niUQk2k7zXc6xu4uo/KC2r7v4vmYlT87diMGu3tPF+nzW95cSrcJBBceSrxwSSlx5SSbyFUlRhx16Yq8fEWlfa0tlvFeRkWTdGrPGqsMqWcAquRyMkZHSgDB8X399/wAIfpF89zJo873Vk926kAQq0iB1YnjaN3OeOOeKxbXUtR07V765srtruG41trb7LtXbKPsIcMGxkEsq4wcYJ45yO90nW9P1cyCwnMjRhWKtGyEq2drgMBlTg4YZBwcE4oh1qxm1RtOWSRbsbsLJC6K+3G7YzAK+MjO0nFAHLfDnX9R1iWT7ffWNyGtkmaKOVDLbyk/MhRVBRewV8sCCCT27qiigArnfH1zd2mgRSafL5Vy2o2EStkgEPeQoynHOCGIPsTXRVW1EWYtGfUvs/wBmiZZmafGxCjBlY54BDAEHsQDQBwk3jLWftS6Xa2UFxqiSXYeSOImOQQsgG1C4K7vMXJ3Ntx0bPE8vjS9TVrILZh7F54rS6jEfzW8zxCTb5m/DsMjhUIwfvA8VvaknhebT0k1NNFkspnNwjXAiMcjHALgngk7gM+4qIDwp/bl0DBpCarpyI0rvCiyQoFBU7iOgXHQ8cdKAMrwjrOpat4htLi8ngFpe6NHfRW0AbbFvcEBiSQzAHG4Bc+lGs+LdUsZ9daGytXtLC+g06I72MjyzJbsGK8AKPPP8XzYA+XrXS6TZaJAjahpFtpsaTqWNzaxoBIpOSdy9RnnrWRD4k8KXyRqs9g9prMH2tpZFRY7gYjQCTdjLlWjG1hnAx2xQBUs/EOvXd7baW9pa2OoOtxM010h2SRxmMDbGrkqW80Zyx27Secisa58WX+krrNyzG5+ypqtykbSfIfISJlTpnHzHpjrXYS6V4XDw6PLYaKGyZ4rFoYs56F1jx7HJAqPVJvDdpqaabqdvp8T3cEz5njjVJFZkSRCT1L7lBH8QHPSgDE1Hxdq1hqEmlPbW02oPeR28UsMTFFV4Gl5QuCzDy2X7y5znjGKo674n1y50e8jWKLSbqzt7ea6VstIxknePCFWwoxETk7vvbeME1215Dod5eTafexaZPd3CrLLbSrGzyqv3WZDyQOxI4rMsE8J6vqUum2VhpV2+lwRuDHBE8cKyPIAikZ2nMTEjjHHrQB1NFFFABRRRQBwo8U6vPau8cVnFJPqVzYWMSRvPJMYJZkYspaNVysWeXAHPPIFUbTxlq9/BFPY2O64lsbeZ4QRIsRaaVJHVAQXICZ2hue3Tns7qx0O5sfs91a6bNZ73ufLkjRo9xYlpMHjO5mJb1Y+tUZ4vCrxXlobbR7j7HDme0SKORo0QlgDGBkAEkgY6n3oA55vGd0ds1mYblpIbFF3K8UfmTXptmJRhvUjuCTyMe5kbxdqpa5s0SwW+s0vZZpnjfy5Vt2jACJuypYSLkljtx3yK6LTG8OX9zcWVjDp7z2BihkgEKgw7Ak0YAx0UurDHCsexBxR17RdA8RzPphvLWOeJnmntrdbd5CWADMwdGZTj+IbTz16UAWNX1iaPwtpmooCkl1c6erBDjAmuIUYZIPGHP4enWsXTNR1ifwxbavfXiPcQam0YEIKLLF9qaFkdejHafl91X3z0i33h9tJx9s0yTTbNowWaZHjiZGBTJJwCGUEZ5BA7iq0tnoU11bSQtDDC7/2m7W6osN0ykbXkcD5iGZWHPJAPOKAH+K9XutPNnbaXsfULku0cLQeaXVBljzIiqBleSw69DXN23jnULyztdQgtbSK0Nrpl1LG+5pGF2+0qrAgDb1yQc9MDrXYyRaN4gs45ZU0/VLWNyyOwSdFcZBIPIBHIrG0LVfC+o6dFJbQafbWMrx2tt5ohRbgRcxhFBJwvBVSAR1AHFAFDSNc1HVfFOizPNFFp11Df7LWMMGHlSRoDIc4Y9eABtyRz1ru6y7Wx0WLV5Z7W105NUbc0kkcaCY5xuJI+b+7nPtSf27bLrEenSxXUMspdYZJISscrKNzBT7DJycA4OCaANWisbQfEdjrjstn56nyUuI/NiKebC+dki56qdp9+mQMjOzQBz3ju+v8ATtDhn0qaKG5bULKDdIm5dsl1FGwI9w5HrgnGDgjAg17VtP8AEGrfaXhuLEazDYmIKxdN9jA58s5wFDknaQc7jyO/U+K77TNP0OebXIo5rFmSJoZEVhKzuFVcN8vLEdeB1JAGaj059CmCxwxadFcBY7x7b915kRCKquwUkZChVDAkYUAHAFAGV4G8Sapr4huL3ThDYXdqt3BKoAC5I/d53HfwwO8BRweBxWRN4o1W117UNMsY2ubma/uDE0iGVY44obc7Au5eplz14AY4Ndnp1lolrLc3+m22mwyOW+0XFvGik87jvYfmc1Un/wCEW1PTJbi4/sS8055jJJI/lSRNKFwWJORuCjr1wKAOH1LWfEkuoXGoRTpYNHJpEK2kjM4h+0SxCVWAOx/vspbBIA+Ug813fiTVLnTNPs1haM6ldTLbwoIDKJJNjOQq71/hRjywAA5NOlTw6tlFFKukC01BUijRhHsuVAwigdHAGMDnjpVDVdY8LyWM1jerY3VraXcVlLbPErJBISoXKtwFG5eRwPwoA56Tx5qraHLfxWdpE1nplxqNzHLli5gkdGjXa2F3bCQcsB/tdavza5qV74n0TypooNN/tq4sHgUN5snl2lwSXbdjaWQELt7Kc9q3dvhiLTYjjRU0+7RrWM4iEUyOSWjHZgxJJXuSatCx0VtaNyLXTjqytu83y088EJtzn72dj4+jY6GgDE8YeLLnw/qK2sdiLkzW/n24BIL+WxM4+ojwR6k471j6z49vbbRJdSsLeGfyLe4v3gWMvutUkcRv5hdQu9UzwHOTwpxz1lxqen/2/aWl3ZzLdOzwW1zLb/IzbC7ojnnlUJPQHaeTis3Tj4W8SCCzGj2k0MFr/oi3NivltbH5MxZGNhwBgY428YIoAz/7c1ebxlDYWdxElt/aNxBKky79yJBC4CkYI+834+3Fd7VKbSdOnYNPp9pIRMLnLwqf3oAAk5H3sADd1wKu0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVm6tpf9oX+i3PneX/Zt211t258zMEsW3OeP9bnPP3cd8jSrmPHGrtpLaEp1GLTLa9vzbXF1JsHlp9mnkGC/yg7o0AJB+hoA5zxL4T1S2hvxoe+6udThvoZSYo/LjWeTeoJaVWUgsfmUPwDlc4FdAfCRZ52N7gy31ne4EXTyFjG3rzu8vr2z0OK4651nUNQhtPtrfOW0h96gp5oOqhBJtzgb0VWxj+LHSmWviPUNN0m5SG+S2kgiubmxgdVY6lcfbLgGAFueAkYwuD+9BzgYoA7/AEDRb/R7W0s49Shezt55HKfZcPJEwYqhbefmDMDuAGQuMDOaXV/DFjq+vW2oalFDcwwW0luLaaIOpLujbjk442YxjvXIa34t8QWV9qdpbxQsbW4azErRZBluBm0PHUKSiMO5cdOa3fiLOtqnh15dQGnxjVED3TMihB5M3OW+X8xjPagCHVfA73t1dSrfwGK4uJZ3trm0M0J3xxICU3qC6+VlWOQN7fL0NP0zwXNp9hc6dHqaNp17bxQ3iNbHzHK26QFo334TKxrwVbBzzzXL3XjLXxHbj7ZY2ii3kktrq7kSCLUGW4lRSSynIMccTlU2t++BHAxV+0v7/T9WnaO8ZrW91y8s2tmRdqhbWWYOG+9u3RAdcYJ4zzQB0/hHwydAaQu9hKzRJCJLezMMjBc/fJdt3XsFGSeOeKemeDJLPxPDq819DcNFJcOrNanz3WUkhHlLnKpkBQFAAHSuf0zxFq5sLK5W8CwQf2NEbfywwlF00SSFmbLcbyRgjkc5qx4V1abVvHGkXF1qPm3L6ZqHn2I2AWTie0HlkAbsgcHcSeCRgHFAHpNFcfqOs6rB4xi0KJQftjx3UE/l5WO2Qfv1PuGVAD/08L/dNc3B4y1VdPhuhfQ3EjWiXWoxGNANLk8+FXibHIGx5vv5P7ktnHAAPVKxvFWmT6np8CWnktPb3UN0sc5Ijl8tw21iASOmQcHBAODiofCWtf222syRzwz21vfmC3khIKsgijbqOvLNzUnjO7uNP0CW/tZTH9jliuJsAHdArqZQc/8ATPfQBzkfgy9ecz3H2ENJaapG0KsWSKS6khZQhKjKgRvubAJLHjk4ZL4O1INN5Y06UulhKWkkYFpLZkJjYbDlG2fezkHHynFVND8T6lc6tb213ebYpppNZDbQNulmNvLXp/f2ZPXFSQ+M9TlVorqEJuk0uaCeOPyfMiuLtYiNpdzjGeTtJBPyr1oA67wxpk+n218b0QLNeXT3LwwMXji3ADapIUn7uScDJY1yNn4F1BNBttPnXTBJa6BPoyOjswkdljVZTlBtyEORzjPVq6PwLfarqXh+S51Oe3mnNxcRxske3ASZ0AYDrjaBxjgevNcZ4a8T61ZeEUvZ3gupo9Gg166adpWe5EqtmOLLYRh5TcAbcuoCjJNAG5D4OvY/ET3cxiu7aW7gvCzXssTRPHGiY8sIVfGzgll4bBHHN3xhoGpanqfn6fDp0sUumXGnSC7lZdnmsh3BQjbgApyuVz61oaHqmoajresRSQ2senWNwbZGV2MrvsjfJGMAYc9z26VkeILy+0jxJZTW1zczW92tyojaQOjypE7rEEAGwDyyd4zz8p6g0AZsvgC8NzeRfafOgnk86O8e9lSWBjCIt3lBSrsADg7l4OMcc62h6NrenXd7ei30iKd9PsbGGGOeQx/uZJi7E+WCAVlGAAeRg+tN8C3l2+oG3nv5r+GXSbO/MkrBtssplDEYHCtsBA6DBx1rtKACiiigAooooA84m+H902oyTrdQCNtQyEJbH2FpvtEkWMfeMpI9NoXn0bqXgzXdQvLuW4uLV2aG/hjlN1LhlnUiMeSE2R7flBILE4ySaluvHGpWKXiX1nFHel0W2tfJcYV51hWTzd2yVfnUnG05IXjORes/EOvXd7baW9pa2OoOtxM010h2SRxmMDbGrkqW80Zyx27SecigDS8M6LdaRq2sSypaNb30kc6yo58xWWCGIoV2425iLZ3fxYx3rmdd8G61qd5dS3V5GsZ+3BLmK4lLrFNDIiBbcKEDJuTJBLNtznnFaD+ML+IfangtGtJbm8s44U3ebG9ukzeYzdCjeScDAwHQ5OeIofF+qm4isZorEXl5HZS28qq/lxC58/hwWyxX7O3IK7iyjC0AUNNsdc1efUry0tItNV/sUQiJmthMkQk3qrPEskf30wwTtgHqQsfgHUzpP2WSSyyYbyPa00kgHnXy3Cgsy5YBBgk859etGn+KNY0/Sopb1opLVL3UFur9oXmVdl9LGqbVbdGm0cOdwAUA9M16VHLHIX8t1fY21tpztPofegDK0LS5dP1DX5pDEYb++W5hVM/KgtoYiGGODujY8Z4I75A45fA2owaDFYQLpkrzaQdKuDKzBYSScyx4Q7zzyp252LyMV6TRQBgeG/D66VqOs3kqW73N7deYs6rmUx+XGoV2wD1QnHTmqt7ouoaj4ntL24isra3tvNjaeGd3luIWRlEbIUCqNzB87m5QY6mupooA5LwfoGo6bcW8mqG0/wBD02HTYfs7s3mBCcyNuUbScLhRuxz8xrraKKAMbxZpUms6XDaxeVuS+s7k+b0KRXMcrjoeSqMB7kZwOa5qbwfqDs1upsUtorq+u4rgO3myG4SVRE67MBV80chjxEnHFdP4pvr/AE/S/O0q2FxcGVExt3lEJ+ZwgILkDJ2ggmuRXxxqd3PHHo9il+YbWO5uCkTR+bukkQqA7KYseU2SwbnjtkgHSw6HNYeCjpOj/ZLG9Fn5KSRxDy1l2bd2McjI7j8O1c7pvgzUV1VLy7+yqn9owXrRteS3RxHBJGTvdBk5ZSBgAAcYwKuSeKNT/sq51WNLD7Ib06fBA4YSI/2kW4kkbOMZyzKFBAHU0i+JNYm1RdHhWwF+t3NavdNG5ibZBHMGVN2ekgUjdwQeTjFAGfL4J1RdOubWI6bN9stLqxk852At0knkkV0Gw7jiQZX5QSi/Nxmr03hK8a4vo9tjJbT6tbaiJpHPmMqeVvRl2Yz+7JBzznoKypfF+pa7o2nXtiYbC3NxozTp8zSv9pmgZlVgQAm2Tacg7vmHGK6Lw94kurnVby11tYLF0Rpo4WjZcRiTaGEpJSQEFTkbSCwBFAGHe+BdQe6lmDW9zFK98jWpvJLZfLnm8wfOqNyRwy7cHg5456Twv4cXSdS1m9nhtTcXk8TRSplpFiS2gi2MxGfvRucZPBB6kiukooA5m90rUr3xVp1+0Vjbw2UrkXEc7tNNEUZfKKFAoG5gxO5vuDA54q+DvDd/pM+nC/a08nS9NXS7YwSMzSoCvzuCoCnEacAtyW56V2FFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWP4hudKtZdNuNW3GaCdpbRY0kkfzPKdGIRAS2Ed88EDOfQ1sVgeL9AfX7SGKKa2gkjZmWWWF3ZCRjKMkiMje4P4UAWh4h0ptRSxF2puHKqAFbbuZdyoXxtDFSGCk5I5xUWpeI7LT9Zi0uZZzdy2z3SbYyUKqQCCw6HJ+nv0zl2/hCaG6VW1RprA3UN9KksOZpJokRQfN3AbSY1YjaTnPODgaeq6JLd63b6jb3aQlLWazljeEvvSQocqQw2kFO+Rz0oAr6J4w0zVNHS+RplYW8M8kAgkd1Ev3doC5cZyMqCCQfSpIvFulS6pp1jDJNJJfxzSRMIW2qYpEjdHBGVbc+MEcbTnHGcebwNI1pbRQ6psaCws7I7oCUlEDMx3qHBKtuwVyOnUjipdB8GS6Ld6dcWt9bK9s14HjSz2RNHcSxyMqKH+QqYlAOSMZ4oA39U13TdLuI4L+6WKR1342swRc4DOQCEXPG5sDPemxeIdLm1X+zo7sNd+Y0W0I23zFG5k3Y27goJ25zgZxis3xJ4Xk1e51Bob5beDUrFdOvY2hMheEGQjY24bGxNIM4bqOOKdF4X8u/tbn7ZnyNWm1Tb5X3vMgli8vOeMeZnd7YxzkAFy98QW1lryadd4iV4UlWZm43PKI1THqWIGffFJc+JtLtrySGW6jVIYp5ZpSwCxeUYg4Pfjzl5HA781Q8W+Hm1FdUu4w88sumPaRW0ZCMZN29GVycKQ2ME9CM5rPn8BtcaRbW0mobbhdNu7O4l8rd5s1zJDJJN1H8cTHb/ALfUY5ANZNZ0A3EurrK5ugV08/upTLnHmCNYsbskHd8q/MoB5AGNvTr621Kyiu7GVZraUZRxnBGcd65PXvD93b6lJrOlma5vjfpdRwpCjBB9m8hgweWMMMZOQwIJHBGc7PgrTrnSvC2n2d/t+1RoTIF6BmYsR+GcUAbdVtSks4rCdtTe3Sy2FZjcECPaeCGzxg5xzVmsXxbpcmraWsMESSTxzJNGWuGg2MpyGDqrYIPPKkHvQBJHNoME9hNHJpkc1xELe0dWjDSR8EJGe69DgcdKq21l4Vsri5tLW20O3nhCTTwxxxIyBGDo7KORtbDAnocEVysngfV5XSS/mt9Qee0jtrlftb2oUpI7gjy48Sf6wdk+Zc8bsLfl8Lam2k3WmeVpjxfbmv4rp5G3zE3Qn8uRNnAYDYzBmyB07AA6O3utAsLSTULe40u2trpjK9zG8aJM2eWLjhjk9c1Q1yXwtpi6RHf22mM6SQW+nweVGXQPIkaeUp6KCy/d6Ae1UtP8LXn9vw6pfLZLuvJ7uW3jcuse+COIBCUGc+WWJIHLnrWRpngjWbLSdPsGfTp9n9kNPO0zhozZtCXRBsO5T5TFSSvLnI5zQB3thc6Y93eQ6fNZtcrJuuo4GUuHwBlwOc4UDnnj2ot9H0231CS/t9Os4r6XPmXCQKsj565YDJzgflXL6JoOuaNc30liLBLYxsLW0kuXlQSNJuLbzGHjU5Py5cZPbHPbUAU9O0uw0xZV02xtbMStvkFvCse9vU4AyauUUUAFFFFABRRRQBmw6DpEK3aw6VYRrdgi4C26ATA5yH4+bqevqajbw3obWaWjaLphtUcyLCbWPYrHgsFxgE+ta1FAFAaNpYu5roabZC5mQxyzCBd8ikYKs2MkYA4PpSz6PplxFJFPp1nLHJGkLo8CsGRCSikEchSzEDoCTjrV6igDL/4R3RD9nzo+nf6MxeH/AEVP3TFt5K8cEt82R3561et7W3tjMbaCKEzSGWTy0C73OAWbHU8Dk+lTUUAFFFFABRRRQAUUUUAV9QsbTUbY2+oWsF1bkgmKeMSKSOhweKqT6Bo1xHax3Gk6fKlqu2BXtkYQjjhAR8o4HT0FadFAGc+h6S9zc3D6XYNPcqUnkNuhaVTjIY4ywOBwfSpbTStPs1gW0sLSBYCxhEUKqI933tuBxnvjrVyigDMOgaMXtXOk6eWtUjjgb7MmYVQgoqcfKFIBAHQjiiPw/o0aXSx6Rp6rdf8AHwFtkAm5z8/HzcknmtOigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACuO+ItzHa3XhSSbUl0yH+1XD3TMiiMGyuu75XrgDIIzjiuxqCe7gguLaCaVUluGKRKerkKWIH4An8KAPK7/xxqsFnYP9rSK8jiilaOcxxJextOyB0QozuWRdxClAu4cnpVjX9cnvPDuvNPqqm/ilkT+xkEavEiXAVG5w+WUKdzHad4xgYrt5vFmiQrAz36FZo1mVlRmHlsSodiB8q5BG44FMvfFNjb69p+kxb5p7m6a2kdVYJCVgkmOXxtJxGBtzkbgaAG+CNVuNX0uee/lj+3rcOk9oq7TZsOkLd2IGDu6NncPlIrlfhVqd3e3ERv8AVHJn0jT7mKxdsjDW673TdliN2cnJ5PPNdaPF+g/Zpbh9Siigj2EySq0akOcIylgNyseAwyD2NaR1OzFvZTtOqxXjKsDMCN5YZUexIHegDg/E3i/W9H1PWUit45rXTSZm/d/M8UsSrbge5n80H2T3qvql1dnxFbW11Lvkt9WEbMhIDE6POxOM4A3c4GK7afxTosEgSS/TO50YqrMqbXMbFyBhVDgrubAyCM5q5Hq1jLLFHHdRs8s0lugB+9Imd6/UbW/KgDiNUn8r4Q+HZ3uhbYbRme4dgBGPtNvliTxgDJOeKzb3xbrCLFDDqdslg0t0sGsTvFElzs8vywXKmP8AjkBwAWEeVIwa9G0TWtO120+1aRdx3dtwPMj5U5APB+h/pWjQBV0qaW50yznuPK86WFHfySSm4qCdpPUZ6VaoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKx/EGkz6jcaZdWN3Ha3dhO0qNLCZUYNG8ZBUMp6PkHPUd62K5H4i6xdaNZWk1tfQ2kRdjNmWKOZwEJCxGUbCc4JBwSOhFAFWLwEU0SfTzqWTLpEel+Z5GMbGdvMxu77/u57dasTeDZJr+MvqCf2Yl/Pf/AGfyD5paaCaJ18zfjGZmYfLkYxz1rCtNUv4tbv8AUbe7mWGbUtOgktZYVXcs0EKsWByysN2QARgg5zUEHjLVV0+G6F9DcSNaJdajEY0A0uTz4VeJscgbHm+/k/uS2ccAA2tN8AfY4rWP7VY/6NJbMksViUlkWGRXAdvMIJO3qAoyScdhveNrC41LwvfW1hGXvyqvakMF8udWDRvk8YVgrH2B4PSuN1TxJcX91Z3lg0d8tnrtxHaLAciZV0qd1XI+9liefpWaviK8t73V9Q0/V49TaWw0pZbv92I7UPPdCQ/KuFC+rg7cgtkA0AdXceBR9gksrLUPJtbvTU0u+8yEyPPGpkJZWDDY586XLENy2ccVatPClxb67b3f9oxtZW99cX0dv9mIfdMrhgZN+CAXJHyjjjnrWNoWt65qOqWFoNW054BDcXEk0AW485Y5Ywql12qGw5DFRjPQDtP4F8V/ao7iPWtSjuLhXt4/OieKS2eWXcAkLx4yMr91xvUFck7hQB1fhjS/7D8N6TpPnef9gtIrXzdu3fsQLuxk4zjOMmtKiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This maneuver should be carried out three times a day. Repeat this daily until you are free from positional vertigo for 24 hours.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from Http://www.charite.de/ch/neuro/englishL.htm",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_17_31002=[""].join("\n");
var outline_f30_17_31002=null;
var title_f30_17_31003="Sports mouthguard PI";
var content_f30_17_31003=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F68070&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F68070&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Activities and sports that have a risk of mouth injury",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Acrobatics",
"       </td>",
"       <td>",
"        Racquetball",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Baseball",
"       </td>",
"       <td>",
"        Rugby",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Basketball",
"       </td>",
"       <td>",
"        Shotputting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bicycling",
"       </td>",
"       <td>",
"        Skateboarding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Boxing",
"       </td>",
"       <td>",
"        Skiing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Equestrian events",
"       </td>",
"       <td>",
"        Skydiving",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Field hockey",
"       </td>",
"       <td>",
"        Soccer",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Football",
"       </td>",
"       <td>",
"        Softball",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gymnastics",
"       </td>",
"       <td>",
"        Squash",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Handball",
"       </td>",
"       <td>",
"        Surfing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ice hockey",
"       </td>",
"       <td>",
"        Volleyball",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inline skating",
"       </td>",
"       <td>",
"        Water polo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lacrosse",
"       </td>",
"       <td>",
"        Weightlifting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Martial arts",
"       </td>",
"       <td>",
"        Wrestling",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    A mouthguard is recommended for children and adults who participate in any of the above activities.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Ranalli, DN. Prevention of sports-related traumatic dental injuries. Dent Clin North Am 2000; 44:35.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_17_31003=[""].join("\n");
var outline_f30_17_31003=null;
var title_f30_17_31004="Strategy breast ca screening";
var content_f30_17_31004=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F63099&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F63099&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical strategy for breast cancer screening in average risk patients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Age, years",
"       </td>",
"       <td class=\"subtitle1\">",
"        Risk per 1000 women*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Relative risk reduction (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Absolute risk reduction per",
"1000&bull;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Number needed to screen&Delta;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Harm&loz;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Strategy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        2.4",
"       </td>",
"       <td>",
"        Uncertain, probably 0 to 13",
"       </td>",
"       <td>",
"        Low to zero",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        61",
"       </td>",
"       <td>",
"        Discuss if asked",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        7.8",
"       </td>",
"       <td>",
"        13 to 23&sect;",
"       </td>",
"       <td>",
"        1.0 to 1.8&sect;",
"       </td>",
"       <td>",
"        1000",
"       </td>",
"       <td>",
"        44",
"       </td>",
"       <td>",
"        Raise issue routinely; discuss benefits and harms; use",
"patients values to help make individual decision",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        50",
"       </td>",
"       <td>",
"        12.9",
"       </td>",
"       <td>",
"        15 to 30",
"       </td>",
"       <td>",
"        1.9 to 3.9",
"       </td>",
"       <td>",
"        256",
"       </td>",
"       <td>",
"        22",
"       </td>",
"       <td>",
"        Raise issue routinely; discuss benefits and harms;",
"elicit patient's values and preferences; recommend screening",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        19.5",
"       </td>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        5.9",
"       </td>",
"       <td>",
"        169",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        Same as for age 50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        70",
"       </td>",
"       <td>",
"        25.3",
"       </td>",
"       <td>",
"        30&yen;",
"       </td>",
"       <td>",
"        7.6",
"       </td>",
"       <td>",
"        132",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"       <td>",
"        Same as for ages 50 and 60 for those with 8 to 10 years",
"life expectancy",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Risk for dying in the next 15 to 20 years of breast cancer diagnosed in the next 10 years. Data from Surveillance Epidemiology, and End Results (SEER) program, 1973-1980 and 1989-1991.",
"     <br>",
"      &bull; Number of lives ultimately extended per 1000 by screening over the next 10 years.",
"      <br>",
"       &Delta; Number needed to screen to extend one life at least 20 years",
"       <br>",
"        &loz; Number of procedures per cancer detected for first mammogram in excellent mammography practice.",
"        <br>",
"         &sect; From meta-analysis of Swedish trials and from Edinburgh trial (which studied women 45 years of age and older).",
"         <br>",
"          &yen; Extrapolated from data on women 60 to 69 years of age.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Harris, R, Leininger, L, Ann Intern Med 1995; 122:539.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_17_31004=[""].join("\n");
var outline_f30_17_31004=null;
var title_f30_17_31005="Ability of dietary modification to maintain normotension after discontinuation of chronic antihypertensive therapy";
var content_f30_17_31005=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F71815&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F71815&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ability of dietary modification to maintain normotension after discontinuation of chronic antihypertensive therapy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 367px; height: 251px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ability of combined nutritional intervention - weight loss, salt restriction, and avoidance of excess alcohol (squares) - to maintain normotension as compared to a control group without dietary modification (circles) after cessation of previously successful antihypertensive therapy. Hypertension recurred in over 90 percent of control patients but in only 60 percent with dietary modification.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Stamler, R, Stamler, J, Grimm, R, et al, JAMA 1987; 257:1484.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_17_31005=[""].join("\n");
var outline_f30_17_31005=null;
var title_f30_17_31006="Sulfonamide metabolic pathways";
var content_f30_17_31006=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F72628&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F72628&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 547px\">",
"   <div class=\"ttl\">",
"    Sulfonamide metabolic pathways",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 527px; height: 324px; background-image: url(data:image/gif;base64,R0lGODlhDwJEAeYAAP///wAAAIiIiICAgLu7u0BAQERERMDAwCIiIv8AAN3d3b+/v5mZmT8/P2ZmZn9/fxERETMzM6CgoO7u7vDw8DAwMFVVVczMzP+7u/+IiP8iIv9ERHd3d6qqqv9mZv+Zmf/d3UBm//8zM7/M///u7gAz///MzP8REe/y//9VVYCZ/w8//6+//x9M/09y/xAQECAgIODg4P+qqmBgYC9Z/4ig/8/Y/5mt/2+M//93d9DQ0CJO/9/l//Dz/z9m/5+y/5CQkBFB/7CwsNDZ/3BwcF9//1BQUMDN/xBA/zBZ/3+Z/8zW/3CN/+7x/4+l/y8vLyBN/2CA/6Cz/5Cm/1Bz/93k/1V3/3BzgKq7/4+Pjw8PD19fX2aF/xAsnzBT3wAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAAPAkQBAAf/gACCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5ufo6err7O3u7/Dx8vP09fb3+Pn6+/yjAf8AAwocSLCgwYMIEypc+K+fw4eqAqSTCLGiRVAUz2W8yLFjpY3lQHocSVKRyHEnS6pUmTJcy5UwOb78NjOmTYciFQTkIEiAAUgETgoAaEGBoQAEECF1tLQQ0qBMb0rtmDOAUQIRLEyCWogDggsAFBhI6pTsUbOVuDKqObVtvapG/wFcCDDBJwADPhEoiPDPQVi+ASwg+IeAEIQOhHQmDeoAoIKhASJcaPzv8T/JQRFH8LvUwj8IAJAODoAAgQAAEw4fdcu6H9xBSO0aiGDUgl8FEC5Y+ClILey4gxz4FR466VywDn4uPQ4gOYAOEHYLiq0XNgGuDApnP8S2tXd2r+XSlX0awOh/2RkM8i0IgnpCBCDoNLp0OwAChesXvr+/8YTpBBBnHVepYfWeU98l+JYh8923GQDkCWIbIdL1RldXCCQlVlKzaRUaYsxJFwCIAYAlXQcIGMAbdcA9dSGEEYDGnYI0xlMVQOVF+Jdje/1jwQR87RccQA4Y1UFTlFkWGf9ylUGGWYkTIMAZh58VByRpqAVQ3mo1dgkeLHatEt9/M3ppJjrdhYIbYqtEwJNSZ8YZ0kRy1ukSnXbmyU2a2vCp55/J+ImNoIAWOgxDiCaq6KKMNmToo5BGKqlNBxAx6aWTxmBEADpg6mmhFAzwzwwPMQDBPwZcoBZxCBwYFEA/CXBqYP8ZoGVYTXEQwHtD8brrq4VRFhlZ51n1qU0SvPDPCxQ4NMGIqFnAwKp+tbqesYIcqd5eWhkwmAKKoQaBij1FJshg6nElYGNgWXsspRUENMBDz255X0asuootABa8Kd4EBiRnQLimNihAaQR0YGu6FAnIL0/uvrvSDALBUBH/A7YG4MAE1JqnL0D4bTlfwEENxSFPeEFomgPS7nqvIA7bVSxwEndEcUBCcAQkB2r16/G1wPksyFwA++UZUjoBVNjBOoHmsrp+SQjxgTWXVABABVREQKqoRSBAvXK597OFwDHgMrd33fYPAQJEIEhqHRzM72lPNxx1Y0ZFXPVIEgRwdQAxVKTA0YEJYuo/bxYbFM2y+ljr3aJtybLcsE1LWHMASXZuQDTvDVHfEgAwg6Wel84a6KanfnoAoavu+k2ovy77SrHPbrtHtd+ue0W57+47P73/Lvw9wQ9vvDzFH698O8nHpEII0Ecv/fTUR6/C8rCz3toRK7Awwvfghy/+//gjsLDCEZ4fMMD67Lfv/vvwxy///PTXb//9+Oevf+uENA9TD0j4ASZ+gIQe7G0ADXiAAhfIwAY68IEQjKAEJ0jBClrwghi84Bay1j/ttSYERdBEEUJAj6YAYwAP+M4COCgI/8FEBTRAASJsgAMflOCGJfABDmyACBTQ4HrWuABgTGMI9iTChJ54VWSAYyvDBYRKGksEClXIQheuZAgr4KEhWNCCFuCABTwQBA9YgIMusuAQNjhfNXATNQF4CD7dQWInFncXD1HGcEJS2QTWhIgpemeFLfQga3oABScYAgUuWIEAE/GDFbhAhoVwAhQMOI22FcI5d/EKYXoUgDcdzf9pgFEPXrzFSZ4c7DKAQQx+0ANHo8iNA16jiNn+cRqhpewQfmwNIK24Eiq44JA0eCQjEBlDQ7iACtQQQNQGMZ/5cMUCWrkABNhWnemcRm6zqU00p8k0nZzGOWKDTiuB5ACmma0QZrvALQPWxxT+sQC8VMkUWgDJQfgwhI8oQjEJgYIWTKGSeRQEXjjgF664ywAMcFhxALCdWx6UAWFaik+S5phrXSZKAimLLe1FiFyyZgHK4h9rhlACLRLCBb+MBEoNYYMSDEEauPGQG/mTm3v9B5rioWaLktLQ8uB0LmxbUVLsIrYi7msQ5+SXekxVFwTsUTW4dGckJOooUIQpE0b/jMRVQ7GACuTMOz1IghK2uIJ6PgIF3TOEEpJASWhg5TLliQBvrqQXwLwpY07jaWFuWUoICdWv/Lkc0AyRVMgUNWPLNIRHBaGrvpCpLM9CSyZu2RPeIIKOzbHsIbIKia02Qo6MAOR3ouCDQ7RgkZL4QQsO4YMoZKNA1lgsdIwixM4BaC6k8GwhMIvJyxKKELr1hGhbI4WysnS1lWiBSe25AilgA5bXkO00CZFU4oimL/EJgNhm0xeGEkllqPwHYlIGmQD8ZJUuG2xmwxUUjp3Hr0MRC6rqIh/cZOc0cLOLsEQ5Gm9plz7XiYx2wQKZrxRiuG4ZAhJGcAgc4MASDj7E/wiQ8NJLLRZG2j1NdafEFQhoGAIAO+++zNZUcN3KOXgBKmDDKSMLBeQnxCGOh192sKE6FUingaXXGKqdpWnWAW4jl9mSQkQXccgB0gQLB94oCATLowYlsIIgdlADAJTgBoK4QQkkIVZE+OCMlWBBaQ+x1kUczrxgkS9pqLaWEnlXZYMgYiLKSxt1XHgQ0uzAhosDlQaFRiynmQ8DAGOViA71J3ixz0QFAhzenlc+VmkQVMIkIGWey23iMhBgG4ellHElZS6CmQNmKdhBODkeNQhCELBMZStjGQBajgQTaJCIEoSxEjzYMiJowIREPAsxE5AWACIQgf8MBSxMKc2bKf9nHo4WgnJuwkVwU7FYZf5HmgEG14NCDYAZywpggbYKAnhypMf8lTwh+klRd4stTHaoPdeUSJgONoEo5dhbOYpRZXWCGK/c5TSfpluARZ1kRJwaHjWgchCa0OorZ1nXhDiCCiZOcYozYQW3PgTEK7HxQvBgBVeAnwTAhucXPawQ8Qucljx8TmYTUeRwtjcmbBVuyUJoVj86BGUBa4hbgrYTi30rLQWq3W0P/D6n2m64lfQtQwM2ZZSRa2CxpF5MHokss+QLz+8yX3rPRT0klw1h9gpwioD66MQpb2IBcPB3JLwJQeBCw3F4Q0E0YQmCkHjFK37xjBui45MA/CA+HvL/94UOY45NqqiHJoiUhwaiWpK3QE4Dc7VP9lvhIoS2/sLkOWt2EDsfxZ2TMW1JjAkVbXdHwgEA5RJU2eGw3vINVC3lRcy61n6XRK4TwetG7Ixog+gXbiDgVJMwAKPyFpKcESE3IE9WYJkPvr+OM24AwBLcEIIV5tBD6iFz3bz/EXB6KzH6Y/AxE9FGPQvnsXoA7MD1rn44AKrQBAAEAe+L6DJrwUwJMSOizImwNWCBY+ZRbNkHFmARek6xVA3hcs4GXPvxIJdAMpFHALNUGMvXTNFRHSkmUT8WZOVBHfW2Y7fCbJRQfjaReu3Qflr2eq8Wa4KwBDvQCArGYIYQYZWA/4OFMGEVhgiDQxSCoGZ6Y2BH9B6DAWfn8oCDQDkKsHyUwE5HI1lC8y/exSaJth92wWlkByCVNiU8dgkoGBMqyA9VsANY4AjFZVaCYAPIRQnKdUjNxQkG4C++wE5JI1lmsy1ZERYbaBQdaCIDAy3+NocAQm8ypx9gKFVuZXbmJQqlBwljqA9leIaPQFqmhVqRoFqs5VqbQIjBwE6YY3Oc9iNNWEvFBnWXgWhj5127shQZYwDhp1eJ+IRD92yF02x89luJ0Fga81jX8hwg1gk794iPEIn5YAWqtmqOEFZjVQjmo4aNgFb8NwhOwFabICsQAAF0aBNhiAhzoQCmYgjYqP8ey8dZlDBbclFn7LZ1oUCMjmCM+HB3S4B/jkBSyyUIK6VSKUUILdWDmnABAOmL3KiIjwAku+FsB/NtRYZepoEXVvGK9YZXSKddbAYdaIFJrbI4AAF5S3IXgOEXpOYXpxQZqfRv2YcqU8dm77h+3jFPanhPkKBPL+lPhTIAFUAEQtAsikWQjkBOeqE39AYBDrCQXFFjeoRj7TUIM8ZUo6EebZNhmXUulgNYzIFiIlY246EX3hSVHXho3aYe4iQJ8BgTvgRMwrQIxASNx2QoooI1A3AAHcWTjbBkDJWNyNYTSzN03EZpbeQXuuJhfnZUhJBnGDmVdmEf+GGSgkZo5gb/IE8nAIoWiJwjliwJVoV0SImEiYbQSGdJCJLUVsqgPvozmqRZmvnzNwLxAkYABDHQjYfgFUbhADW1hPsxGAKXlPN2Y8v3jd4WjEu4MWFDTUhnmD+RboopbuRWaOeGaAJgnOs2CWMZE1h0j4LARV4ERmJERmaERmrUDKJpmuAZnuGJmgEBAzMgAaEil4xwJYERHwdCOWYjcHR1VRCpRAWVdGwmdLfShJHhHpPGG06SgEtXYMrpmBESdec1GgG1kl4CQ9C4hjVEdzpEnYLgQ0DElgChmqwZl1RkJiAkQiQEKQNQAG/ZTh3qJQCkmZNAQKD5Lq6pEtF5E9zjPeRTo+Nj/z7oc0DqeRMxehPPUz3Q4wVdAKTSc6FV86KHgCJ3SQw/B3pKuAieCJ2VqScHMKWyg6SGgACqpDQ2xwhcYY6bFUX3snaOyR1d6qS52JPTJaWQUqW/g6XUhWl0BF2RAKaK8Cr/0RhkulBmqgiUZaeEQFCU0KMK4qa+A6fB8SZ0hFOcBJLfxUmCQRhQQURwg15UExR4kRoPYqnCwp+kARbily74aZLXhSVHU2xC5CPZ0mKRQKgJYqi7g6gC9R5KNDD8chuz6V3BZllfmnxwxmJwdF/J4RfAKkfVV4KgsZQgdnZFaYBeY0mJ8Vuu+h2wqjuyehe0ahUFYx4BwQCD5hgR0/+rmRYBDEBRlQE0g6FORcJoSzEBwuKFGhkXD3mbDRMQReIZ5BqE0goDOlko1Xo71+oAimos1zchcZacg8OrF6IuCBCMzwk0skGsVAMtJDZsXuhvvYl9LmJsBvhs+xGWYhkAFdCvf/KvtnOtg0Y2AjUwjEmg2uY4QcIVWzl1eYRZaUOz28dJUhIakjqRSmclQcIvG1le7yGo0FkBSEuyeWKys3Ot5sEm5wBbUkoBSQsoTHulO8oISooOUUqZAEC1I1uyVvo6TmsRogW2ShsnV0u2WSuGLIS2Szu2rlO2FYFgcFsnazu3bQsTTna3aiu3qkO3EHFqfmsmeRu4jZK4irv/uIzbuAkxpYXbJYerOwUAlwkSuTQyubdTuTSCua8KuJRruQriud6hubbDuTVCuqxhurODuqlbtZkLupsruq8btoUqu6dLu7Wbtm7BurLjul6CtjrwAoGzurjburrbJWCrLMfrEb77OsBruDhjvNgDANHbJcNbntSLPddbIzoAAwIxL23xvK7TvV0CBMqyLLy7EuSrOuarvDcTAKQyFe2bOu/rJTrwN50iFfVrOvdrJkIAA81bEf1bOv97JiV6EwXsOQdcveGwwHvTwA78DRBcNRI8Dm3puBq8wRosvtVQwTVzweIguNjwAB5MDSAsMSIcDiR8DSZ8DSn8LisMDi1s/w0vbA0xDAkYkACgsMMJgAH9MMOUkAEJwMPHUMPVcMMfzJIbkAAZAAAg8MOGIAMJ4AGOIMWGsMOEoAFF3MVPTAki8MVBrLsf0MUaIMaFgMWM8MMkIMUbgMaI8MaCoMaxgMTUoMQozMRcDAJRDMSFsAEbcAIk0Ah0PAhaXAiHbAkn4MdjXAgfoAGCkAEnAMdzzMiNYAJG7AhyfAsepUTqmAgKKFBPei9x0VuK4I6+ZSGVgMfT8K8b4AGA3MeFEMUmoAEfIAgpUMQnAABEnAAaYAIe0MUfIMi8LAKJbMhG/MYboAHBXMS3nAEawMUiQAImIAJFnALNrAEgYM1VzMtvnP8AZVzEVjzMRfzEuZwA0zwO0fvIg5ABIgAAGMDF4NzMCQACvSwCJrDDMgAAImDFPyzPsPzEvZwAwCzM4QzOblzEGzDI6OzMqNDJxmIAnddzo3yn7fZ5zIfRjgCojcDK0uDKHrDDRIwB4QzJ7uzNvKzNgmACJ2ACAJADKQAAWGzLAGDLxywIh7wBIgAChOAB7wzNIEACJ/ABJz0IUozNUNzS0GzJZUwCG5AD7ZzOYazOZAzJOM3DQw0AMrDLUozJLg3LWn0CKbABlZzTGYDJliwIPg0Am/zD0EwCJDDVTpzSD62IdCQ3uyIl2eUe3Wep/xYUfJGrpAwzMLaRHtkXFFX/JB952FFEUcWmoH1mVyozGB1rCB4dDSANAOec1vJcxCDgAVYsCAftyzLtxxmwATIAyTcNz8n8xZJcxCZN1jX9ASCQyyJwy1Lc2eB82qLNzfWMAda8AQXdxaEdDuts1cUcxV1cz1LMzvBs1cE8yKVt1s4dyScA22z9xT8M2pHsz0Bc3aUA0QpATqHhIcqKfV8JjH/tiomlRCgZHEEWTSUSJhOCG+p0lcw0IuL6U9ykF6mhkoJw2dCQ2cptyTss3U8N1Cvd0oSQAPsMAEI91att1lDs4C8d24JA05EMyUdd3Chd01BNxTyNyx7gztJNDsdt3bec1Ua9z16t2WSd2oBc/9atjdaCEMX7nAOQ/NSV/NYkcMalDQDgTQoQfVELFZiAhiucgxdQ00qEfXOX43MQxRvFgjFLp04bKa4PFSZ6QwgC/gyZDQDBbMkeENOivctNnAC7PNBW3Mw8nQPEPOGtLQhpHs0fbssDjdtAvM1dbM+y3ct7XOcufc7gTNWObMa3/NzY7eb3nM8E/ePeTeEDbQJ1DsnhXMZAnOYLHeRDLnp2fVRNkbGe+JxMbjdOvl6CuIXlBq0GK8q4ogDO9yyW8x9Q8VOxQeXqUSGD8OXOkMOLsMl2IsTeIN6E0BR7zYC/oqDrvXhVp4qksVc4EjYaw0nz+urZhS50FdmIw3PWsv+mu37CrTzAlkDFJ14nwt4NdiyHFS0KCmPZ4P7R4u6+ybsO6d6J654KvO6d8W6/825ne0sO+c4Mvu4prrvajsDbQyzbvVDv0RDwyzDwmFLwmRwJCI/IE08ICF/xlYwLDA8NDh+a++6/omvwjaDxyIwIGa/wvFB+wKIKSpQhs/DxyQDxlyLx1vzLwzzIRY3TnY3SQB7FICDPtkzcyl3F0CzNDI0BfJ4AUL3D1szggO7S4Z21HJ1EBItpsSDzyEDzkyLxgx7TNK3hgnACTc/DvP3zv33xTZ3x2izUep4CMc3SGLDDme4BLO3SMG0KKMgVpNEXl3EvgxEd216YoRFKKen/5Iy62Lx4AQdzKgZYnwJWU4vfqIqg9cfA9ZIi8RvuzalNCEDP2j7/xEB/yB/g234eybJN0/+c6BvwAYcM2qON3J5u0dbUHFppZObxE+dE+CVYGMBqUeZVG7g6F1BriKZhiF4TFEf2IcE3/Ilg+caA+ZGi+fxsxREOx5PMy2ZP1q+s/SBw4CCu1fVc1Aiv+hgA9wCA1q9v9wxe17S/UIYWcC/D+3plrvuyONta5ae0MWECCAYOgwAAAg4EAYWEAggBDhOOAZMMhZaXDwOXm5ydnp+goaKjhQcFpKipqqusra6vsK8FB5YYCbciIIU5JySbH7caCQAZGwC2CSIJICTK/xoZwcsmJwkexYUaHwAJGCDKCTnHwwAeHsS31bGkAw+giYUBBIYG8ATvAAYCAO+N+xCV8QAwQADgX6dECgBwiDDBgoNO/wTQUxARwYRIAu4RsvTP4ahM6kKK/GRqpMmTKFOqjDUr1IYMnzJoWEmzFbtPiQIQDCix3r18+xQpcBTBYMCB+yQRtISwkAEDCiJMCnABwiSGAqZacDrJwASNkKwGYBh1akJPIGuqHVVyrdu3cONyavlJRgJfm6AlOIFBrt9CN/+K7FkzrWC3bQ8rXsw4FN3GkD0FjryKME3DlE8mzsy5c83HniFPDs0YM2lYm0+rXq0KNOu/o1/LNS07Vf/q2rhru4YFrBW3Qr85x869ljbxULePK/e822/w0AOmSp9Ovbr169iza9/OXbum5WxPgR/fubklb7dSANhwawMJW8pOmAA2zIMxANnOtccfzIQHdCD8xl4C7sG3lwnkJaigKskt6CBc5hWSwn3EaEBCMxnY0tcG5thCzn3ZmJCADMRQiF84wXEj04UiZCigOQ/GKCMADc5o40kR4qdNIeUUkoEHHpLTYX0gfvDBTCWS8N8t5qSIQY/EADkOlDdWuVyNVmbpSo4TWrIiCc8E2aOHMh1zwgciIjghML6I0CSJ22DwZZhTwqjlna9hieeeouSIXgLqDVhgneIAAIIwIpz/SU4wG/ypgTlLBrhhe+8RyuelnumJ6aaW5LhKBieEkoKdnJZ6pXimpnqJp6gEmABMnQyYi6q04qZprXeyiuuue97Ka5W6/irsjb4OK2Owxia7YLHKkhfDAAPAMMMAQDRr7bHTxXDtjdMZse23CUY3VQXgzmiEdNWWqy5xOkhHxLoPAiGdDvDWK9sLUwlhr4LtTgLDvgCfdu4kFARMHr4BzGDwwpnJGwCqDB83wyQSRGzxYjFM8t3FuUlAMMcg+wVDALSEXFvG5Jqs8lozvLBybTC8+/LMKUngLc2rEaEvzjyHREG6PYdWctBEF2300SpRcMDSTDft9NNQRy311FRX/2311VhHTe+DSmft9ddghy221FsjvdYBWjSg9tpst+3223DHLffcdNdt991uPwGxgmjj7fffgAcuONx6m41YA/susHeCByD+reKGn+14vZA/2Di4lUdO0+X2Zr7s5Nd6rnlKnDNmGSo8TbLS6Z6Izjjo1ro+ukmlW5LVVgAgoE8hWcnDCQcBVCLKPZywDvwkkHQSzwQBjQSU7fSEIvt4tSv4vCesrzL97CFVbwgEBuleCAOT+H7JBBA8NQrxm5zeAQQJXRDBWZvEc4EiNGXPyfZXwg7AJBcQCP5Sob9OXI8TiXhIUBS4iQNewoHtowdQmocK/nEPNf5rhAAggBEAvP+vAxS0BAPgF4CElCUAW7HAVSIxCQSID30dcB8EzAcAB0QPAQAhgCQQYRWDGEAqjxAg8gwhiQgAsQP40EdWupIUSuxvceTxnk4IQr7KRA8WOZlADYPICQg6ZXfYu+L/aDgKC17QFd5rBPocoLtEEEABAXHAEA3AgSQCwAJXFABDABCBjOAPKUhhnR4DAAF92LAQOBzjPQopEA6qrynjC8AEGqEAOBpSggK4nzx6YpD3PTFGUtygAKp4wjomQioQCKAl4Ii8UuIjAh5MJVCWSBWmBCAf6IvAQ3RICfJRQo5O/OEQCdDDSvQkH8AsoQrHMgH5TQJ3ljDjGVmRRoIs8RD/06EhK1uYO+FtcSqIwB/6CBABY4rxElXpwCG7qUihlBAeCgAKHBXAACCWkDA8wSRS5rHNSdCvENLMjRQZkJWs3HErVbFHQASxTQUQxgIInSEfLSDRfGgSgcHTnQ0f0kkI2PESDoClARBKFUaOcJKYHKMh9thHPbYOitPEYPGW4ggwwpGMLgUADPFouz0WIhFaXKlH53GJQ2gxof0gZg4XqURH6mOeCKgjCB0avXwm8X4B5KlBXgpK/wWPhYpIJD4YAJYIIlJ4BqgEHOuYxH1uAiGOuABDpxPP3W2Qm88L3jv/R1U7xlE6DlCACsu5iYDGFBXVjKRNQ5g7MDrAAidM/+FUGDABqRCEeXYVIzmn8lSiGEWhPy2mHee5REf0VaXHNORV6MFLnXzScl6thC8PCgBNlrWosKTtRSOgQnlYlLFB6asgCuJNfNQRjkjkAEGAMlVGbhClfkWiHoNa1KVEE6aHbYX34EJM6i7HsLUZKCKFAkRT4m8jlqjKI1w50u/JVYlTUWVwLTHc1lKREgZo4XI56w9CmtOOwBTsZGlZXACAN7vI8R9cIsDW8Rw4TwpO1oMR7IntYg67/bswhdVh4cdhWDkdHtaEN7wJC1OkwMoB7gPBCIqhILETI1ZNiIUVYxKXIsIOYCsABWhFUnjxp1xMoPLIaAkV01cf8WDfW/85COMPH2fGv6qxjbcLx6BOkceqKKAqsrhFBl7CyEb+oi1BQdjXOgjKvJIyibdbzyKLkpTlJSJRvLvNwJZ3KHVcyARmGV9b4hICumxi8JI5lBYGcCxOJKZ//WrfO66wEByA5iXUnKknLODSmM60pjfN6U57+tOgDrWoRz3qLDjZxqDY7iGKTNAAGBSitZ0hJdHHgIY+NKJvhIAFEJCQ3xI5EQM5xHA7qtJLRPV/TS2IPk46QdCuVIt9HN85AXrq3OigANjOtra3ze1ue/vb4M42vsJN7nKbO9wyQzU1FbxqeFBWEuwcK2HECr2zOkW2AXhxPtx6CbhSZa7SualOk/n/kIAgZK8lbLZGACvtJq/MYxVTN2w70WZ3C1G38Zh3gXMKa01SZNe9ziRwEXJMjhY33wKEdsHloVxlf2/PSFaoFqe7iUg73GQQl3hXO1Fli+eOvJOoo8Y3oV47B30o+rAAQ/i8YyDTr75K+eYJEVDwFspD0T6MeWVdu8zgFaLMha12vXKu84l3Ise76u7NOUb2sp85wieulYu5yvYARNztb0+c2MvVdrx/Tu8X67vf+RZhD1tM8INnnKVJzfjGO/7xkIe8qSOG+MST59rnzrzmzV2BAFRg86AP/bbTHbDKW15lFKhABQp2+k+YvvUmS/3qYc+J19M+ZLJn/e1tf3vc/6te963nfe99P/vg2334Rcv96YWP/Nj/PvHMb77zi+/26Et/+sBXt/Wvj32db5/73Uf198Ef/g2Pn/zlz+750Z/+aa6f/e3n3vvhH3/NzZ/+9Tfb/fGff6Ptn//9FzT/B4ABiDMDSIAF+DIHiIAJiHPHx4DZpXwC+IAQGIHPxzMLWIErI4Ezk4EauIEX+HAU+IEUxoEh44Ek+DImGHgjmIIbtoIMg4IuODMwWHotOIMkVoP2IoM4SDM6uC482IM+GII7eINCiGo/uC1BeIQ4k4TNsoRM2IRE+C1QGIVSSH1KaIRWqHNOyCtVuIU804W18oVgGIZTKCxkWIZmiIW/kv+GariG2YcrbviGcNiGWkiHgyeGezKHeNgzeqglfNiHfniGmBKIgjiIbHgphniIiBiHeLKIjNiIhXiHkQh7f7ggkFiJQXOJ5JGJmriJhCgjnviJoJiIMTKKpFiKjoiJlJiKw8eJtYGKrkg0sMgasjiLtBiKynGLuJiLpngcvNiLvriKuBGMwjiM4GGMx4iMwNiKywh+tdgYyviMyaeLoTGN1FiNv+gZ2JiN2kiMmdGN3viN11gI4jiO5CgBQyONCXOO6KiN8vIvkEEBI0Mx7+iC9DgVG7MY4jIJCnOPJOgxU/EC4PgWGTMdQAOQDBgDCDMV/6gYAzMJL5CQCsmAFED/BNNRNn9xANIxAwVZkfgXAwUwFXuXEp33MBoJkiQoBPW4M37hMTDgkiqJgwPwAjDwkSlBj/s4kz1IAdPiFzGgLTxphUI5lEZ5lEiZlEq5lEzZlE75lK7YHVI5ld4BleQ3QJlhHFbZe1hJGVq5lbTXlZHxlWDZemIJGWRZlpZ3lo2Rlmo5eGxZGjv5lrAnlv1kXazwPD8GCm5Jl25nl3sFC3v5EXPpl2vJCfNkS0gUaMvkURmFCJLAAL4UPEwXAYcGRCjWl4YpcYA5FQTxPjxFSUWGO8SmlyIXQIfkakTECZq5magGmP+0RVqEXirVTwm3O/u2FDqkUvxWCK3pmiQGkZuX0AEIoD6iWQ+FsFVOwVa/lVX0cBR46ZuFCZx/iZjSgQCJcAGR8BD5RUjF1mi+xACVeWjy0JsA8JvUiWBxuRjomZ6HtZ6K0Z7uOU3weRjyOZ8XVJ+CcZ/4OTv6+Rf82Z+a859+EaACajhUmaAKqo8H2qAO+qAQGqESOqEUWqEWeqEYmqEauqEc2qEe+qG8EggAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sulfonamide antimicrobial drugs are metabolized by oxidation of the arylamine group (shown in blue). Nontoxic metabolites are then excreted. Factors that slow metabolism, such as slow acetylator status or depletion of glutathione stores (in HIV infection) can affect the steps shown in red. This may lead to prolonged exposure to reactive metabolites and increased rate of hypersensitivity reactions.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Solensky, R. Drug desensitization. Immunol Allergy Clin North Am 2004; 24:425. Copyright &copy; 2004 Elsevier Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_17_31006=[""].join("\n");
var outline_f30_17_31006=null;
var title_f30_17_31007="Construction of a loop colostomy- defunctionalized distal limb";
var content_f30_17_31007=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F78445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F78445&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Construction of a loop colostomy- defunctionalized distal limb",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 361px; height: 355px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure depicts the matured loop colostomy with an everted proximal limb and defunctionalized distal limb. Full-thickness distal bowel is sutured to the dermis of the skin. The proximal functioning limb is constructed by suturing the end of the full-thickness bowel wall to the seromuscular layer 3 cm proximal to the colotomy, then suturing to the dermis of the skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_17_31007=[""].join("\n");
var outline_f30_17_31007=null;
